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ABSTRACT 
 
In-register, parallel alignment of similar or identical side chains is a common 
structural phenomenon in amyloid fibers. In the crystal structure of an amyloid fiber, 
these residues not only align, but take identical side chain orientations, creating long 
stacks of identical residues with identical orientations. This phenomenon of side chain 
stacking is a dominant component of the amyloid structure, and may take an equally 
important role in the seemingly sequence-independent formation of amyloid fibers or the 
sequence-dependent species barrier to amyloid transmission. 
Side chain stacking has long been observed as a prominent feature of the soluble 
parallel β-helix fold, which exhibits a cross-β structure reminiscent of amyloids. To 
investigate the sequence requirements of these stacks for directing a polypeptide chain 
into a β-helical fold, we performed systematic mutational studies using the complete P22 
tailspike protein, which contains a 13 rung β-helix domain. The in vivo folding and 
assembly of 150 single mutant polypeptide chains were characterized at multiple 
temperatures by SDS-PAGE, which distinguishes the fully native, SDS-resistant state 
from partially folded or misfolded conformers. The vast majority of the buried core was 
completely intolerent to subsitution at physiological temperatures, while only a few sites 
composing a continuously contacting network of residues called the folding spine were 
intolerant of alanine mutations at 18ºC. 
These results indicate that the β-helix folds through a processive folding 
mechanism, analogous to the nucleation and elongation mechanism of amyloids, but 
requiring recurring sequence-dependent stacking contacts that stretch the length of the β-
helix. 
Numerous avenues of investigation demonstrated that the observed folding 
defects of the full length tailspike were due to a sequence effect on the folding of the β-
helix domain. Alanine mutants capable of reaching a native-like trimeric state were as 
thermostable as the wild-type trimer, indicating that mutants affect a folding intermediate 
rather than the native state. In vivo folding efficiencies of eight β-helix folding mutants in 
the context of the isolated β-helix domain paralleled the folding of the full length 
tailspike, demonstrating that these mutants act at the level of β-helix folding. In vitro 
refolding of both full length and isolated β-helix tailspike mutants demonstrated that the 
observed mutant folding deficiencies were solely caused by the single amino acid change 
and not due to interactions with cellular components. 
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Folding spine mutations were further tested in the context of a suppressor 
mutation, A334V, which was previously shown to stabilize the β-helix and rescue classic 
temperature sensitive folding mutations. Most mutations could not be rescued by the 
addition of A334V, a number of which were in fact further hindered in folding by the 
presence of the suppressor mutation. Eight folding spine mutations located between rungs 
4 and 6 were rescued in a position specific manner, though only one of these positions 
directly contacts the suppressor. The pattern of rescue and hinderance observed with 
double mutants indicates that A334V is not a global suppressor and instead acts on a 
likely nucleus for folding. 
These studies provide evidence for a nucleation and elongation mechanism for 
folding of the parallel β-helix. Single mutations throughout the β-helix are capable of 
blocking this step-wise folding mechanism in a temperature dependent manner that likely 
leads to the population of a partially folded β-helix species that would be inherently 
aggregation prone. 
 
Thesis Supervisor: Jonathan King, Professor of Biology 
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A. PROTEIN MISFOLDING IS A MEDICAL PROBLEM 
 
In order for the human body to work properly, cells must not only synthesize 
proteins but must ensure that these proteins fold into the structure that allows them to 
perform their evolved task. The primary control of a protein’s ability to fold into a 
specific, native three-dimensional structure is the sequence of amino acids in the 
polypeptide chain itself. In 1961, Anfinsen demonstrated that a mammalian protein, 
RNase, could refold spontaneously without the aid of cellular factors (Anfinsen et al., 
1961; Haber and Anfinsen, 1961). 
Although RNase is capable of spontaneously folding in the test tube, Anfinsen 
and Haber demonstrated that folding yields dropped off significantly as the protein 
concentration increased to physiologically relevant levels (Anfinsen and Haber, 1961). 
Subsequent research revealed that a number of proteins necessary for the proper function 
of the cell cannot fold from sequence alone and require the activity of chaperone proteins 
to reach their native state. For example, the structural protein actin requires the presence 
of a specific chaperonin, TriC, in order to fold (Gao et al., 1993). Environmental stresses, 
such as increases in temperature, enhance the incidence of protein misfolding. In 
response, most tissues increase their production of chaperone proteins, particulary a 
group of chaperones known as the heat shock proteins (Whitesell and Lindquist, 2005). 
The failure of purified proteins to refold in vitro can be due to the absence of a required 
chaperone, other essential components, or to intrinsic limitations in the sequence control 
of folding. 
When proteins are unable to fold to their native state, they cannot perform their 
functions. The “natively unfolded” proteins may be an exception to this (Fink, 2005). In 
the case of the cystic fibrosis transmembrane conductance regulator (CFTR), the most 
common disease-associated mutation, ∆F508, prevents the protein from folding into its 
native conformation in the cell (Qu et al., 1997). The misfolded protein is retained in the 
endoplasmic reticulum and is quickly degraded before it can be trafficked to the surface 
of epithelial cells (Rowe et al., 2005). The lack of folded CFTR proteins on the cell’s 
surface leads to improper regulation of osmosis, which in turns leads to the symptoms 
associated with cystic fibrosis.  
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Although loss of function through an inability to fold can lead to disease, it has 
become apparent in the past decade that misfolded proteins may go on to aggregate. 
Aggregation can disrupt the homeostasis of the cell and lead to cell death and disease 
(Dobson, 2006). Although proteins may precipitate out of solution in a non-specific 
manner that depends on environmental conditions and protein concentrations, a number 
of protein misfolding and aggregation diseases have been discovered that depend upon 
the protein’s amino acid sequence. Diseases involving aggregation or misfolding of 
polypeptide chains are becoming increasingly common, particularly as the average 
human life span increases in the modern world. In order to develop therapeutics towards 
these classes of diseases, it is important to understand how polypeptide chains misfold or 
aggregate and how the amino acid sequence of these proteins contribute to the 
development of these diseases. 
 
1. Native-state Polymerization: Sickle Cell Hemoglobin 
 
Sickle cell anemia is a disease in which mutant hemoglobin aggregate through the 
interactions of natively folded proteins. A single amino acid change, a glutamine to 
valine mutation at position six of β-hemoglobin, causes native hemoglobin molecules to 
polymerize (Ingram, 1956). This substitution of a charged surface residue with a small 
hydrophobic group allows the association of hemoglobin molecules through the 
interaction of the valine mutant residue with a surface hydrophobic pocket comprised of 
F85 and L88 on the β-hemoglobin subunit of another molecule (Bihoreau et al., 1992). 
This interaction can only occur under low oxygen conditions due to the fact that the 
hydrophobic pocket is buried in the oxygenated state and only reveals itself on the 
surface of β-hemoglobin upon a conformational change induced by deoxygenation 
(Wishner et al., 1975). Since every hemoglobin tetramer contains two β-hemoglobin 
subunits, repetition of these sickling interactions with more hemoglobin molecules 
generates long polymerized fiber-like threads. 
As stated, low oxygen conditions induce polymerization across the erythrocyte, 
causing the red blood cell to stiffen and stretch into its sickle shape. This polymerization 
process proceeds through a double nucleation and polymerization mechanism (Ferrone et 
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al., 1985). In this mechanism, the first phase of aggregation is a homogenous 
polymerization that is induced by the formation of a slow-forming and metastable 
oligomer through the hydrophobic binding described above. Single unbranched fibers can 
then proceed to polymerize from this nucleus. In the second heterogeneous nucleation, 
fibers are seeded on the non-growing surface of pre-existing fibers, allowing for the 
generation of thicker, branched fibrils and gels.  
 
2. Loop-Sheet Insertion: The Serpins 
 
Serine protease inhibitors, or serpins, are the largest and most widely distributed 
superfamily of proteins that regulate proteolytic cascades (Irving et al., 2000). This is 
most typified by α1-antitrypsin, which controls proteases that are involved in 
inflammatory cascades. This superfamily also includes anti-thrombin, C1 inhibitor, α1-
antichymotrypsin, and plasminogen activator inhibitor-1. These latter proteins play 
important roles in the control of coagulation, inflammation, as well as other protease 
cascades (Lomas et al., 2005). Although quite functionally diverse, the superfamily has a 
high degree of sequence similarity and a conserved tertiary structure. This conserved 
structure is composed of three β-sheets and an exposed mobile loop. 
Inhibition of proteases occurs through a mousetrap-like system. The exposed 
mobile loop contains a peptide sequence that is a pseudosubstrate for its target protease. 
Critical residues (P1-P1’) in this loop act as bait for the protease, which cleaves the 
peptide bond between these two residues (Johnson and Travis, 1978; Wilczynska et al., 
1995). Upon cleavage, the mobile loop of the serpin swings the covalently linked 
protease over the entire length of the serpin, approximately 70 Å, while the reactive loop 
inserts itself into β-sheet A to form an additional β-strand (Huntington et al., 2000). This 
drastic change leaves the protease in a deformed and irreversibly inactive conformation. 
The resulting conformation of the serpin-protease complex is subsequently recognized for 
degradation. The large shift in conformation of the serpin is possible due to the fact that 
the serpins exist in a kinetically trapped, metastable active form. Upon peptide bond 
cleavage, the kinetic trap is released and the final loop-sheet insertion conformation is 
more thermodynamically stable that the initial structure (Carrell and Gooptu, 1998). 
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Point mutations in the reactive loop or the β-sheet region of the serpins can lead 
to distortion of the structure that allows for the insertion of the reactive loop of one 
molecule to lock into the β-sheet of a second molecule to form a dimer. This loop-sheet 
insertion oligomerization can ultimately lead to polymerization of serpins. In the case of 
α1-antitrypsin, the Z mutation (E342K) generates a structural distortion that allows for 
polymerization. These polymers may either be degraded (Wu et al., 2003) or accumulate 
in inclusion bodies in the endoplasmic reticulum (Janciauskiene et al., 2004). 
Alternatively, the mutation may lead to an early insertion of the loop into the β-sheet, 
generating an inactive latent confirmation (Silverman et al., 2001). Seeding has been 
shown to accelerate the polymerization of serpin proteins, indicating that a nucleation 
dependent process may describe this specific aggregation process (Crowther et al., 2003). 
Polymerization of the serpins leads to two medically relevant outcomes, one being 
the accumulation of the polymers in liver tissue and the second being the failure to 
secrete serpins that leads to plasma deficiency. The accumulation of misfolded α1-
antitrypsin in liver cells leads to the development of cirrhosis (Lomas et al., 2005). 
Neuroserpin polymerization and accumulation in neurons causes dementia (Miranda and 
Lomas, 2006). Deficiency of a number of different serpins can lead to clinical syndromes 
such as thrombosis, angioedema, and emphysema. 
 
3. Domain Swapping 
 
The loop-sheet insertion mechanism of the serpin polymerization reactions is an 
example of a broader class of oligomerization mechanisms known as 3D domain 
swapping. This general mechanism of protein oligomerization occurs when two or more 
proteins swap identical structural features, such as secondary structural elements, with 
each other to form dimers or oligomers (Liu and Eisenberg, 2002). This results in native-
like intermolecular contacts being formed in place of their intramolecular counterparts. 
Exchanged structural elements range in size and complexity. In crystal structures of 
domain swapped dimers of RNase A, the swapped components were single units of 
secondary structure, such as a single α-helix or a single β-strand (Liu et al., 2001; Liu et 
al., 1998). In contrast, entire domains constituting half of the protein may swap, as is 
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apparent when the native structures of the dimeric βB2-crystallin and the homologous 
monomeric γB-crystallin protein are compared (Bax et al., 1990). 
Domain swapped proteins may exist in closed conformations, where all domains 
are partnered with another protein. Dimers and trimers have been crystallographically 
observed for RNase A (Liu et al., 2001; Liu et al., 2002; Liu et al., 1998), which have led 
to proposed models for tetramers and the notion of higher order domain-swapped 
oligomers (Liu and Eisenberg, 2002). Domain swapping may provide a functional 
advantage, as is the case for glyoxalase I where the domain swapped homodimer displays 
enhanced enzymatic activity in comparison to the monomeric state (Saint-Jean et al., 
1998). 
While closed domain swapping may result in functional proteins, aggregation 
may be a result of an open conformation of domain swapping where swapping may 
produce unsatisfied domains that can cascade into a monomer addition aggregation 
pathway (Rousseau et al., 2003). Kinetic studies on domain swapping have revealed that 
the mechanism of domain swapping is dependent upon the properties of the protein and 
that there is not a universal mechanism for domain swapping. RNase domain swapping 
appears to occur through a partially folded monomeric intermediate (Liu et al., 2001). In 
contrast, the cell cycle regulatory protein p13sucI requires complete unfolding of its 
monomer in order to generate a domain-swapped dimer from the unfolded state 
(Rousseau et al., 2001). The kinetics of domain swapping of p13sucI correlated with the 
rates of aggregation upon heating, indicating that aggregation may occur through a 
domain swapping mechanism (Rousseau et al., 2001). 
Domain swapping has been proposed as a mechanism for the aggregation of the 
human γD-crystallin protein (Flaugh et al., 2006). This aggregation is likely a strong 
contributor to the eye disease cataract, which is the leading cause of blindness in the 
world. The γD-crystallin protein is composed of two domains that display differential 
stability, with the C-terminal domain being more stable than the N-terminal domain 
(Flaugh et al., 2005a). Mutants in the interface between these domains destabilize the N-
terminal domain resulting in a proposed unfolding intermediate where the C-terminal 
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domain is folded but the rest of the protein is unfolded (Flaugh et al., 2005b). Since C-
terminal domain interface residues nucleate the folding of the N-terminus, aggregation of 
the protein may proceed through a domain swapping mechanism where the C-terminus of 
one monomer would refold the N-terminus of another monomer, which then in turn acts 
on another monomer resulting in linear polymerization. Oxidative damage can cause 
deamidation of glutamines in the domain interface, which destabilizes the protein and 
leads to aggregation, while fluorescent quenching of tryptophans in the crystallin may 
have evolved to protect the protein from cataract-associated UV damage (Chen et al., 
2006; Flaugh et al., 2006). 
 
4. Amyloidosis 
 
Domain swapping has been proposed as one mechanism by which amyloid fibers 
form. Amyloid fibers are insoluble protein aggregates that have been associated with a 
number of degenerative and deposition diseases. These diseases include Alzheimer’s 
disease, Huntington’s disease, Parkinson’s disease, transmissible spongiform 
encephalopathies, senile systemic amyloidosis, type 2 diabetes, and hemodialysis-related 
amyloidosis (Chiti and Dobson, 2006). Although the proteins involved in each of these 
diseases have dissimilar amino acid sequences and native structures, they all involve the 
formation of unbranched fibrils that display green birefringence upon Congo red binding, 
thioflavin T binding, and a high degree of β-sheet content arranged in a cross-β structure 
that produces a characteristic X-ray diffraction pattern (Nilsson, 2004; Sunde and Blake, 
1997). 
The basic structure of amyloids is a cross-β structure, where β-strands are 
arranged perpendicularly to the fibril axis at a regular distance of approximately 4.8 Å 
from each other (Bonar et al., 1969; Eanes and Glenner, 1968; Sunde and Blake, 1997). 
X-ray crystallography of short, fiber forming peptides taken from larger amyloidgenic 
proteins (Nelson et al., 2005; Sawaya et al., 2007) and NMR of the Alzheimer’s 
associated Aβ-(1-42) protein (Luhrs et al., 2005), have revealed atomic level details of 
the structure of amyloid fibers (Figure 1-1A). These structures and electron paramagnetic 
resonance spectroscopy have shown that a large number of amyloids form  
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in-register, parallel β-sheets, where identical residues from different polypeptide chains 
align in the β-sheets (Margittai and Langen, 2006). Alternatively, X-ray crystallography 
and isotope-edited IR spectroscopy demonstrate that some small peptide sequences form 
anti-parallel β-sheets, where specific alignments of β-strands in the β-sheets are observed 
(Petty et al., 2005; Sawaya et al., 2007; Silva et al., 2003). 
A common feature of the parallel β-sheet amyloid structures is apparent in the 
positioning and orientation of side chains. Not only do identical residues align in-register 
with each other from one β-strand to the next in a β-sheet, but the side chains display 
identical orientations with respect to each other (Figure 1-1A&B). This is a phenomenon 
known as side-chain stacking, which will be described in more detail in Section C2. It is 
apparent from all of the current atomic resolution structures of parallel β-sheet amyloids 
that stacks, such as aromatic stacks, polar zippers, and hydrophobic stacks, dominate the 
side chain component of the amyloid structure (Luhrs et al., 2005; Nelson et al., 2005; 
Sawaya et al., 2007). It is important to note, however, that in-register, parallel alignment 
is a base criteria for side chain stacking, which further requires that side chains have 
similar chi angles or orientations with respect to each other (Petersen et al., 1997). A 
hypothetical example shows how alignment of tyrosines can be maintained while 
stacking is disrupted in a reimagined amyloid structure shown in Figure 1-1C. 
Understanding the pathway that polypeptide chains follow in folding to these 
fibrillar structures is important for understanding the cause of cellular degeneration and 
disease, particularly because it has been proposed that the final fiber forms are not the 
toxic species in amyloidosis (Caughey and Lansbury, 2003). In this proposed model of 
toxicity, non-native oligomeric species that form “donut-like” shapes or early forming 
protofibrils may be toxic by either acting as membrane pores or by disrupting the 
function of membrane channels, while the formation of fibers may protect the cell against 
these toxic effects (Blanchard et al., 2004; Caughey and Lansbury, 2003). It is therefore 
important to investigate the kinetics and intermediates of the amyloidogenesis pathway. 
Amyloid formation follows nucleation and growth kinetics according to 
aggregation experiments in vitro (Harper and Lansbury, 1997; Scheibel et al., 2004; Serio 
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et al., 2000). In the majority of nucleation-growth models for amyloid formation, the rate-
limiting step for aggregation is the formation of an unstable nucleus. This nucleus may 
act as a template for further polymerization and conversion of other polypeptide chains 
(Petty and Decatur, 2005a; Scheibel et al., 2004). In aggregation kinetics, nucleation 
appears as a lag phase that precedes exponential growth of fibers. The exact mechanisms 
by which nucleation and conversion occur are highly debated. 
Different amyloids appear to reach a nucleation state via different mechanisms. 
The soluble human prion protein is largely α-helical and must convert to the primarily β-
sheet structure of the amyloid (Nguyen et al., 1995; Zhang et al., 1995). It appears that a 
refolding intermediate may be involved in this process, though the exact mechanism of 
conversion remains unclear (Prusiner, 1998). One model derived from a dimer structure 
of human prion protein suggests that domain swapping leads to the generation of an anti-
parallel β-sheet that may be important for the transition to an amyloidgenic form (Knaus 
et al., 2001). Domain swapping has also been proposed as a mechanism for β-sheet 
formation in the cystatins, the T7 endonuclease I, and in the formation of amyloid fibers 
from an RNase A protein containing a poly-Q stretch (Guo and Eisenberg, 2006; 
Sambashivan et al., 2005; Sanders et al., 2004). Whether or not complete unfolding or 
partial unfolding is necessary for these domain swapping mechanisms is yet unclear. 
In the case of transthyretin, amyloidogenesis proceeds from a partially folded 
monomer that is derived from the dissociation of the native tetramer (Colon and Kelly, 
1992). Alternatively, a number of amyloids are derived from natively unfolded proteins, 
such as the NM region of the yeast prion Sup35 and the tau protein that is associated with 
amyloid deposits in Alzheimer’s disease (Mukhopadhyay et al., 2007; Schweers et al., 
1994). In these cases, the generation of nuclei either proceeds through oligomerization 
and conformational rearrangements, or from a rarely populated conformation that must 
proceed to oligomerization. FTIR studies on small peptides have revealed that β-sheet 
rearrangements and registration appear to be important steps in the nucleation and 
conversion of amyloidgenic peptides (Petty and Decatur, 2005a; Petty and Decatur, 
2005b). This may be an important mechanism for nucleus formation independent of the 
folding state of the source of the amyloid. 
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Although most of the discussion above has concentrated on disease-related 
amyloidosis, not all amyloids are disease related. In yeast, prions have been shown to 
confer selective advantages under certain environmental conditions or stresses (True et 
al., 2004). Functional amyloids have been discovered in bacteria, where curli proteins 
form amyloid fibers to assist in biofilm formation (Chapman et al., 2002). Humans have 
functional amyloids, as best characterized in the case of Pmel17 whose amyloidogenesis 
is required for the polymerization of melanin (Fowler et al., 2006). Given the number of 
completely different proteins that are capable of forming amyloid under various 
environemental conditions, it has been proposed that the amyloid structure is a generic 
property of polypeptide chains that is independent of the amino acid sequence of the 
protein (Dobson, 1999). 
Although the generic hydrogen bonding of the backbone may be the primary 
controller of amyloidogenesis, side chain identities play a role in the aggregation 
propensities of polypeptide chains (Kim and Hecht, 2005). Amino acid sequence also 
plays a role in the existence of species barriers in prion propagation and the specificity of 
cross-seeding reactions (Tessier and Lindquist, 2007). Examination of the relationship 
between amino acid sequence and folding pathways that lead to β-strand conformations 
both in vitro and in vivo may lead to curative or preventative agents for these diseases. 
 
 
B. THE PROTEIN FOLDING PROBLEM 
 
When Anfinsen originally demonstrated that RNase could refold when diluted 
from denaturants in vitro, he proposed that it could do so because the native state is the 
conformation with the globally lowest free energy for that particular amino acid sequence 
(Anfinsen, 1973; Anfinsen and Scheraga, 1975). According to the Levinthal paradox, if 
the polypeptide chain randomly sampled all possible conformations, then proteins could 
take the lifetime of the universe to reach their native state (Levinthal, 1968; Levinthal, 
1969). In reality, proteins fold through folding pathways specified by their amino acid 
sequence that allows most proteins to fold on time scales from milliseconds to minutes 
both in vivo and in vitro. The essence of the protein folding problem is to understand how 
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a protein’s sequence encodes folding pathways as well as the final structure. 
Given the notion that the native conformation represent a globally minimal free 
energy, it has been proposed that many proteins may misfold and aggregate as discussed 
above due to the presence of kinitecally trapped local minima or alternative folding 
funnels in a protein sequences free energy landscape (Baker et al., 1992; Clark, 2004). 
The above discussion on diseases caused by misfolding and aggregation highlights the 
importance of understanding how the amino acid sequence encodes productive folding 
and avoids non-productive local free-energy minima. The discovery that severe 
neurodegenerative diseases like Alzheimer’s, Huntington’s, and prion diseases involve 
the generation of cross β-sheet structures demonstrates a particular importance for 
understanding the mechanisms of folding β-sheet proteins (Capaldi and Radford, 1998). 
 
1. β-sheet Protein Folding 
 
The sequence requirements for β-sheet formation are poorly understood. Recent 
Critical Assessment of Structure Prediction experiments (CASP5 and CASP6), have 
shown that current computational methods of predicting structure predict α-helices 
significantly better than β-strands when tested on sequences unrelated to known 
structures (Aloy et al., 2003; Vincent et al., 2005). The comparative success of α-helical 
predictions is in large part due to a number of biochemical studies that have elucidated 
sequence rules, such as the heptad repeat found in coiled coils (O'Shea et al., 1991; 
Woolfson and Alber, 1995), and general understanding for small, globular α-helical 
proteins like the four-helix bundles and globins (Kay and Baldwin, 1996; Kim and 
Baldwin, 1990). The elucidated sequence rules for α-helices have allowed for the design 
of new α-helical proteins (Ali et al., 2005; Lombardi et al., 1996; O'Shea et al., 1993). 
Without similarly detailed characterizations of β-sheet proteins, deciphering how amino 
acid sequences direct the folding of polypeptide chains will remain an unsolved problem. 
One problem in elucidating the folding rules for β-sheet proteins lies in the fact 
that β-sheets are inherently more complex than α-helices. β-sheets are high contact order 
structures, meaning that hydrogen bonding or interacting residues are far apart in 
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sequence but are close in space in the final protein structure (Plaxco et al., 1998). In 
contrast, α-helices are low contact order structures where each residue in the helix 
hydrogen bonds with a residue only 4 positions away in the sequence. This low contact 
order allows for the chain to overcome the unfavorable entropic costs of nucleating the 
helix by having a high probability of formation due to the proximity of residues that must 
hydrogen bond (Clarke et al., 1999; Laurents and Baldwin, 1998). According to helix-coil 
transition theory, this nucleus is the most unstable transition state in the folding pathway. 
Once formed, the rest of the helix can rapidly zipper into the helical structure. 
In contrast, the initial formation of β-structure may involve the interaction of 
residues that are hundreds of amino acids apart. This makes it more difficult to elucidate 
a generic pathway of folding for β-sheet proteins. Investigations on the folding of small 
β-sheet proteins, such as the Src homology 3 (SH3) domains of a number of proteins, 
have revealed that these β-sheet proteins appear to fold via a two-state mechanism 
(Capaldi and Radford, 1998). Phi analysis of small, fast β-sheet folders revealed that the 
formation of β-hairpins was primarily responsible for stabilizing the transition state, 
though this was not assumed to be sufficient evidence to state that hairpins initiated 
folding (Viguera et al., 1996). 
In contrast to small β-sheet proteins, larger β-sheet proteins have been shown to 
populate partially folded intermediates. One example is the cellular retinoic acid binding 
protein I (CRABPI), which displays a β-clam topology where two β-sheets surround a 
central cavity (Thompson et al., 1995). Mutational studies on CRABPI, in conjunction 
with fluorescence spectroscopy and quench flow hydrogen exchange, have shown that the 
protein folds in four phases. These studies further showed that the substrate-binding 
pocket formed in the second phase while the protein’s hydrogen bond network formed an 
order of magnitude slower in the third phase of folding, indicating that a near native 
confirmation could be obtained without the formation of stable hydrogen bonds (Clark et 
al., 1997; Clark et al., 1996). Gierasch and coworkers went on to demonstrate that β-turn 
and β-hairpin regions in CRABPI are encoding by local sequence rules, as two of the 
seven β-turns were able to form native-like structures when synthesized as peptides 
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(Rotondi and Gierasch, 2003a; Rotondi and Gierasch, 2003b). These β-turns participate 
in a network of conserved residues important for folding and stability and are likely 
amongst the first parts of the protein to fold (Rotondi et al., 2003). This indicates that the 
amino acid sequence of the β-turns conformationally restricts the structures of folding 
intermediates, driving the polypeptide chain towards its native structure.(Rotondi and 
Gierasch, 2003b; Rotondi et al., 2003). 
Non-native-like folding intermediates have been observed as on-pathway folding 
intermediates for the β-trefoil protein interleukin-1β. Interleukin-1β rapidly collapses to a 
molten globule folding intermediate that possesses 90% of the native structure’s β-sheet 
content, as discovered by circular dichroism (Ptitsyn et al., 1990). This collapse occurred 
on the order of milliseconds, while stable intermediates detectable by NMR did not 
appear until after 1 second of folding. Once stable intermediates were detectable with 
NMR, hydrogen-deuterium exchange showed that they had native-like β-sheets in two 
regions of the protein, indicating the formation of a more native-like folding intermediate 
(Varley et al., 1993). The authors suggested that these experiments indicate that the 
protein rapidly folds to a non-native β-sheet structure that slowly rearranges to a more 
native-like β-sheet structure. This indicates that β-sheets may fold through complex 
folding pathways that may include non-native-like conformations. 
 
2. Protein Folding In Vivo 
 
Due to the complexity of the cellular environment, protein folding studies have 
been almost strictly limited to in vitro refolding in the test tube. Since aggregation and 
off-pathway folding events have traditionally been considered nuisances rather than 
physiologically relevant, these in vitro experiments are often performed under conditions 
that minimize aggregation, such as low homogeneous protein concentrations and at low 
temperatures (Clark, 2004). These environmental conditions do not reflect physiological 
conditions in a living organism, where macromolecular crowding, heterogeneity, and 
cellular organization have profound effects on the folding and stability of proteins 
(Cheung et al., 2005; Minton, 2006). 
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Studies on the folding of the β-clam protein CRABPI have been extended into the 
context of the cell (Ignatova et al., 2007). Utilizing a fluorescence-based system known 
as FlAsH, the investigators determined the free energy of folding of the protein in vivo. 
The results demonstrated a close correlation between the in vivo and in vitro free energies 
of folding. However, kinetic rates for unfolding were altered in the cellular environment 
so that equilibrium was reached more quickly. The authors suggest that this may be due 
to the crowding effects of the cell. 
Fluorescence-based methods have further demonstrated that the ribosome 
interacts with the nascent chain it is translating to induce conformational changes 
(Woolhead et al., 2006). In turn, the nascent chain encodes sequences that interact with 
the ribosome to control the rate of translation. 
These experiments highlight the fact that co-translational folding of nascent 
chains occurs in a complex and interactive environment that is not accurately reproduced 
by refolding experiments out of denaturant. To truly uncover how the sequence of a 
polypeptide chain encodes the folding and structure of a protein in its in vivo 
environment, complementary in vivo and in vitro experiments must be performed on 
model protein systems. This is of particular importance for β-sheet proteins, which 
appear to have complex folding pathways that are often aggregation prone. 
 
 
C. THE β-HELIX FOLD 
 
The parallel β-helix, a structurally repetitive fold created by the coiling of the 
polypeptide backbone, is one of the topologically simplest β-sheet folds (Jenkins and 
Pickersgill, 2001; Jurnak et al., 1994; Pickersgill et al., 1998; Yoder et al., 1993a). Each 
coil or rung of the canonical parallel β-helix fold consists of three β-strands (A, B and C) 
interrupted by variable turn or loop regions (T1, T2, and T3) (Figure 1-2A) (Jurnak et al., 
1994). In most of the parallel β-helix proteins, loops may be large in sequence and may 
contain entire folding domains. Rungs are aligned, forming a cross-β structure of 
elongated β-sheets lying parallel to the helical axis. Structural repetition of coils creates a 
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cylindrical hydrophobic core. β-helices are often capped by α-helix motifs or anti-parallel 
β-strands in order to avoid exposure of the hydrophobic core and unfulfilled hydrogen 
bond donors and acceptors at the ends of the helices (Richardson and Richardson, 2002) 
Three main subclasses of parallel β-helix fold currently exist: the right-handed 
parallel β-helix, the left-handed parallel β-helix, and the triple-stranded parallel β-helix. 
The right-handed β-helix proteins coil around the axis of the helix in a right-handed 
fashion and are further characterized by the presence of a kidney bean shaped cross-
section (Figure 1-2B) (Jenkins and Pickersgill, 2001). In contrast, both the left-handed 
and triple-stranded β-helices wrap around the helical axis in a left-handed direction and 
have a cross-section that is triangular in cross-section (Figure 1-2C) (Jenkins and 
Pickersgill, 2001; Weigele et al., 2003). Examples of these distinct classes of β-helix 
folds are shown in Figure 1-3. 
A number of monomeric and trimeric parallel β-helix proteins display an unusual 
stability, whereby the proteins have extremely high melting temperatures, are resistant to 
protease digestion, and are stable in the presence of detergents (Jenkins and Pickersgill, 
2001; Weigele et al., 2003) 
As of this writing, there are 168 β-helix structure files deposited amongst the 
44,018 known structures in the protein data bank (PDB) (Berman et al., 2000). These β-
helix structures represent approximately 40 different protein classes. Overall, the β-helix 
fold is not a common structural fold (Bradley et al., 2001). The sequences of these 
proteins are quite diverse, displaying typical sequence similarities between any two β-
helix proteins of less than 15% (McDonnell et al., 2006). 
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1. β-helix Functions 
 
Known β-helical proteins are predominantly associated with disease or infection. 
Examples include a number of viral adhesin proteins, virulence factors such as the 
pertactin and hemagglutinin of Bordetella pertussis, and the major pollen allergen from 
the mountain cedar tree (Clantin et al., 2004; Czerwinski et al., 2005; Emsley et al., 1996; 
Jenkins and Pickersgill, 2001). A non-canonical four-sided β-helix fold, which displays a 
square cross-section, has recently been discovered that confers antibiotic resistance to 
Mycobacterium tuberculosis by mimicking the structure of DNA in order to protect DNA 
gyrase against fluoroquinolone inhibition (Hegde et al., 2005). Human retinitis 
pigmentosa 2 protein (RP2), mutations of which are the cause of 10 – 15% of X-linked 
retinitis pigmentosa (RP) cases (Hardcastle et al., 1999; Schwahn et al., 1998), contains a 
right-handed parallel β-helix domain. A large number of mutations associated with RP 
are located in the β-helix domain, many of which are in the buried core of the β-helix 
(Kuhnel et al., 2006). 
The most common functional theme in the β-helix proteins is the use of an 
elongated lateral surface to recognize an extended polysaccharide sequence. (Jenkins and 
Pickersgill, 2001). The structures of P22 tailspike, pectate lyase C, and chondroitinase B 
have all been solved in the presence of polysaccharide ligand and demonstrate the use of 
a cleft on one of the β-sheet faces of the β-helix to bind ligand, though the angle of this 
binding with respect to the axis of the helix depends on the particular protein (Huang et 
al., 1999; Scavetta et al., 1999; Steinbacher et al., 1997b). An alternative mode for 
polysaccharide binding has been observed in the cleft between monomer subunits of the 
trimeric β-helix inulin fructotransferase of Bacillus sp. snu-7 (Jung et al., 2007). In the 
crystal structures of ι-carragenase with and without a cell wall polysaccharide ligand, the 
β-helix surface acts as part of a binding cleft but the extended loops that emerge from the 
turn regions of the β-helix fold over the substrate to form a catalytic tunnel (Michel et al., 
2003). This motif of binding long molecules is not limited to polysaccharides. The non-
canonical two-sheet left-handed β-helical collagen binding domain of YadA from 
Yersinia enterocolitica appears to bind human collagen in a similar manner along the 
long lateral surface of its β-helix (Nummelin et al., 2004). 
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YadA from Yersinia enterocolitica, P.69 pertactin from Bordetella pertussis, and 
hemoglobin protease from E. coli are all β-helical autotransporters, whose folding and 
toxicity is coupled to membrane translocation (Emsley et al., 1996; Otto et al., 2005; 
Roggenkamp et al., 2003). The β-helical filamentous hemagglutinin from B. pertussis 
must also couple its folding to membrane translocation, but does so through a two-partner 
secretion pathway (Clantin et al., 2004). In both transport pathways, outer membrane 
translocation is ATP-independent and proton-gradient independent (Henderson et al., 
2004; Thanassi et al., 2005). It has been proposed that in the case of pertactin, a vectorial 
folding of the β-helix structure may contribute the requisite energy for efficient energy-
independent translocation (Figure 1-4) (Junker et al., 2006). Greater than 97% of 
autotransporters have been predicted to be β-helices, implicating that the energetic 
coupling between folding and secretion may be a more general phenomenon (Junker et 
al., 2006). 
Multiple computational methods have predicted the existence of hundreds of 
additional β-helical proteins that are largely associated with infectious disease, 
pathogens, or allergens (Bradley et al., 2001; Ciccarelli et al., 2002; Jurnak et al., 1994; 
McDonnell et al., 2006). Given the rarity of currently known and predicted human β-
helical proteins, this fold represents a potential target for novel therapies against 
pathogens. Since a number of these potential targets are likely to fall into the family of 
autotransporting virulence factors, not only is the native state a target for therapeutics but 
so are the folding intermediates that contribute to the virulence factor’s secretion from the 
pathogenic cell. It is therefore critical to not only know the native state of the β-helix 
proteins, but to understand their sequence-dependent folding pathways. 
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2. Side Chain Stacking 
 
When the β-helix fold was first discovered upon solving the crystal structure of 
pectate lyase, it was noted that the side chains of the β-helix structure formed linear 
stacks that included asparagines ladders, serine stacks, aliphatic stacks, and aromatic 
stacks (Yoder et al., 1993a; Yoder et al., 1993b). As more β-helix protein structures were 
solved, it became apparent that the existence of elongated stacks composed of aligned, 
similar side chains with similar orientations was a prominent feature common to all β-
helical proteins (Jenkins and Pickersgill, 2001). “Cupped stacks” of aliphatic residues, 
aromatic stacks, and polar zippers that are nearly identical in appearance to the side chain 
stacks observed in amyloid structures (Figure 1-5C, Figure 1-1, Section A4) have all been 
observed in β-helical structures (Jenkins and Pickersgill, 2001; Petersen et al., 1997; 
Raetz and Roderick, 1995). While side chain stacks in the currently solved amyloid 
structures are always composed of identical residues, the side chain stacks observed in β-
helices are often composed of similar side chains that continue to exhibit similar 
orientations, in spite of a lack of sequence identity. Although stacks are composed of 
similar residues, structurally repeated rungs do not exhibit an overt sequence repeat nor 
do they exhibit sequence similarity across β-helical proteins (Bradley et al., 2001). This is 
particularly true for the right-handed parallel β-helix proteins, while the left-handed β-
helix proteins sometimes display a mild sequence repeat. In the right-handed β-helices, 
identical residue stacks of more than four rungs in length are rarely observed. 
It should be noted that stacking of residues in parallel, particularly aromatic 
residues, is not a common feature in the buried cores of globular proteins. In the case of 
aromatics, edge-to-face orientations are more common in non-β-helix proteins (Burley 
and Petsko, 1988). In the context of the β-helices, aromatics do stack as if mimicking the 
stacking of bases in DNA. This can be seen in an aromatic stack composed of twelve 
aromatics in the buried core of the chondroitinase B protein (Figure 1-5C, left). 
When examining the structures of β-helix proteins in the protein database, I 
noticed that side chains that point into the core of the β-helix tend to be aligned in well-
organized stacks, where as those side chains that point out into the solvent tend to align 
 37 
 
 
 
 
Figure 1-5. Side chain stacking in the buried core of chondroitinase B. (A) Inward-
pointing, buried core residues are shown in sphere representation on top of the ribbon 
diagram of the chondroitinase structure (PDB ID: 1DBG) (Huang et al., 1999). Each 
stack is colored individually. The image on the right is rotated by 180º around the helix 
axis relative to the left image. (B) Cross-section of rungs 3 – 5, demonstrating the 
organized stacking of side chains in the core, as opposed to the solvent exposed exterior. 
(C) The green and yellow buried core stacks in (A) are shown in sphere representation 
absent the rest of the structure. 
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poorly in their side chain orientations (Figure 1-5B). We found this to be particularly true 
for the right-handed β-helices. The organization of these buried core residues is likely an 
indicator of their packing constraints, which may indicate that they play an important role 
in encoding the conformation of the protein. 
One notable exception to this observation is in the group of insect anti-freeze 
proteins, which are left-handed β-helices. These proteins display a high degree of well-
ordered side-chain stacks on the exterior of the protein. In particular, one β-sheet of the 
spruce budworm anti-freeze protein displays nearly perfect threonine stacks on its 
exterior face (Graether et al., 2000). It has been proposed that this stacking has an 
evolved function, whereby the geometry of the threonine stacks mimic the lattice of water 
molecules in ice, thereby allowing the protein to bind ice crystals and prevent further 
crystallization. 
Side chain stacking is a dominant feature of both β-helices and amyloids. It is 
unclear how this apparent one-dimensional crystallization contributes to the folding of 
these proteins, but it is clear that it plays a crucial role in their final structure. 
Understanding the contributions of side chain stacking in the context of the β-helices may 
lend clues to its role in amyloids. Due to a number of common features, the β-helix fold 
has been proposed as a model for that of full-length amyloid protein fibers (Kishimoto et 
al., 2004; Lazo and Downing, 1998; Perutz et al., 2002; Wetzel, 2002; Williams et al., 
2004). In one such model, the NM region of the yeast prion Sup35 has been proposed to 
form β-helical units that interact in a tail-to-tail and head-to-head fashion in order to form 
a fiber (Figure 1-6A) (Krishnan and Lindquist, 2005). A head-to-head assembly has been 
observed in the crystal structure of the globular, soluble potato ADP-glucose 
pyrophosphorylase (Figure 1-6B&C) (Jin et al., 2005), indicating that experimentation 
into the folding and structure of the β-helix proteins may lead to a better understanding of 
β-sheet formation and the assembly of higher order structures that underlies 
amyloidogenesis. 
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D. P22 TAILSPIKE 
 
 
1. Structure of the P22 Tailspike 
 
The tailspike protein of Salmonella phage P22 has been one of the principal 
systems for studying protein folding in β-helices (Jenkins and Pickersgill, 2001). The 2 
kilobase long gene 9 in the phage P22 genome encodes the tailspike’s 72kDa polypeptide 
chain (Sauer et al., 1982). Three of these 666-residue polypeptide chains come together to 
form the multi-domain native structure of the tailspike (Figure 1-7A) (Steinbacher et al., 
1996; Steinbacher et al., 1997a; Steinbacher et al., 1994). At the N-terminus of the 
homotrimer is the head-binding domain, which allows the tailspike protein to assemble 
onto the tail machine of the phage particle but is not necessary for the folding of the rest 
of the protein (Chang et al., 2006; Danner et al., 1993; Lander et al., 2006). 
Subsequent to the N-terminal head-binding domain, each polypeptide chain 
contains a 13 rung, right-handed parallel β-helix domain (residues 143-540). This β-helix 
domain includes the globular dorsal fin domain, which sticks out of the β-helix at turn T3 
of rung 3 (Figure 1-7B). Tailspike’s β-helix is capable of recognizing the O-antigen of 
Salmonella’s cell surface lipopolysaccharide and cleaving it via an endorhamnosidase 
activity (Seckler, 1998). Upon binding, the long, floppy O-antigen sits in the elongated 
lateral cleft of the β-helix, located between the dorsal fin and the ventral fin (Figure 1-
7C). This binding mode brings the polysaccharide into close contact with the active site 
residues D392, D395 and E359, which are capable of cleaving the α(1,3)-O-glycosidic 
bond between rhamnose and galactose in the O-antigen (Steinbacher et al., 1997b). 
Although this endorhamnosidase activity is not necessary for phage adsorption, it is 
believed to help bring the phage to the cell membrane so that DNA injection can occur 
(Berget and Poteete, 1980; Israel, 1978; Iwashita and Kanegasaki, 1976). 
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C-terminal to the β-helix domain, monomers wrap around each other to form an 
intertwined β-sheet domain where each chain’s residues contribute to a single buried 
hydrophobic core, consisting of one rung of a triple β-helix (residues 541-557) and a 
triple β-prism structure (Kreisberg et al., 2000; Seckler, 1998; Steinbacher et al., 1994). 
The ultimate step in tailspike’s productive folding pathway (Figure 1-8) coincides with 
the folding and assembly of this interdigitated region to form a molecular clamp that 
makes tailspike resistant to trypsin degradation and SDS denaturation, and raises the 
melting temperature by approximately 40°C to 88.4°C (Goldenberg and King, 1982; 
Kreisberg et al., 2002; Sturtevant et al., 1989). Because of the native structure’s SDS 
resistance, final native structure can be easily separated and identified from folding 
intermediates and aggregates by SDS gel electrophoresis. 
At the far C-terminus of the homotrimer is a region of the protein called the 
cysteine annulus (Figure 1-7B), so called due to the total presence of six cysteine 
residues, two (C613 and C635) from each polypeptide chain. 
 
2. In Vivo Folding Pathway of P22 Tailspike 
 
Extensive studies of the in vivo folding pathway of tailspike have revealed a 
number of long-lived, partially folded intermediates (Figure 1-8) (Betts and King, 1999). 
The first of these intermediate structures, a β-helical conformer [I0], rapidly develops 
while nascent chains are still attached to the ribosome (Clark and King, 2001). Upon 
release from the ribosome tailspike, thermolabile monomeric intermediates, [I], may 
oligomerize and further fold into the SDS-resistant trimeric tailspike, NT (Goldenberg et 
al., 1982). 
Oligomerization of the tailspike into a natively structured heterotrimer appears to 
involve the region of the protein C-terminal to the β-helix (Gage and Robinson, 2003). 
Part of this assembly reaction involves the formation of a transient disulfide bond that is 
not present in the final native structure (Danek and Robinson, 2003; Haase-Pettingell et 
al., 2001; Robinson and King, 1997). Initial evidence suggests that this disulfide bond 
may first form in the monomeric folding intermediate [I] (Kim and Robinson, 2006),  
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where it may aid in the formation of an intermolecular disulfide bond in the dimer and 
protrimer intermediates (Betts and King, 1998; Robinson and King, 1997). The transition 
from the protrimer to the native trimer involves the reduction of transient disulfide bonds 
and is coincident with further folding of the interdigitated and β-prism regions of the 
protein (Kreisberg et al., 2002). Mutations have been isolated in these regions that block 
or delay this final transition to the native trimer (Gage et al., 2005; Weigele et al., 2005). 
From such mutants, it has been shown that mutations that block oligomerization or trimer 
maturation result in the accumulation of soluble, SDS-sensitive species (Betts et al., 
2004; Kreisberg et al., 2002). 
Alternatively, the presence of any of over 60 genetically isolated temperature-
sensitive folding (tsf) mutations at temperatures in the higher range of cellular growth 
will generate a misfolded monomeric conformation [I*], which specifically self-
aggregates and accumulates in inclusion bodies (Haase-Pettingell and King, 1997; Haase-
Pettingell and King, 1988). Higher temperatures prevent the wild-type tailspike protein 
from folding successfully, causing wild-type chains to aggregate in the cell. This in turn 
limits the growth of the P22 phage (Pope et al., 2004). Aggregation proceeds via 
monomer addition of aggregation prone intermediates that are conformationally similar to 
productive folding intermediates (Speed et al., 1997; Speed et al., 1995). Though a 
specific aggregation pathway exists, the conformation of polypeptide chains in these 
aggregates is unknown and may contain native-like conformations. 
The tsf mutations, predominately located at surface loops and turns, appear to act 
by destabilizing the β-helical structure found in the thermolabile, monomeric folding 
intermediate (Haase-Pettingell and King, 1997; Schuler and Seckler, 1998). Global 
suppressors (su) of the tsf mutations or lower temperatures stabilize the β-helical fold or 
otherwise inhibit aggregation (Danner and Seckler, 1993; Schuler and Seckler, 1998). 
The GroEL chaperone does not assist tailspike chains in efficiently folding or preventing 
aggregation in vivo (Gordon et al., 1994). Partitioning between native and aggregation 
states is therefore a reflection of the folding state of the β-helix. As a result of the native 
tailspike’s SDS-resistance, SDS-PAGE of whole lysates provides a sensitive and reliable 
measure of in vivo folding (Goldenberg and King, 1982; Goldenberg et al., 1982). 
 45 
3. Stacking in the P22 Tailspike 
 
The numerous surface site tsf mutations represent residues essential for the 
creation of the β-helical fold at higher temperatures but do not carry the essential 
information for β-helix folding, as they are unnecessary at lower temperatures. In 
contrast, five phenylalanines and one leucine in the hydrophobic core stacks are essential 
for the folding, but not stability, of tailspike at high and low temperatures (Betts et al., 
2004). This suggests that stacked core residues contain the necessary sequence 
information to direct β-helix formation. 
It has been observed that disruptions of hydrophobic side chain packing in the 
cores of β-sheet and β-barrel proteins disrupts their folding or destabilizes the native state 
(Gunasekaran et al., 2001; Sauer, 1996). This implies that the buried core residues of the 
P22 tailspike may be particularly important in encoding the β-helix structure. We have 
observed that the buried core of the P22 tailspike is dominated by the presence of side 
chain stacks (Figure 1-9). In total, we identified ten main columns of stacks, each of 
which is displayed in its own individual color in Figure 1-9. These stacks encompass 113 
buried core residues, six of which are the amino acids discovered to be essential for 
folding in vivo (Betts et al., 2004). Like the observations made on other β-helix proteins, 
these stacks appear better organized in relation to shared side chain orientations than 
residues that point out into the solvent. These observations further indicate that these 
buried core, side chain stacking residues are primary candidates for the residues that 
encode the folding and structure of the P22 tailspike protein. 
Investigating the role that buried, side chain stacking residues play in the folding 
of the P22 tailspike’s β-helix domain may yield information relevant to amyloid 
formation, especially since a fragment composed solely of the isolated β-helix domain is 
capable of forming amyloid fibers (Schuler et al., 1999). 
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Figure 1-9. Side chain stacking in the core of the P22 tailspike β-helix. (A) The C-
terminal portion (113-666) of a single chain of the P22 tailspike trimer is shown as a 
ribbon diagram and a transparent molecular surface. Backbone and side chain atoms of 
inward pointing, buried core residues are shown in space-fill and colored according to 
their stack. Solvent exposed residues are not shown for clarity. (B) Rung 6 cross-section 
of the β-helix domain, demonstrating the locations of inward pointing stacks (spheres) 
and outward pointing residues (sticks). (C) Side chain atoms of the buried core. Single 
spheres represent glycines. The left image is in the same orientation as (A); the right is 
rotated by 180º. Figure reprinted from (Simkovsky and King, 2006), © 2006 by The 
National Academy of Sciences of the USA. 
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E. THESIS OBJECTIVES 
 
The aim of this thesis is to elucidate the role that the amino acid sequence of a 
protein plays in the importance of the side-chain stacking phenomenon. Specifically, this 
thesis investigates the contributions of the amino acid sequence of the buried core stacks 
of the β-helix domain of P22 tailspike towards the folding of the β-helix. The roles of 
these buried side chains was first investigated through a large-scale scanning alanine 
mutagenesis experiment (Chapter 2). The results of this mutagenesis experiment lead to a 
model pathway for the folding of the β-helix domain, which is subsequently tested and 
examined in the remaining chapters. 
These studies lead to a better understanding of the tailspike’s folding pathway, 
with particular attention to the folding of the β-helix domain. In the broader scheme, the 
results of the thesis contributes understanding into the mechanisms by which an amino 
acid sequence may direct polypeptide chains into a folded state or into aggregation. 
Given the similarities between tailspike and other aggregation prone proteins, such as 
amyloids, this thesis has general application to our understanding of β-sheet folding, 
assembly, and aggregation. 
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CHAPTER TWO: 
 
 
IN VIVO MUTAGENESIS OF THE P22 
TAILSPIKE β-HELIX BURIED CORE 
 
 
 
 
 50 
A. INTRODUCTION 
 
 
1. Stacking in the Buried Core of the P22 Tailspike 
 
Upon inspection of the structure of the tailspike protein (PDB file 1TYU 
(Steinbacher et al., 1996)), it became apparent that the majority of the β-helix buried core 
is composed of stacked residues whose side chains have similar conformations (Figure 1-
9). In total, ten buried core stacks were identified containing 113 amino acids that 
comprised the entirety of the β-helix domain’s core: six stacks participating in the 
structurally conserved β-sheets (red, orange, yellow, green, magenta, and purple stacks in 
Figure 1-9), two pseudo-stacks located in T2 and T3 (cyan and gray), one short stack 
preceding sheet C running from rungs 5 to 13 (blue), and a second shortened stack of 
three residues at the N-terminus of the β-helix in the conserved turn T2 (brown). 
 
2. Experimental Design 
 
Side chain stacking is a prominent feature of the buried core of the P22 tailspike 
β-helix domain, in spite of the fact that this domain does not display an overt sequence 
repeat (Figure 2-1). How does the amino acid sequence of these stacks contribute to the 
folding of the protein and how are residue mismatches in stacks tolerated? 
To investigate the contributions of all stacked, buried core side chains to the 
folding of the parallel β-helix, I have carried out a high-throughput, scanning alanine 
mutagenesis study on the folding of the P22 tailspike (Cunningham and Wells, 1989). 
Scanning alanine mutagenesis allows for an unbiased evaluation of the contributions of 
side chains to the folding and stability of a protein’s structure (Yu et al., 1995). Each of 
the 103 buried, non-alanine residues was individually replaced with alanine and the 
mutant chains expressed in E. coli. 
Capping regions exist in β-sheet structures to fulfill hydrogen bonding potential 
and prevent aggregation (Richardson and Richardson, 2002). To investigate this in the 
case of the β-helix, all residues in the N-terminal capping region (122-146) and the C-
terminal region of the β-helix domain (521- 545) were chosen as targets of  
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mutagenesis, irrespective of their solvent accessibility. Six further solvent exposed 
residues located throughout the β-helix domain were added to the target list due to their 
proximity and potential chemical reactivity with cysteine residues. One disordered 
glycine, G511, was chosen for mutagenesis due to its potential location at a stacking 
position. 
As further positional controls, five residues outside of the β-helix domain in a part 
of the structure known as the cysteine annulus were chosen for mutagenesis. The cysteine 
annulus is known to be important for the oligomerization of P22 tailspike (Danek and 
Robinson, 2003). The positions selected included two cysteine residues (C613 and C635) 
believed to be important for the presence of a transient disulfide bond in a oligomerized 
protein folding intermediate as well as residues that appeared likely to affect the 
reactivity of those cysteine residues (H610, D632, and P638) (Fomenko and Gladyshev, 
2003). 
 
 
B. MATERIALS AND METHODS 
 
 
1. Production of Single Alanine Mutants 
 
Gene 9, which encodes the Salmonella phage P22’s tailspike protein, was 
previously cloned into the vector pET11a (Novagen) as described (Kreisberg et al., 
2002). The resulting vector, pET(gene9), encoded the full length wild-type tailspike 
protein. 
Methylated pET(gene9) DNA was purified to act as template DNA for 
mutagenesis from XL1-Blue cells (Stratagene) using a QIAGEN Plasmid Midi Kit. 
Scanning alanine mutagenesis was performed using the PCR-based QuikChange 
mutagenesis procedure (Stratagene) in a parallelized, high-throughput manner. Sequences 
of mutagenic primers (IDT) are listed in Table 2-1. Mutagenesis reactions were 
performed in parallel in 96 well plates and utilized multi-channel pipeting to achieve 
high-throughput processing. 
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Table 2-1. Mutagenic primers used to construct single alanine mutants. Forward 
mutagenic primers that were used to produce the specified single alanine mutations are 
listed. Reverse mutagenic primers used in the reaction were the exact reverse 
complement of the forward primers. 
 
Mutation Forward primer 
K122A 5'-CAATAGAAGCTGATAAAAAATTTGCGTATTCAGTAAAATTATCAG-3' 
Y123A 5'-CAATAGAAGCTGATAAAAAATTTAAGGCTTCAGTAAAATTATCAG-3' 
S124A 5'-CAATAGAAGCTGATAAAAAATTTAAGTATGCAGTAAAATTATCAG-3' 
V125A 5'-GCTGATAAAAAATTTAAGTATTCAGCAAAATTATCAGATTATCC-3' 
K126A 5'-GTATTCAGTAGCATTATCAGATTATCCAACATTGCAGGATGCAG-3' 
L127A 5'-GTATTCAGTAAAAGCATCAGATTATCCAACATTGCAGGATGCAGC-3' 
S128A 5'-CAGTAAAATTAGCAGATTATCCAACATTGCAGGATGCAGC-3' 
D129A 5'-CAGTAAAATTATCAGCTTATCCAACATTGCAGGATGCAGC-3' 
Y130A 5'-GTAAAATTATCAGATGCTCCAACATTGCAGGATGCAGCATCTG-3' 
P131A 5'-GTAAAATTATCAGATTATGCAACATTGCAGGATGCAGCATCTG-3' 
T132A 5'-CAGATTATCCAGCATTGCAGGATGCAGCATCTGC-3' 
L133A 5'-GATTATCCAACAGCGCAGGATGCAGCATCTGCTGC-3' 
Q134A 5'-GATTATCCAACATTGGCGGATGCAGCATCTGCTGCG-3' 
D135A 5'-CAACATTGCAGGCTGCAGCATCTGCTGCG-3' 
S138A 5'-GCAGGATGCAGCAGCTGCTGCGGTTG-3' 
V141A 5'-CAGCATCTGCTGCGGCTGATGGCCTTC-3' 
D142A 5'-CTGCTGCGGTTGCTGGCCTTCTTATCGATC-3' 
G143A 5'-GCATCTGCTGCGGTTGATGCCCTTCTTATCG-3' 
L144A 5'-CTGCTGCGGTTGATGGCGCTCTTATCGATCGAG-3' 
L145A 5'-CTGCTGCGGTTGATGGCCTTGCTATCGATCGAG-3' 
I146A 5'-GATGGCCTTCTTGCCGATCGAGATTATAATTTTTATGGTGGAG-3' 
R148A 5'-CGGTTGATGGCCTTCTTATCGATGCAGATTATAATTTTTATGGTG-3' 
Y150A 5'-GGCCTTCTTATCGATCGAGATGCTAATTTTTATGGTGGAGAG-3' 
F152A 5'-GGCCTTCTTATCGATCGAGATTATAATGCTTATGGTGGAGAG-3' 
Y153A 5'-GAGATTATAATTTTGCTGGTGGAGAGACAGTTGATTTTGGCGG-3' 
E156A 5'-GATTATAATTTTTATGGTGGAGCGACAGTTGATTTTGGCGG-3' 
V158A 5'-GGTGGAGAGACAGCTGATTTTGGCGGAAAGG-3' 
F160A 5'-GGTGGAGAGACAGTTGATGCTGGCGGAAAGGTTC-3' 
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Mutation Forward primer 
K163A 5'-GAGAGACAGTTGATTTTGGCGGAGCGGTTCTGACTATAG-3' 
L165A 5'-GAGACAGTTGATTTTGGCGGAAAGGTTGCGACTATAGAATG-3' 
T166A 5'-GATTTTGGCGGAAAGGTTCTGGCTATAGAATGTAAAGC-3' 
I167A 5'-GTTGATTTTGGCGGAAAGGTTCTGACTGCAGAATGTAAAGC-3' 
C169A 5'-GCGGAAAGGTTCTGACTATAGAAGCTAAAGCTAAATTTATAGGAG-3' 
K172A 5'-CGGAAAGGTTCTGACTATAGAATGTAAAGCTGCATTTATAGGAG-3' 
F173A 5'-GGTTCTGACTATAGAATGTAAAGCTAAAGCTATAGGAGATGG-3' 
G175A 5'-GCTAAATTTATAGCAGATGGAAATCTTATTTTTACGAAATTAGGC-3' 
L179A 5'-GAGATGGAAATGCTATTTTTACGAAATTAGGCAAAGGTTCCCGC-3' 
F181A 5'-GATGGAAATCTTATTGCTACGAAATTAGGCAAAGGTTCCCGC-3' 
L184A 5'-CTTATTTTTACGAAAGCAGGCAAAGGTTCCCGCATTGCCG-3' 
S188A 5'-GAAATTAGGCAAAGGTGCCCGCATTGCCGG-3' 
I190A 5'-CAAAGGTTCCCGCGCTGCCGGGGTTTTTATGG-3' 
V193A 5'-CCCGCATTGCCGGGGCTTTTATGGAAAGC-3' 
M195A 5'-CCGCATTGCCGGGGTTTTTGCGGAAAGCACTAC-3' 
S260A 5'-GCAAAAGGGCAAAACATAACGGCTACGTTAGAAATTAGAG-3' 
L262A 5'-CATAACGTCTACGGCAGAAATTAGAGAATGTATAGGGGTCG-3' 
I264A 5'-GTCTACGTTAGAAGCTAGAGAATGTATAGGGGTCGAAGTTC-3' 
C267A 5'-GAAATTAGAGAAGCTATAGGGGTCGAAGTTCATCGGGCTAG-3' 
V270A 5'-GAGAATGTATAGGGGCCGAAGTTCATCGGGC-3' 
V272A 5'-GTATAGGGGTCGAAGCTCATCGGGCTAGC-3' 
G277A 5'-GTTCATCGGGCTAGCGCTCTAATGGCTGG-3' 
F282A 5'-GGCTAGCGGTCTAATGGCTGGTGCTTTGTTTAGAGG-3' 
F284A 5'-GCGGTCTAATGGCTGGTTTTTTGGCTAGAGGGTGTC-3' 
C287A 5'-GTTTAGAGGGGCTCACTTCTGCAAGATGGTAGACGC-3' 
C290A 5'-GAGGGTGTCACTTCGCCAAGATGGTAGACGCC-3' 
M292A 5'-CTTCTGCAAGGCGGTAGACGCCAATAATCCAAGCG-3' 
V293A 5'-CTGCAAGATGGCAGACGCCAATAATCCAAGCG-3' 
P298A 5'-GACGCCAATAATGCAAGCGGAGGTAAAGATGGC-3' 
G300A 5'-GACGCCAATAATCCAAGCGCAGGTAAAGATGGC-3' 
G301A 5'-GCCAATAATCCAAGCGGAGCTAAAGATGGCATTATAAC-3' 
I305A 5'-GTAAAGATGGCGCTATAACCTTCGAAAACCTTAGCGGCG-3' 
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Mutation Forward primer 
I306A 5'-GTAAAGATGGCATTGCAACCTTCGAAAACCTTAGCGGCG-3' 
F308A 5'-CATTATAACCGCCGAAAACCTTAGCGGCGATTGGGG-3' 
N310A 5'-CATTATAACCTTCGAAGCCCTTAGCGGCGATTGGGG-3' 
N319A 5'-GGGGAAGGGTGCCTATGTCATTGGCGGACG-3' 
V321A 5'-GGGGAAGGGTAACTATGCCATTGGCGGAC-3' 
G324A 5'-CTATGTCATTGGCGCACGAACCAGCTATGGG-3' 
T326A 5'-CATTGGCGGACGAGCCAGCTATGGGTC-3' 
G329A 5'-GAACCAGCTATGCGTCAGTAAGTAGCGCCC-3' 
S333A 5'-CAGCTATGGGTCAGTAAGTGCCGCCCAGTTTTTACG-3' 
F336A 5'-GGGTCAGTAAGTAGCGCCCAGGCTTTACGTAATAATGG-3' 
N339A 5'-GCGCCCAGTTTTTACGTGCTAATGGTGGCTTTGAACG-3' 
G347A 5'-GGTGGCTTTGAACGTGATGCTGGAGTTATTGGG-3' 
V349A 5'-GCTTTGAACGTGATGGTGGAGCTATTGGGTTTAC-3' 
F352A 5'-GGAGTTATTGGGGCTACTTCATATCGCGCTGGGG-3' 
S354A 5'-GTTATTGGGTTTACTGCATATCGCGCTGGGGAG-3' 
G361A 5'-CGCGCTGGGGAGAGTGCCGTTAAAACTTG-3' 
V362A 5'-GCTGGGGAGAGTGGCGCTAAAACTTGGC-3' 
T364A 5'-GTGGCGTTAAAGCTTGGCAAGGTACTGTGGG-3' 
N376A 5'-GGGCTCGACAACCTCTCGCGCCTATAATCTGC-3' 
L379A 5'-CGCAACTATAATGCGCAATTCCGCGACTCGGTCG-3' 
F381A 5'-CTCGCAACTATAATCTGCAAGCCCGCGACTCGG-3' 
S384A 5'-CAATTCCGCGACGCGGTCGTTATTTACCCC-3' 
V386A 5'-CCGCGACTCGGTCGCTATTTACCCCG-3' 
P389A 5'-CTCGGTCGTTATTTACGCCGTATGGGACGG-3' 
G393A 5'-CCCCGTATGGGACGCATTCGATTTAGGTGC-3' 
F394A 5'-CCCCGTATGGGACGGAGCCGATTTAGGTGC-3' 
L396A 5'-GGGACGGATTCGATGCAGGTGCTGACACTGAC-3' 
L424A 5'-CAATACCCACTGCATCAGTTACCCGCAAATCACCTGATTG-3' 
H426A 5'-GTTACCCCTAAATGCCCTGATTGATAATCTTCTGGTTCGC-3' 
I428A 5'-CTAAATCACCTGGCTGATAATCTTCTGGTTCGCGGGG-3' 
L431A 5'-CACCTGATTGATAATGCTCTGGTTCGCGGGGCG-3' 
V433A 5'-GATAATCTTCTGGCTCGCGGGGCGTTAGG-3' 
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Mutation Forward primer 
G440A 5'-GCGGGGCGTTAGGTGTAGCTTTTGGTATGG-3' 
F441A 5'-CGGGGCGTTAGGTGTAGGTGCTGGTATGGATG-3' 
M443A 5'-GCGTTAGGTGTAGGTTTTGGTGCGGATGGTAAGGG-3' 
G445A 5'-GGTTTTGGTATGGATGCTAAGGGCATGTATGTGTC-3' 
M448A 5'-GATGGTAAGGGCGCGTATGTGTCTAATATTACCGTAGAAG-3' 
V450A 5'-GGATGGTAAGGGCATGTATGCGTCTAATATTACCG-3' 
I453A 5'-GTATGTGTCTAATGCTACCGTAGAAGATTGCGCTGGGTC-3' 
V455A 5'-CTAATATTACCGCAGAAGATTGCGCTGGGTCTGG-3' 
C458A 5'-CGTAGAAGATGCCGCTGGGTCTGGCGCG-3' 
S461A 5'-GATTGCGCTGGGGCTGGCGCGTACC-3' 
G462A 5'-CGCTGGGTCTGCCGCGTACCTACTC-3' 
L465A 5'-GGGTCTGGCGCGTACGCACTCACCCACG-3' 
T467A 5'-GCGCGTACCTACTCGCCCACGAATCAG-3' 
S470A 5'-CCTACTCACCCACGAAGCAGTATTTACCAATATAGC-3' 
F472A 5'-GCGTACCTACTCACCCACGAATCAGTAGCTACCAATATAG-3' 
I475A 5'-CCCACGAATCAGTATTTACCAATGCAGCCATAATTGACACC-3' 
I477A 5'-CAATATAGCCGCAATTGACACCAATACTAAGGATTTCCAGGC-3' 
T480A 5'-GCCATAATTGACGCCAATACTAAGGATTTCCAGGC-3' 
Q489A 5'-CCAGGCGAATGCGATTTATATATCTGGGGCTTGCCG-3' 
I490A 5'-GGCGAATCAGGCTTATATATCTGGGGCTTGCCGTG-3' 
I492A 5'-GGCGAATCAGATTTATGCATCTGGGGCTTGCCGTG-3' 
S493A 5'-GATTTATATAGCTGGGGCTTGCCGTGTGAACGG-3' 
C496A 5'-GATTTATATATCTGGGGCTGCCCGTGTGAACGGTTTACG-3' 
V498A 5'-GGGGCTTGCCGTGCGAACGGTTTACG-3' 
N499A 5'-GGGGCTTGCCGTGTGGCCGGTTTACGTTTAATTG-3' 
L501A 5'-CCGTGTGAACGGTGCACGTTTAATTGGGATCCGC-3' 
L503A 5'-CCGTGTGAACGGTTTACGTGCAATTGGGATCCGC-3' 
G511A 5'-CCGCTCAACCGATGCGCAGGGTCTAAC-3' 
T515A 5'-GGCAGGGTCTAGCCATAGACGCCCC-3' 
I516A 5'-GGCAGGGTCTAACCGCAGACGCCCCTAAC-3' 
S521A 5'-GACGCCCCTAACGCTACCGTAAGCGG-3' 
T522A 5'-CCCTAACTCTGCCGTAAGCGGTATAACCGG-3' 
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Mutation Forward primer 
V523A 5'-CCCCTAACTCTACCGCAAGCGGTATAACCG-3' 
S524A 5'-CCCCTAACTCTACCGTAGCCGGTATAACCGGG-3' 
G525A 5'-CTACCGTAAGCGCTATAACCGGGATGGTAGAC-3' 
I526A 5'-CGTAAGCGGTGCAACCGGGATGGTAGACCC-3' 
T527A 5'-GTAAGCGGTATAGCCGGGATGGTAGACCC-3' 
G528A 5'-GCGGTATAACCGCGATGGTAGACCCCTC-3' 
M529A 5'-GCGGTATAACCGGGGCGGTAGACCCCTC-3' 
V530A 5'-GGTATAACCGGGATGGCAGACCCCTCTAG-3' 
D531A 5'-CGGGATGGTAGCCCCCTCTAGAATTAATGTTGC-3' 
P532A 5'-CCGGGATGGTAGACGCCTCTAGAATTAATGTTGC-3' 
S533A 5'-CCGGGATGGTAGACCCCGCTAGAATTAATGTTG-3' 
R534A 5'-GTATAACCGGGATGGTAGACCCCTCTGCAATTAATGTTGC-3' 
I535A 5'-CCCCTCTAGAGCTAATGTTGCTAATTTGGCAGAAGAAGGG-3' 
N536A 5'-GGGATGGTAGACCCCTCTAGAATTGCTGTTGCTAATTTGG-3' 
V537A 5'-GGTAGACCCCTCTAGAATTAATGCTGCTAATTTGGC-3' 
N539A 5'-CCCCTCTAGAATTAATGTTGCTGCTTTGGCAGAAGAAGGG-3' 
L540A 5'-GACCCCTCTAGAATTAATGTTGCTAATGCGGCAGAAGAAG-3' 
E542A 5'-CTAATTTGGCAGCAGAAGGGTTAGGTAATATCCGC-3' 
E543A 5'-CTAATTTGGCAGAAGCAGGGTTAGGTAATATCCGC-3' 
G544A 5'-GGCAGAAGAAGCGTTAGGTAATATCCGCGCTAATAG-3' 
L545A 5'-GGCAGAAGAAGGGGCAGGTAATATCCGCGCTAATAG-3' 
H610A 5'-GCTGTATCATTAAAAGTTAACGCCAAAGATTGCAGGGGGG-3' 
C613A 5'-CCACAAAGATGCCAGGGGGGCAGAGATACCATTTG-3' 
D632A 5'-CGCGTCAGATGATTTTATAAAGGCTTCCTCATGTTTTTTGC-3' 
C635A 5'-CAGATGATTTTATAAAGGATTCCTCAGCTTTTTTGCCATATTGGG-3' 
P638A 5'-GGATTCCTCATGTTTTTTGGCATATTGGGAAAATAATTCTACTTC-3' 
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Clones encoding full length, but potentially altered, tailspike were identified via 
over-expression in Escherichia coli NovaBlue(DE3) cells (Novagen). Plasmid DNA was 
purified using QIAprep Spin MiniPrep kits (QIAGEN). DNA sequencing of a 400 base 
pair region (20% of the tailspike gene) containing the targeted codon confirmed mutant 
clones (MGH DNA Core, Cambridge, MA). 
 
2. Expression of Tailspike Constructs 
 
Plasmid DNA encoding confirmed alanine mutants was transformed into E. coli 
BL21(DE3) using a single step protocol, as described in (Chung et al., 1989). 
Transformations were performed in parallel in 2 ml 96 deep-well plates (Bel-Art) and 
were prepared in a high-throughput manner. Cultures were selected on individual Luria 
Broth (LB) plates containing 100 µg/ml ampicillin. This selection stage was the only part 
of the experimental procedure that could not be performed in a high-throughput way. 
Cultures were made into 40% glycerol working stocks and 8.3% DMSO freeze 
stocks after 8 hours of growth in LB containing 100 µg/ml ampicilllin at 37ºC. Working 
stocks were stored at -20ºC in 96 deep-well plates while freeze stocks were stored at -
80ºC in dram vials. Expression cultures were inoculated via 100-fold dilution of the 
working stocks into LB media containing 0.5% glucose, 50 mM 3-[N-morpholino]-
propanesulfonic acid (MOPS) and 100 µg/ml ampicillin. Cells were grown shaking (225 
rpm) in 500 µl volumes in 96 deep-well plates for approximately 4 hours at 30ºC until 
cultures reached an OD600 between 0.4 and 0.5. Isopropyl-β-D-thiogalactopyranoside 
(IPTG) was added to a final concentration of 1.5 mM to induce protein expression. 
Cultures were transferred to 37ºC, 30ºC, 18ºC, or 10ºC and were allowed to express 
protein for approximately 4.25, 6.5, 18.3 hours, or 24 hours respectively. Cultures were 
harvested via centrifugation for 15 minutes at 4000g and 4ºC. Cells were resuspended to 
1/10 volume in lysis buffer (50 mM Tris-HCl, pH8.0; 25 mM NaCl; 2 mM EDTA; 0.1% 
Triton X-100) and stored at -20ºC. 
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3. Cell Lysis and SDS-PAGE 
 
Frozen expression samples were thawed at room temperature and lysis was 
initiated by addition of freshly dissolved lysozyme (1 mg/ml final concentration from 10 
mg/ml aqueous solution) and PMSF (9 mM final concentration from 90 mM stock in 
isopropanol). After 30 min of slow stirring at room temperature and addition of DNase I 
(Sigma) (10 µg/ml final concentration from 0.06 mg/ml stock in glycerol; 1 M MgSO4), 
lysates were stirred for an additional 30 min. 
Half of each lysate was removed as a complete lysate sample, while the remaining 
lysate was centrifuged for 30 min at 4,000g and 4ºC in shallow well plates to separate 
soluble and insoluble fractions. Lysate pellets were resuspended in lysis buffer by gentle 
agitation. Lysate fractions were mixed with 2% SDS sample buffer containing 15% BME 
as previously described (Betts et al., 2004). SDS-PAGE was run at 4ºC on 7.5% 
polyacrylamide, 102-lane Triple Wide gels (C.B.S. Scientific) using the discontinuous 
buffer system of King and Laemmli (King and Laemmli, 1971). A multichannel pipet 
was used to ensure rapid and efficient loading. 
 
4. Optical Densitometry and Folding Efficiency Calculations 
 
Coomassie-stained gels were individually scanned at 300ppi and 8-bit gray scale 
via a ScanMaker 9800XL tabletop scanner (Microtek). Optical densitometry of the gel 
image was performed using the GelAnalyzer plug-in (Appendix A) for ImageJ (NIH). In 
brief, gel images were calibrated using a Kodak OD step tablet (AI-04-0057, Tiffen 
Company) that ranged from 0.6 to 3.09 OD. Profile plots of lanes were calculated as the 
average OD across a lane’s width. Background levels of cellular protein expression, as 
calculated as the average profile plot of expression cultures containing pET11a vectors 
lacking any tailspike gene, were scaled and subtracted from each complete lysate sample 
lane. Integration of the positive area of peaks corresponding to tailspike bands, as 
determined from the migration of purified tailspike standards, yielded relative protein 
amounts. 
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Folding efficiencies were calculated as the percent of all tailspike chains found in 
the native, trimeric tailspike (NT) band, according to the following formula: 
! 
Percent Folded =  
OD
NT
OD
NT
+ OD
U
"100% 
Folding efficiencies were normalized to the average wild-type folding efficiency, which 
was calculated as the average of 22 independent lysates, according to the formula: 
! 
Folding Efficiency =  
Percent FoldedMutant
Percent FoldedWT
"100% 
 
 
C. RESULTS 
 
 
1. Production of Single Alanine Mutants 
 
In total, 150 non-alanine sites were individually mutated to alanine, as confirmed 
by DNA sequencing. As detailed in Section B1, DNA sequencing was performed on a 
400 base pair region containing the targeted codon. Although the entire gene was not 
sequenced for each individual mutant, only one sample out of 241 samples sequenced had 
a second site mutation outside the primer region, resulting in approximately 0.02 second 
site mutations per gene. This low error rate indicated that this limited sequencing was 
sufficient to confirm single alanine mutations, thus allowing for these mutants to be 
assayed for their affect on folding, as detailed below. 
In addition to the desired 150 single alanine mutants, a small number of insertion 
or deletion mutants were produced. The deletion of base T553 in the codon encoding 
L184 of tailspike or deletion of base A586 in the M195-encoding codon resulted in 
reading frame shifts that produced truncated proteins 214 amino acids in length that 
appeared exclusively in the insoluble fraction of 37ºC expression lysates. Another 
deletion mutant, a deletion of T1564 in the codon encoding S521 generated a frame shift 
that produced a 523 amino acid polypeptide chain. When expressed at 37ºC, this protein 
also appeared exclusively in the insoluble fraction of the cellular lysate. 
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An insertional mutant was recovered that contained an F472A mutation with a 
subsequent duplication of residues 468-472, thus creating an insertion of 6 amino acids 
into the tailspike protein that included two F→A mutations. When expressed at 37ºC, 
30ºC, or 18ºC, this insertional duplication yielded insoluble, SDS-sensitive polypeptide 
chains. 
2. In Vivo Expression of Single Alanine Mutants 
 
All single alanine mutants were individually over-expressed from a pET plasmid 
in Escherichia coli cultures incubated at 37ºC, 30ºC, and 18ºC in order to assess the 
contribution of the altered residue to the in vivo folding of the β-helix domain. Some 
mutant strains were sensitive to freeze stock storage conditions. These strains would not 
express tailspike proteins even after several rounds of growth following freeze storage 
and would only produce tailspike protein after the appropriate plasmids were freshly 
transformed into bacteria. 
Cells containing pET11a plasmids lacking any tailspike genes were induced as a 
negative control of tailspike expression. Positive controls included wild-type and ∆N 
tailspike, which lacks the N-terminal domain (1-108) (Miller et al., 1998b). Mutant 
expression at each temperature was performed in triplicate. Induced samples were lysed, 
mixed with SDS sample buffer, and unheated samples were analyzed by SDS-PAGE. 
Sample gels are shown in Figure 2-2. 
As can be seen in Figure 2-2, host protein translational levels were consistent 
across all samples. Mutant and wild-type lysates accumulated tailspike polypeptide 
chains as clearly resolved bands. These observations proved true for all expression 
samples at all three temperatures. Thus, alanine substitutions at the targeted sites had no 
noticeable affect on translation or degradation of the tailspike polypeptide chain. 
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When complete E. coli lysate samples were electrophoresed through an SDS 
polyacrylamide gel, over-expressed tailspike chains partitioned between two bands in the 
gel (Figure 2-2). Chains that reached the SDS-resistant, native tailspike structure did not 
dissociate in the presence of SDS (Goldenberg et al., 1982). These chains appeared on the 
gel as a slowly migrating native trimer band (NT) of approximately 210-kD. In contrast, 
partially folded intermediates and inclusion body aggregates are dissociated and unfolded 
in detergent, causing these species to electrophorese as a rapidly migrating, 72-kD band 
(U). Quantification of the percent of tailspike polypeptide chains reaching the native state 
provided an accurate and precise measure of the in vivo partitioning between productive 
and non-productive folding. 
Negative control samples were used to subtract background cellular protein levels 
so that tailspike bands could be accurately quantified. Normalization of the percent 
folded measurement to the average wild-type value generated a useful measure, the 
percent of wild-type folding efficiency. Comparison of these folding efficiencies allowed 
for an unbiased assessment of the effects of individual alanine substitutions with respect 
to a known standard, the wild-type sequence. 
 
3. Overall Folding Efficiencies 
 
At each temperature, the distribution of folding efficiencies among mutants 
proved bimodal, allowing for the classification of each mutant as either a wild-type-like 
folder or as folding deficient. Mutants whose folding efficiencies were less than 75% of 
wild-type’s folding efficiency were classified as folding deficient. This 75% threshold 
was conservatively chosen based upon the distribution of averages, examination of the 
statistical overlap of sample values with wild-type, and the expectation that a mutant 
classified as defective at a low temperature should be similarly classified at higher 
temperatures. 
Quantitative analysis of the in vivo folding of all mutants at all three temperatures 
is shown in Figure 2-3 and Table 2-2. Though a few mutant sequences were able to reach 
the native state at the presumed physiological temperature of the Salmonella phage P22, 
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Figure 2-3. Quantitative results of folding experiments. Average percent of wild-type 
folding efficiencies are shown for all alanine mutants when expressed at 37ºC (red 
circle), 30ºC (brown triangle), and 18ºC (blue square). Colored lines indicate the standard 
deviations of triplicate experiments. Note that WT and ∆N average percent of wild-type 
folding efficiencies and standard deviations are shown as insets. The 75% threshold 
delineating wild-type-like folders and folding deficient samples is shown as a dashed 
line. 
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Table 2-2. Folding efficiencies of single alanine mutants. The percent of WT folding 
efficiencies for all 150 single alanine substitutions, as well as the WT and ∆N positive 
controls, at the four temperatures tested are given as averages and standard deviations of 
multiple expression experiments, as described in this chapter. 10ºC expression data was 
not collected for mutants capable of folding like wild-type at 18ºC. These samples are 
marked by “NA”. Folding deficient average values (<75%) are shaded and bolded. 
 
Percent of WT folding efficiency 
Sample 
37ºC 30ºC 18ºC 10ºC 
WT 100.0 ± 9.9 100.0 ± 5.7 100.0 ± 1.8 100.0±4.3 
∆N 95.4 ± 13.3 108.9 ± 3.2 103.9 ± 1.0 100.5±4.4 
K122A 111.9 ± 2.3 110.4 ± 4.1 103.3 ± 3.0 NA 
Y123A 100.1 ± 11.8 105.4 ± 8.4 104.6 ± 3.0 NA 
S124A 109.9 ± 2.9 107.3 ± 4.7 101.5 ± 4.0 NA 
V125A 110.9 ± 5.4 104.6 ± 2.6 99.8 ± 5.3 NA 
K126A 81.4 ± 15.9 94.4 ± 18.1 102.3 ± 4.1 NA 
L127A 62.6 ± 5.8 99.8 ± 8.6 101.8 ± 4.0 NA 
S128A 42.6 ± 10.2 99.1 ± 7.8 103.6 ± 1.2 NA 
D129A 79.4 ± 18.4 106.3 ± 1.1 103.2 ± 2.0 NA 
Y130A 8.9 ± 5.0 39.4 ± 15.0 102.4 ± 0.8 NA 
P131A 108.8 ± 6.1 101.2 ± 3.3 99.6 ± 1.7 NA 
T132A 64.8 ± 11.6 102.0 ± 12.2 99.5 ± 1.0 NA 
L133A 10.1 ± 8.5 46.0 ± 25.9 100.4 ± 0.5 NA 
Q134A 56.7 ± 9.8 107.9 ± 6.0 103.4 ± 3.2 NA 
D135A 82.0 ± 13.3 105.4 ± 7.2 101.9 ± 4.7 NA 
S138A 97.5 ± 15.1 109.4 ± 4.6 102.2 ± 3.1 NA 
V141A 15.7 ± 4.5 39.6 ± 11.6 68.6 ± 17.0 40.6±12.1 
D142A 84.8 ± 14.8 103.8 ± 2.2 99.2 ± 2.4 NA 
G143A 108.5 ± 9.1 105.7 ± 0.4 100.1 ± 3.9 NA 
L144A 0.0 ± 0.0 8.4 ± 6.2 40.7 ± 19.5 36.4±23.5 
L145A 46.8 ± 17.9 106.9 ± 4.2 103.7 ± 0.5 NA 
I146A 14.6 ± 10.7 44.0 ± 8.0 96.6 ± 0.7 NA 
R148A 79.6 ± 15.1 97.3 ± 1.2 99.2 ± 1.9 NA 
Y150A 0.2 ± 0.1 10.0 ± 6.3 99.5 ± 4.4 NA 
F152A 0.0 ± 0.0 0.0 ± 0.0 10.1 ± 12.1 7.7±6.7 
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Sample 37ºC 30ºC 18ºC 10ºC 
Y153A 67.1 ± 30.2 88.4 ± 12.4 99.9 ± 4.2 NA 
E156A 6.0 ± 4.9 20.0 ± 8.0 96.2 ± 3.1 NA 
V158A 20.6 ± 9.0 93.8 ± 7.4 99.3 ± 1.6 NA 
F160A 8.8 ± 4.9 77.4 ± 2.7 100.4 ± 0.8 NA 
K163A 19.1 ± 16.9 74.4 ± 18.7 100.4 ± 3.3 NA 
L165A 7.1 ± 3.3 54.2 ± 1.5 101.0 ± 0.2 NA 
T166A 87.6 ± 20.2 105.0 ± 3.5 100.1 ± 1.1 NA 
I167A 0.0 ± 0.0 0.5 ± 0.4 72.4 ± 10.4 68.5±19.9 
C169A 55.7 ± 18.3 96.2 ± 5.5 101.0 ± 2.9 NA 
K172A 43.1 ± 27.4 105.7 ± 6.8 100.4 ± 1.1 NA 
F173A 10.4 ± 13.1 10.4 ± 7.2 100.0 ± 1.9 NA 
G175A 2.1 ± 1.9 22.9 ± 9.5 98.4 ± 2.2 NA 
L179A 0.5 ± 0.4 1.8 ± 2.0 47.4 ± 14.3 68.9±16.4 
F181A 1.8 ± 1.4 20.7 ± 7.1 100.6 ± 2.5 NA 
L184A 3.0 ± 1.3 31.4 ± 16.7 102.2 ± 1.5 NA 
S188A 52.1 ± 10.8 92.8 ± 7.7 100.1 ± 1.4 NA 
I190A 8.9 ± 5.6 56.2 ± 7.8 100.8 ± 0.4 NA 
V193A 62.5 ± 17.3 86.1 ± 18.9 95.1 ± 5.3 NA 
M195A 0.5 ± 0.6 2.4 ± 3.4 39.3 ± 24.3 48.7±25.5 
S260A 60.7 ± 16.3 92.0 ± 8.6 97.7 ± 4.1 NA 
L262A 0.0 ± 0.0 0.3 ± 0.4 29.8 ± 10.8 28.5±21.6 
I264A 0.4 ± 0.6 0.1 ± 0.1 92.0 ± 4.1 NA 
C267A 59.8 ± 18.4 97.5 ± 7.8 99.9 ± 3.9 NA 
V270A 3.0 ± 2.7 49.1 ± 9.2 100.0 ± 3.1 NA 
V272A 2.8 ± 2.5 14.3 ± 3.8 100.7 ± 3.2 NA 
G277A 0.0 ± 0.0 0.0 ± 0.0 8.3 ± 11.6 0.0±0.0 
F282A 0.0 ± 0.0 1.8 ± 2.6 7.0 ± 9.9 1.6±2.2 
F284A 0.3 ± 0.4 0.0 ± 0.0 5.2 ± 4.8 4.1±2.9 
C287A 1.1 ± 1.3 1.7 ± 0.7 93.6 ± 2.6 NA 
C290A 2.4 ± 2.1 31.1 ± 10.0 99.3 ± 1.1 NA 
M292A 2.5 ± 1.8 28.8 ± 4.1 101.3 ± 3.5 NA 
V293A 10.2 ± 9.2 83.1 ± 3.4 98.9 ± 2.7 NA 
 67 
Sample 37ºC 30ºC 18ºC 10ºC 
P298A 7.4 ± 5.4 63.4 ± 7.2 101.1 ± 3.6 NA 
G300A 0.0 ± 0.0 13.1 ± 9.9 9.7 ± 11.0 26.3±20.3 
G301A 2.1 ± 1.5 30.3 ± 8.2 100.1 ± 2.9 NA 
I305A 7.1 ± 2.0 60.1 ± 5.7 99.1 ± 2.5 NA 
I306A 1.2 ± 0.9 15.3 ± 20.1 99.8 ± 2.2 NA 
F308A 0.0 ± 0.0 0.7 ± 1.0 8.4 ± 10.7 3.5±4.4 
N310A 0.0 ± 0.0 2.7 ± 3.9 13.2 ± 15.4 15.8±18.2 
N319A 0.0 ± 0.0 0.0 ± 0.0 4.6 ± 4.1 6.0±5.4 
V321A 1.4 ± 1.6 12.1 ± 7.9 98.3 ± 2.5 NA 
G324A 0.0 ± 0.1 7.3 ± 9.7 4.0 ± 4.2 6.3±5.1 
T326A 59.1 ± 21.5 66.1 ± 27.2 98.2 ± 2.6 NA 
G329A 0.0 ± 0.0 0.0 ± 0.0 32.3 ± 25.7 30.7±18.2 
S333A 38.2 ± 13.3 95.6 ± 10.7 98.9 ± 2.0 NA 
F336A 0.0 ± 0.0 0.1 ± 0.1 28.5 ± 32.8 42.3±27.3 
N339A 2.4 ± 2.5 37.1 ± 3.4 99.1 ± 4.2 NA 
G347A 5.2 ± 3.5 75.2 ± 9.7 99.4 ± 2.2 NA 
V349A 13.4 ± 4.5 77.6 ± 12.4 101.5 ± 2.0 NA 
F352A 0.6 ± 0.9 11.7 ± 16.1 95.8 ± 4.5 NA 
S354A 25.8 ± 11.6 96.7 ± 3.9 100.0 ± 2.3 NA 
G361A 1.3 ± 0.9 21.0 ± 5.9 92.2 ± 4.4 NA 
V362A 4.2 ± 2.8 47.3 ± 11.4 100.0 ± 2.2 NA 
T364A 14.9 ± 1.1 50.8 ± 28.0 98.5 ± 4.1 NA 
N376A 2.5 ± 1.1 35.9 ± 20.1 95.6 ± 4.3 NA 
L379A 0.0 ± 0.0 0.0 ± 0.0 21.0 ± 23.7 8.7±8.8 
F381A 0.0 ± 0.0 0.1 ± 0.0 6.9 ± 2.6 15.6±13.3 
S384A 40.8 ± 18.7 106.3 ± 3.1 100.1 ± 2.6 NA 
V386A 83.5 ± 13.1 100.3 ± 6.9 99.6 ± 0.9 NA 
P389A 11.5 ± 7.2 88.5 ± 6.2 100.2 ± 2.2 NA 
G393A 1.2 ± 1.4 10.9 ± 12.7 35.8 ± 17.0 12.5±11.7 
F394A 2.5 ± 2.0 7.0 ± 5.7 90.6 ± 4.4 NA 
L396A 0.1 ± 0.2 7.0 ± 9.8 7.9 ± 8.5 3.3±2.3 
L424A 0.7 ± 0.9 16.9 ± 12.8 70.6 ± 15.0 45.8±24.8 
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Sample 37ºC 30ºC 18ºC 10ºC 
H426A 0.2 ± 0.3 15.0 ± 19.3 0.5 ± 0.8 2.5±3.3 
I428A 46.4 ± 28.5 76.9 ± 25.7 98.9 ± 2.6 NA 
L431A 2.1 ± 2.2 59.0 ± 16.3 94.1 ± 4.5 NA 
V433A 41.0 ± 15.0 101.8 ± 4.0 99.0 ± 3.2 NA 
G440A 33.6 ± 8.3 91.3 ± 1.5 80.9 ± 10.3 NA 
F441A 0.1 ± 0.1 0.2 ± 0.3 1.2 ± 1.6 0.2±0.2 
M443A 10.5 ± 7.0 49.3 ± 36.2 96.3 ± 6.3 NA 
G445A 0.3 ± 0.4 0.3 ± 0.3 1.2 ± 1.7 0.4±0.6 
M448A 15.4 ± 8.9 90.0 ± 5.0 100.5 ± 2.2 NA 
V450A 70.8 ± 13.3 102.2 ± 2.2 98.9 ± 3.3 NA 
I453A 0.1 ± 0.1 29.6 ± 41.8 40.1 ± 27.7 7.4±5.5 
V455A 92.3 ± 21.9 108.5 ± 2.1 88.7 ± 19.4 NA 
C458A 42.8 ± 24.1 90.5 ± 8.9 99.4 ± 1.9 NA 
S461A 98.1 ± 23.2 78.4 ± 31.7 101.4 ± 2.3 NA 
G462A 80.5 ± 18.4 100.8 ± 4.1 86.0 ± 5.6 NA 
L465A 15.7 ± 7.6 89.7 ± 12.1 99.1 ± 3.6 NA 
T467A 71.8 ± 10.9 103.9 ± 2.0 96.7 ± 4.2 NA 
S470A 40.8 ± 10.7 91.8 ± 2.9 94.8 ± 6.5 NA 
F472A 0.1 ± 0.1 1.2 ± 0.3 6.9 ± 1.3 3.3±2.3 
I475A 0.3 ± 0.3 0.6 ± 0.8 7.5 ± 8.7 0.9±1.3 
I477A 12.4 ± 9.2 95.8 ± 4.5 98.6 ± 2.3 NA 
T480A 66.2 ± 16.1 109.3 ± 3.2 101.3 ± 0.8 NA 
Q489A 102.2 ± 11.9 100.7 ± 4.2 92.6 ± 7.2 NA 
I490A 4.8 ± 5.6 67.4 ± 6.0 99.4 ± 1.1 NA 
I492A 0.7 ± 0.6 0.7 ± 0.7 23.8 ± 8.3 2.9±2.2 
S493A 99.8 ± 17.2 91.3 ± 17.8 100.8 ± 1.6 NA 
C496A 0.7 ± 1.0 20.4 ± 19.4 58.5 ± 13.4 15.1±3.9 
V498A 0.5 ± 0.7 19.1 ± 9.3 90.7 ± 3.5 NA 
N499A 59.8 ± 13.5 97.5 ± 0.6 99.6 ± 1.9 NA 
L501A 15.3 ± 1.1 82.5 ± 6.2 99.6 ± 2.1 NA 
L503A 51.5 ± 17.1 86.6 ± 14.1 88.0 ± 9.8 NA 
G511A 86.0 ± 8.8 103.6 ± 1.0 100.4 ± 3.7 NA 
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Sample 37ºC 30ºC 18ºC 10ºC 
T515A 107.7 ± 11.2 109.1 ± 1.8 101.0 ± 1.2 NA 
I516A 6.2 ± 4.1 18.1 ± 0.8 81.5 ± 10.8 NA 
S521A 52.7 ± 23.4 105.4 ± 1.8 101.4 ± 1.9 NA 
T522A 57.6 ± 25.2 107.1 ± 3.8 101.2 ± 2.2 NA 
V523A 21.5 ± 15.2 98.4 ± 10.7 99.6 ± 0.8 NA 
S524A 97.8 ± 37.3 107.3 ± 4.0 99.9 ± 1.1 NA 
G525A 62.5 ± 13.8 105.1 ± 4.5 97.8 ± 1.5 NA 
I526A 25.9 ± 6.6 95.1 ± 11.7 98.8 ± 2.0 NA 
T527A 68.3 ± 9.9 89.9 ± 2.3 80.6 ± 9.6 NA 
G528A 27.3 ± 1.6 88.7 ± 5.2 91.1 ± 4.1 NA 
M529A 89.1 ± 10.3 105.6 ± 4.6 100.8 ± 2.0 NA 
V530A 61.0 ± 32.7 102.7 ± 2.2 99.1 ± 2.9 NA 
D531A 35.0 ± 8.6 90.3 ± 9.5 85.9 ± 3.9 NA 
P532A 96.9 ± 15.3 105.5 ± 4.4 99.9 ± 1.6 NA 
S533A 108.6 ± 7.0 108.2 ± 5.2 100.9 ± 2.6 NA 
R534A 84.1 ± 18.2 104.5 ± 8.1 98.4 ± 2.6 NA 
I535A 40.1 ± 29.0 86.8 ± 4.7 81.5 ± 7.4 NA 
N536A 72.3 ± 30.1 102.0 ± 7.6 99.4 ± 1.0 NA 
V537A 28.4 ± 18.2 67.3 ± 16.6 29.0 ± 14.0 31.2±15.1 
N539A 100.7 ± 12.3 103.6 ± 8.2 97.6 ± 2.4 NA 
L540A 92.7 ± 17.0 100.8 ± 5.2 96.6 ± 3.0 NA 
E542A 96.5 ± 4.9 100.0 ± 8.9 96.4 ± 0.3 NA 
E543A 67.9 ± 19.6 99.6 ± 10.1 99.8 ± 1.3 NA 
G544A 76.4 ± 22.7 104.2 ± 2.4 100.2 ± 2.3 NA 
L545A 57.1 ± 13.0 83.6 ± 10.3 79.7 ± 1.2 NA 
H610A 3.0±1.1 0.1±0.1 10.4±12.1 1.9±2.4 
C613A 0.2±0.2 0.0±0.0 5.6±6.6 1.6±2.2 
D632A 0.1±0.1 0.1±0.2 0.0±0.0 1.2±1.2 
C635A 0.1±0.1 1.0±0.8 11.1±7.7 1.0±0.9 
P638A 2.2±3.0 2.9±2.0 31.6±15.5 15.5±6.8 
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37ºC, the great majority exhibited severe folding defects. As the temperature was 
lowered, many single alanine mutants were rescued back to wild-type-like folding 
efficiencies. However, even at the low temperatures of 18ºC, 36 mutants were folding 
deficient and were unable to reach the native state like wild-type. 
Mutants classified as folding deficient at 18ºC were subsequently expressed at 
10ºC. The overall expression efficiencies observed at 10ºC were consistent with those 
seen at 18ºC. The lowered expression temperature did not rescue any of these residues to 
wild-type-like folding efficiencies. 
 
4. Wild-type and ∆N Folding Efficiencies 
 
For wild-type chains expressed at 18ºC, 94% (average of 22 expression samples) 
of the polypeptide chains reached the SDS-resistant, trimeric native conformation. When 
renormalized to this average, the standard deviation of these samples was 2%. Expression 
at 10ºC generated a folding yield of 93±4% (6 samples). When expressed at 30ºC, 87±6% 
(21 samples) of wild-type chains reached the native conformation. Expression at 37ºC 
yielded 62±10% (22 samples) of wild-type chains reaching the native state. The 
deviations at each temperature were well within the 75% threshold for a wild-type-like 
folder (Figure 2-3 insets; Table 2-2). The small standard deviations observed at each 
expression temperature illustrate the precision of this SDS-PAGE based assay. 
ΔN chains folded with wild-type-like efficiency at 37ºC, 95±13% for 28 samples. 
At lower temperatures, ∆N folded significantly better than wild-type with a folding 
efficiency relative to wild-type of 109±3% for 26 samples at 30ºC, 104±1% for 28 
samples at 18ºC, and 101±4% for 6 samples at 10ºC. It has been reported that tailspike 
chains lacking the N-terminal head-binding domain fold faster than the full wild-type 
sequence (Danner et al., 1993; Miller et al., 1998b). The ability to detect the affects of 
this accelerated folding rate validates the precision and accuracy of this assay. 
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5. Mutant Folding Efficiencies at 37ºC 
 
In contrast to the insignificant effect that removal of over 100 amino acids had on 
the folding of the ΔN tailspike protein, alanine substitution of any one of 95 of the 103 
buried core sites significantly hindered the tailspike chains’ ability to reach the native 
state when expressed at 37ºC. One of these mutants, F308A, was previously shown to fail 
to fold at high and low temperatures (Betts et al., 2004). Our high throughput system was 
able to accurately reproduce the published data for this residue as well as all other β-helix 
residues investigated by Betts, et al (2004) (Table 2-2). Of the remaining 42 
predominantly surface exposed sites, 20 had defective folding phenotypes. When folding 
data for all mutants are mapped to the native structure of the P22 tailspike (Figure 2-4), it 
is apparent that the vast majority of defective folding sites are in the cylindrical buried 
core. These sites were intolerant to alanine substitution when folded at 37ºC in vivo. 
Conversely, the 30 wild-type-like folding alanine mutations map almost entirely 
to surface exposed residues, to the termini of the β-helix, or to the shortened stack that 
precedes sheet C. V386A and V455A, located in a valine stack in sheet B, were the only 
exceptions to this. G511A, located in a disordered loop in the wild-type crystal structure, 
had a folding efficiency of 86±9% at 37ºC, and remained a wild-type-like folder at lower 
temperatures. 
 
6. Mutant Folding Efficiencies at 30ºC 
 
At 30ºC, alanine substitutions at 47 sites prevented folding, as compared to 95 
sites at 37ºC. Thus, a drop of 7ºC in expression temperature rescued 48 defective folding 
mutants back to wild-type-like levels. Amongst these rescued sites are nearly all the 
remaining surface exposed residues. 33 of the rescued positions were in the buried core 
stacks, so that 62 of the 103 stacking residues were intolerant to alanine substitution at 
30ºC. Intolerant sites localized to the central region of the β-helix opposite the dorsal fin 
(Figure 2-4), while more tolerant positions clustered near the termini of the β-helix. The 
fourth and fifth rungs of the β-helix were completely intolerant to alanine substitutions of 
core residues at 30ºC. 
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7. Mutant Folding Efficiencies at 18ºC 
 
In contrast to the requirement for 92% of the buried core residues at 37ºC, only 31 
out of 103 alanine mutations were absolutely incapable of achieving wild-type-like 
folding efficiencies at 18ºC. The sites of these completely intolerant residues were 
located in every rung of the β-helix, except rung 7. Rungs 6 and 8 have the highest 
number of intolerant positions, four and five respectively. Individual substitutions of six 
glycines prevented mutant chains from reaching the native state. Four of these six glycine 
residues have backbone conformations that are inaccessible by alanine, while steric 
packing problems may prevent the other glycine to alanine mutations from folding. 
When non-glycine positions completely intolerant to alanine substitution are 
mapped onto the native structure of tailspike’s β-helix, a continuous network of 29 
interacting side chains is revealed that spans the length of the β-helix (Figure 2-4). This 
chain of mostly hydrophobic residues, which we call the “folding spine”, is composed of 
short stacks that cluster around variable turn regions, such as the dorsal fin. In the case of 
the dorsal fin domain, a cluster of six amino acids is essential for folding where the chain 
detours from the β-helix and into the dorsal fin. At the center of this cluster, two residues 
(M195, L262) pack against each other, as if stapling together the meandering backbone 
(Figure 2-5). 
Although the most frequent wild-type residue found in the folding spine is 
phenylalanine, it is important to note that not all phenylalanines in the buried core of the 
P22 tailspike β-helix are necessary at all temperatures. This observation demonstrates 
that the folding phenotype is not due solely to the type of mutation, but that tertiary 
context contributes to the detected folding efficiencies. 
Two asparagines, N310 and N319, and the only histidine in the buried core, 
H426, are present in the folding spine. In the native structure, these side chains interact 
with resolved, buried water molecules that coordinate the backbone of loop regions. 
These necessary residues highlight the complexity of the folding process in vivo. 
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8. Mutant Folding Efficiencies at 10ºC 
 
When expressed at 10ºC, the 31 buried core alanine mutations that were incapable 
of achieving wild-type-like folding efficiencies at 18ºC continued to display folding-
deficient phenotypes (Table 2-2). Of these 31 residues, only 7 showed statistically 
different folding efficiencies, all but one of which had lower folding efficiencies at 10ºC 
than at 18ºC. The only mutant that significantly improved in its folding efficiency at 10ºC 
was L179A, which had its folding efficiency rise from 47% to 69% with the eight degree 
decrease in temperature. 
 
9. Capping Residues 
 
A number of alanine substitutions in the N-terminal capping region (122-146) of 
the β-helix resulted in folding deficient phenotypes at or below 30ºC. These mutants 
highlight this region’s role in preventing aggregation (Figure 2-6). This region is 
composed of a short β-strand, a turn, and a conserved α-helix. V141A, located at the C-
terminus of the conserved α-helix, is the only mutant in this region deficient in folding at 
all temperatures. This residue may act as a stop signal, ensuring that the α-helix is the 
proper length to cap the β-helix. 
Only two capping mutants are rescued at 18ºC, L133A and Y130A. L133 is 
located at the N-terminus of the α-helix and points directly downward into the β-helix 
core, possibly anchoring the α-helix into its capping position. Y130 sits centrally over the 
core of the β-helix, potentially bridging the hydrophobic interior of the β-helix and the 
polar solvent. It is important to note that Y123A, as opposed to Y130A, displays 
completely wild-type-like folding phenotypes at all temperatures. The folding phenotypes 
observed in the N-terminal capping regions illuminate key roles of wild-type side chains 
that are not simply a reflection of the type of mutation. 
 76 
 
 
Figure 2-6. N
-term
inal C
apping R
egion. (A
) R
ibbon diagram
 of the N
-term
inal capping region (blue) and α-C
arbon trace of the first 
rung of the β-helix (green). (B
) Phenotypic data is m
apped onto the structure of the N
-term
inal capping dom
ain. G
reen residues 
represent positions that fold like w
ild-type at all tem
peratures w
hen replaced by alanine. Y
ellow
 residues are folding deficient only at 
37ºC
 w
hen replaced by alanine. O
range residues are folding deficient at 37ºC
 and 30ºC
 w
hen replaced by alanine. The red residue 
(V
141) is folding deficient at all tem
peratures w
hen replaced by alanine. Figure reprinted from
 (Sim
kovsky and K
ing, 2006), ©
 2006 
by The N
ational A
cadem
y of Sciences of the U
SA
. 
 
 77 
In the C-terminal capping region (521 – 545), only V537A was deficient in 
folding at temperatures below 37ºC (Table 2-2). In the wild-type native trimer, this 
residue is a part of the final rung of the β-helix and interacts with the side chain of F553 
from one of its sister polypeptide chains. This residue may play a greater role in capping 
through oligomerization, rather than capping in a monomeric state. 
 
10. C-terminal Cysteine Annulus Mutations 
 
Alanine substitutions were constructed in the far C-terminus of the tailspike 
protein. These mutants are located in an area of the structure known as the cysteine 
annulus, which is known to be important for the oligomerization of P22 tailspike (Gage 
and Robinson, 2003). These mutations affected cysteine residues (C613 and C635) 
believed to be important for the presence of a transient disulfide bond in a protein folding 
intermediate (Haase-Pettingell et al., 2001; Robinson and King, 1997) as well as residues 
that appeared likely to affect the reactivity of those cysteine residues (H610, D632, and 
P638) (Fomenko and Gladyshev, 2003). 
At all temperatures tested, these mutants were incapable of folding to the native, 
trimeric state (Table 2-2). 
 
11. Solubility and Mobility Shifts 
 
Instead of accumulating as trimers, the majority of the cysteine annulus mutations 
accumulated as SDS-sensitive polypeptide chains in the soluble fraction of the expression 
lysates at temperatures below 37ºC. At 37ºC, all non-native tailspike conformers in all 
37ºC samples accumulated in a consistent manner in the pelleted, insoluble fraction of the 
cell lysates. At 30ºC and lower temperatures, only V537A, H610A, C613A, and D632A 
accumulated soluble, SDS-sensitive tailspike chains in a consistent manner across the 
three independent expression cultures tested per mutant. C635A also accumulated 
soluble, SDS-sensitive chains at 18ºC and 10ºC in a consistent manner. 
As described above, accumulation of soluble SDS-sensitive species represents 
chains that have reached a late stage in folding, with defects either in oligomerization, 
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native state maturation, or stability. Since mutants that accumulated as soluble, SDS-
sensitive polypeptide chains are located at the very end of the β-helix or in the C-
terminus of the tailspike protein, it is consistent to state that these chains were capable of 
creating a folded β-helix domain but were defective in later steps in the tailspike folding 
pathway. In contrast, the folding defects associated with the core β-helix alanine mutants 
occurred at or prior to the monomeric, β-helical folding intermediate.  
A number of native trimeric mutant chains displayed mobility shifts with respect 
to wild-type chains. These mutants primarily corresponded to the mutation of charged 
residues, though not all charge changes produced alterations in mobility. Two neutral 
changes (N499A, G462A) produced reproducible mobility shifts. The physical basis for 
these shifts is not understood, but may reflect an altered native conformation. 
 
 
D. DISCUSSION 
 
 
1. Tailspike β-helix Folds via a Processive Folding Pathway 
 
Previous experiments on small, globular proteins have demonstrated that the 
amino acid folding code is highly degenerate and, in at least one case, half of the residues 
can be replaced by alanines simultaneously (He et al., 2004; Kuroda and Kim, 2000; 
Sauer, 1996). In the P22 tailspike β-helix, the entire core is surprisingly sensitive to 
amino acid changes at physiological temperature. If folding followed a global collapse 
mechanism, then the removal of 2 to 8 atoms out of a core composed of 365 side chain 
atoms would not be expected to completely block the folding process, which has a ∆G of 
-7.6 kcal/mol for the isolated β-helix domain (Miller et al., 1998a) and produces a native 
state that has a melting temperature of 88.4ºC (Sturtevant et al., 1989). 
In contrast, a processive folding pathway, where a series of local folding events 
must occur in a specific order to reach a native structure, is consistent with these results. 
We propose that the in vivo folding pathway of the tailspike’s β-helix occurs via a 
processive folding mechanism, such as the sequential winding of rungs (Figure 2-7). 
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The contribution of wild-type side chains to productive folding was temperature 
dependent. Folding analysis at low temperatures revealed an elongated folding spine of 
essential residues encoding critical contacts that allow for the in vivo folding of the 
tailspike protein. Although it cannot be ruled out that these residues represent positions 
that critically interact with the ribosome in a ribosome-assisted folding mechanism, it is 
unlikely that these residues are required for intermolecular interactions. Instead, we 
postulate the simpler model that these residues may control the folding of the β-helix by 
tethering key positions into a general cylindrical structure, thereby allowing β-sheets to 
form. At lower temperatures, certain packing interactions may tolerate an alanine 
replacement, but the interaction energy of an alanine mutant may not be sufficient to 
overcome added kinetic energies at higher temperatures. 
30ºC data demonstrated that residues located centrally in the β-helix were more 
intolerant to substitution than at the termini. The proposed processive folding pathway 
predicts that inhibition of earlier folding events would have more drastic effects than later 
stages. This suggests that β-helix formation in vivo initiates with the creation of a 
structural nucleus near the center of the β-helix and proceeds via a templating or tethering 
mechanism outward towards the termini. Folding data from mutants located in the N-
terminal capping region suggest that folding of this domain concludes via formation of 
key capping contacts, which may stabilize the β-helix and prevent aggregation. 
All β-helix domain mutant chains incapable of producing native trimers 
accumulated in the insoluble pellet fraction of the lysates, while mutations in the C-
terminus of the protein accumulated soluble, SDS-sensitive chains. This indicates that the 
observed folding defects associated with mutants in the β-helix domain are due to affects 
on the folding of this domain. 
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2. Role of Stacking Residues 
 
These results indicate that stacking of side chains plays a critical role in the 
folding of the β-helix. However, stacks that run the entire length of the β-helix are not 
necessary to direct folding at low temperatures. Instead, the folding spine spans numerous 
stacks and is composed of numerous different amino acid types. This finding supports the 
notion that side chain stacks are necessary to encode an elongated β-helix. This is in 
contrast to the large number of previously isolated tsf mutations that represent solvent 
exposed residues critical in folding at high temperatures, but unnecessary at lower 
temperatures (Betts et al., 2004). The short core stacks may function to stabilize 
intermediate forms or to specifically prevent off-pathway aggregation. Although the 
identity of wild-type side chains in the folding spine does not yield a simple sequence-
based rule for folding, it does reveal that folding is a highly complex process that depends 
both on side chain identities and their tertiary context. 
The continuous nature of the folding spine indicates that a long-range network of 
interactions may act cooperatively to form the β-helix. Such networks have been 
previously proposed based upon sequence conservation analysis of PDZ and POZ 
domains (Lockless and Ranganathan, 1999). Our data demonstrates the existence of such 
a network in the context of the folding of the β-helix domain. If the connectivity of short 
stacks did not act cooperatively, one might expect that these short stacks of necessary 
residues might be more randomly dispersed throughout the core. Instead, we believe that 
the presence of this continuous folding spine represents a cooperative network that directs 
the protein towards its native fold in vivo. 
Understanding the full role key stacking positions play will require further 
investigations into the cooperativity of this network and identification of factors that link 
the amino acid sequence to its contribution towards folding. Seckler and coworkers have 
analyzed the site of the buried global suppressor, A334, in considerable detail (Seckler, 
1998). In contrast to the intolerance of side chain deletions presented here, β-helix 
folding tolerated bulkier substitutions at this site (Schuler and Seckler, 1998). 
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3. Capping Residues 
 
Residues located at the N-terminus of the β-helix indicate that this capping region 
is critical for prevention of aggregation. V141 likely acts as an α-helix breaker, thereby 
ensuring the formation of the capping α-helix. The positioning of Y130 over the core the 
β-helix not only acts as a bridge between the hydrophobic interior of buried core and the 
polar solvent, but it may also register the α-helix into its capping role on the N-terminal 
side of the helix. Overall, it appears that the formation of the α-helix and the positions 
bounding it are critical for the proper formation and solubility of the β-helix. 
In contrast, residues located at the C-terminus of the β-helix did not appear to be 
as important for the folding of the protein. If these residues can tolerate alanine 
substitutions, how does the sequence encode a signal to stop the winding of the β-helix 
domain and to protect the hydrophobic surface that may be exposed until the protein 
trimerizes? The answer may lie in the fact that the region of sequence following the last 
rung of the β-helix contains a large number of charged residues. These residues are 
unlikely to be able to form a rung without causing burial of charged residues (Figure 2-8). 
Packing of buried charges would be incompatible with the sole critical residue in this 
region, V537. Therefore, the C-terminal residues that were tested in this experiment were 
likely unimportant for folding because the true “stop” signal exists beyond the sequence 
region examined.
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CHAPTER THREE: 
 
 
THERMOSTABILITY OF FOLDING MUTANTS 
 
 
 
 
 86 
A. INTRODUCTION 
 
 
1. Thermostability of P22 Tailspike 
 
The last step in tailspike’s productive folding pathway (Figure 1-8) coincides with 
the folding and assembly of the interdigitated region to form a molecular clamp that 
makes tailspike resistant to trypsin degradation and SDS denaturation, and raises the 
melting temperature by approximately 40°C to 88.4°C (Goldenberg and King, 1982; 
Kreisberg et al., 2002; Sturtevant et al., 1989). When exposed to temperatures above 
65ºC and below tailspike’s melting temperature in the presence of 2% SDS, the native 
trimer will partially unfold to an SDS-resistant, high mobility species (Iu) that maintains 
β-helical conformation but lacks structure in the N-terminal head-binding domain (Chen 
and King, 1991). 
Previous experimentation on temperature sensitive folding mutations has 
demonstrated that temperature sensitive folding (tsf) mutations do not affect the native 
stability of the trimeric tailspike protein, but instead affect a thermolabile folding 
intermediate (Danner and Seckler, 1993; Sturtevant et al., 1989). 
 
2. Experimental Design 
 
In Chapter 2, it was shown that polypeptide chains carrying a β-helix mutant 
incapable of producing a native trimer band accumulated in the pelleted fraction of the 
lysate. In contrast, folding deficient mutants located at the very end of the β-helix or in 
the cysteine annulus of the tailspike were capable of producing soluble but SDS-sensitive 
tailspike chains. Although this indicates that β-helix mutants affected the folding of the 
protein before association, it does not rule out the possibility that mutant polypeptide 
chains reached a transient native-like state, but then fell apart to an aggregation prone 
state. Do these mutations destabilize the native trimeric conformation of tailspike? 
To test if these mutations caused low folding efficiencies at the higher 37ºC 
temperature by destabilizing the native state, I performed a thermostability assay on 
mutant trimers produced at 18ºC to determine their approximate melting temperatures. 
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B. MATERIALS AND METHODS 
 
 
1. Production of Mutant Trimers 
 
Natively folded tailspike trimers of mutants generated in Chapter 2 were produced 
by over expression at 18ºC as described in Chapter 2, Section B2. Cells were lysed and 
fractionated by centrifugation as described in Chapter 2, Section B3. The supernantant 
fractions containing native trimers were subsequently mixed with 2% SDS sample buffer 
as described in Chapter 2, Section B3 in a 96 well plate. After the experiments of Chapter 
2 were completed, these samples were stored at -20ºC. 
 
2. Thermostability Assay 
 
Frozen supernatant samples were thawed on ice and 10 µl aliquots were moved to 
new shallow well plates. Plates were sealed with silicon cap lids clamped down by a glass 
plate and binder clips. The sealed plate was partially submerged in a heated water bath to 
either 80ºC or 90ºC for 3 min, and then placed on ice until samples were examined by 
SDS-PAGE, as described in Chapter 2, Section B3. Gels were imaged and analyzed by 
optical densitometry as described in Chapter 2, Section B4. Due to the partial unfolding 
of the N-terminal domain of tailspike at temperatures above 65ºC (Chen and King, 1991), 
optical density values were calculated for the tailspike bands corresponding to the native 
trimer, the partially unfolded intermediate Iu, and the completely unfolded SDS-sensitive 
species. The percentage of chains that were unfolded was calculated by dividing the 
optical density of the completely unfolded band by the total optical density of all three 
tailspike bands, as detailed in the following formula: 
! 
Percent Unfolded =  
OD
U
OD
NT
+ OD
IU
+ OD
U
"100%  
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C. RESULTS 
 
 
1. Unfolding of Wild-type and ∆N Controls 
 
To test if mutations acted by destabilizing the native state, the native trimeric 
forms of the mutant polypeptide chains in the soluble fractions of 18ºC expression 
samples were assessed for thermostability. 114 of the alanine mutants accumulated 
sufficient native-like trimers at low temperature to be assayed. Lysates were heated to 
either 80ºC or 90ºC for 3 min in the presence of 2% SDS and analyzed for unfolding of 
the β-helix region. As described by Chen and King (Chen and King, 1991), wild-type 
proteins partially unfolded to an SDS-resistant, high mobility species (Iu) that maintains 
β-helical conformation but lacks structure in the N-terminal head-binding domain when 
heated to 80ºC (Figure 3-1). Only 3.1±1.7% of wild-type native chains fully denatured to 
a SDS-sensitive species at 80ºC. Heating to 90ºC resulted in nearly complete dissociation 
(89.9±7.9%) to a denatured, monomeric SDS/polypeptide chain complex (Figure 3-2; 
Table 3-1). 
Heating of ∆N resulted in similar thermostability values, with only 4.5±3.4% of 
chains unfolding at 80ºC and 98.5±3.7% of chains unfolding at 90ºC (Figure 3-2; Table 
3-1). Since ∆N lacks the N-terminal region that partially unfolds at these high 
temperatures, ∆N did not produce the partially unfolded species (Iu) (Figure 3-1). This 
reconfirmed that the partial unfolding of the mutant trimers was not due to the unfolding 
of the β-helix region and allowed for the identification of mutant tailspike specific bands, 
such as Iu, in other samples. 
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Figure 3-2. Therm
ostability assay on 18ºC
 w
ild-type-like folders. The percent of native tailspike chains com
pletely unfolded in the 
presence of 2%
 SD
S w
hen heated to 80ºC
 (blue circle) or 90ºC
 (red square) is show
n as the average of duplicate experim
ents. Lines 
represent standard deviations. W
T and ∆N
 controls are show
n in inset. Figure reprinted from
 (Sim
kovsky and K
ing, 2006), ©
 2006 by 
The N
ational A
cadem
y of Sciences of the U
SA
. 
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Table 3-1. Thermostability data of 18ºC WT-like trimers. Thermostability values are 
given as the percent of tailspike chains completely unfolded in the thermostability assay 
when heated to either 80ºC or 90ºC. These values were calculated only for samples 
displaying >75% folding efficiency at 18ºC, as determined in Chapter 2. Otherwise the 
calculation was not applicable (NA). Average percent unfolded values greater than 50% 
are shaded and bolded. 
 
Percent unfolded by heat  Percent unfolded by heat 
Sample 
80ºC heat 90ºC heat  
Sample 
80ºC heat 90ºC heat 
WT 3.1 ± 1.7 89.9 ± 7.9  R148A 3.3 ± 0.4 80.8 ± 8.0 
∆N 4.5 ± 3.4 98.5 ± 3.7  Y150A 3.8 ± 2.0 97.6 ± 1.4 
K122A 24.9 ± 16.7 99.0 ± 0.6  F152A NA NA 
Y123A 29.3 ± 18.3 97.6 ± 1.0  Y153A 2.5 ± 0.3 83.6 ± 5.3 
S124A 24.8 ± 15.4 97.8 ± 1.3  E156A 18.8 ± 18.7 95.8 ± 0.9 
V125A 10.1 ± 7.6 98.2 ± 0.5  V158A 10.4 ± 8.3 96.0 ± 3.1 
K126A 11.2 ± 5.0 97.9 ± 0.0  F160A 7.5 ± 5.8 99.1 ± 0.1 
L127A 3.9 ± 1.1 98.6 ± 0.0  K163A 2.5 ± 0.2 88.9 ± 1.5 
S128A 27.6 ± 25.2 95.7 ± 2.9  L165A 23.8 ± 19.5 98.7 ± 0.4 
D129A 22.8 ± 14.8 97.2 ± 0.2  T166A 24.3 ± 23.4 97.3 ± 0.7 
Y130A 28.0 ± 26.9 97.4 ± 0.4  I167A NA NA 
P131A 22.4 ± 21.7 98.8 ± 0.1  C169A 6.4 ± 1.4 96.2 ± 0.1 
T132A 12.8 ± 11.9 98.3 ± 1.0  K172A 15.3 ± 15.2 95.0 ± 2.0 
L133A 12.4 ± 11.3 98.2 ± 0.7  F173A 8.0 ± 8.0 97.8 ± 0.8 
Q134A 4.6 ± 1.3 96.7 ± 2.5  G175A 3.9 ± 0.9 61.6 ± 30.1 
D135A 2.3 ± 0.3 97.6 ± 0.9  L179A NA NA 
S138A 1.9 ± 0.2 97.4 ± 0.8  F181A 6.0 ± 0.9 98.7 ± 0.5 
V141A NA NA  L184A 8.9 ± 7.9 98.6 ± 0.5 
D142A 49.3 ± 4.4 95.2 ± 0.0  S188A 3.8 ± 1.8 96.9 ± 0.6 
G143A 8.6 ± 5.7 97.1 ± 0.2  I190A 7.7 ± 3.4 95.0 ± 1.4 
L144A NA NA  V193A 2.9 ± 1.4 87.9 ± 10.7 
L145A 34.2 ± 31.9 97.0 ± 0.3  M195A NA NA 
I146A 6.8 ± 6.6 93.0 ± 1.1  S260A 2.8 ± 0.9 92.2 ± 1.3 
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Sample 80ºC heat 90ºC heat  Sample 80ºC heat 90ºC heat 
L262A NA NA  F352A 14.6 ± 0.5 93.6 ± 1.9 
I264A 4.2 ± 3.5 97.7 ± 0.6  S354A 3.9 ± 1.0 94.6 ± 0.3 
C267A 4.8 ± 1.9 96.2 ± 1.4  G361A 43.7 ± 42.4 96.5 ± 2.0 
V270A 4.9 ± 1.7 98.6 ± 0.0  V362A 14.4 ± 10.3 97.7 ± 1.6 
V272A 2.9 ± 0.7 99.3 ± 0.3  T364A 34.6 ± 2.7 95.8 ± 0.3 
G277A NA NA  N376A 23.3 ± 8.7 94.9 ± 1.6 
F282A NA NA  L379A NA NA 
F284A NA NA  F381A NA NA 
C287A 2.1 ± 0.5 98.7 ± 0.1  S384A 3.0 ± 0.6 96.4 ± 1.5 
C290A 3.0 ± 0.5 90.0 ± 7.3  V386A 2.3 ± 0.7 75.9 ± 18.2 
M292A 2.6 ± 0.6 82.8 ± 4.8  P389A 6.0 ± 4.9 84.5 ± 0.3 
V293A 2.8 ± 0.7 97.2 ± 1.1  G393A NA NA 
P298A 2.7 ± 0.1 93.3 ± 3.5  F394A 92.2 ± 4.1 92.7 ± 2.2 
G300A NA NA  L396A NA NA 
G301A 17.7 ± 3.8 82.4 ± 5.0  L424A NA NA 
I305A 4.2 ± 1.9 93.8 ± 2.4  H426A NA NA 
I306A 3.1 ± 2.0 95.9 ± 0.5  I428A 32.1 ± 17.4 96.0 ± 1.1 
F308A NA NA  L431A 5.3 ± 2.4 92.7 ± 3.5 
N310A NA NA  V433A 3.2 ± 0.2 84.2 ± 5.3 
N319A NA NA  G440A 8.3 ± 0.2 93.7 ± 0.7 
V321A 4.5 ± 1.1 96.6 ± 1.1  F441A NA NA 
G324A NA NA  M443A 2.0 ± 1.4 99.2 ± 0.1 
T326A 2.8 ± 0.9 94.9 ± 0.7  G445A NA NA 
G329A NA NA  M448A 15.1 ± 15.1 94.9 ± 0.6 
S333A 3.9 ± 2.1 84.8 ± 1.7  V450A 5.6 ± 5.4 95.1 ± 0.6 
F336A NA NA  I453A NA NA 
N339A 4.1 ± 0.5 84.3 ± 2.8  V455A 44.3 ± 29.5 95.3 ± 1.7 
G347A 7.4 ± 3.2 95.5 ± 0.1  C458A 28.6 ± 20.2 94.6 ± 1.3 
V349A 2.7 ± 1.5 95.2 ± 1.0  S461A 3.5 ± 3.4 93.6 ± 2.9 
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Sample 80ºC heat 90ºC heat  Sample 80ºC heat 90ºC heat 
G462A 14.7 ± 4.6 95.8 ± 2.1  G525A 6.9 ± 4.2 98.6 ± 0.1 
L465A 1.9 ± 0.3 83.5 ± 8.6  I526A 3.8 ± 0.7 97.6 ± 0.9 
T467A 3.5 ± 2.4 96.9 ± 0.7  T527A 7.4 ± 0.4 96.9 ± 2.0 
S470A 4.3 ± 3.6 98.0 ± 0.7  G528A 2.9 ± 2.2 70.1 ± 19.6 
F472A NA NA  M529A 3.5 ± 3.4 98.2 ± 0.9 
I475A NA NA  V530A 4.6 ± 4.6 99.1 ± 0.2 
I477A 5.8 ± 5.8 96.1 ± 1.0  D531A 18.3 ± 11.5 92.7 ± 2.0 
T480A 6.7 ± 5.8 95.2 ± 1.1  P532A 4.4 ± 4.3 95.9 ± 2.9 
Q489A 11.7 ± 8.6 85.9 ± 3.7  S533A 5.9 ± 4.9 96.8 ± 1.2 
I490A 3.2 ± 3.1 97.6 ± 0.3  R534A 7.4 ± 4.6 96.3 ± 0.3 
I492A NA NA  I535A 31.2 ± 4.1 96.3 ± 1.0 
S493A 3.9 ± 3.6 94.0 ± 0.4  N536A 5.3 ± 3.8 97.6 ± 0.1 
C496A NA NA  V537A NA NA 
V498A 2.7 ± 0.2 93.5 ± 2.7  N539A 13.9 ± 9.8 97.8 ± 1.0 
N499A 3.9 ± 0.0 80.9 ± 13.7  L540A 4.4 ± 2.8 97.1 ± 2.6 
L501A 2.7 ± 2.6 89.4 ± 5.9  E542A 20.1 ± 11.5 96.1 ± 1.6 
L503A 5.0 ± 1.8 94.6 ± 2.4  E543A 5.3 ± 2.8 98.7 ± 0.4 
G511A 2.1 ± 1.3 92.9 ± 4.7  G544A 2.9 ± 1.5 97.9 ± 0.7 
T515A 2.3 ± 2.2 80.2 ± 0.6  L545A 17.5 ± 6.3 94.9 ± 1.3 
I516A 2.9 ± 2.7 92.3 ± 1.5  H610A NA NA 
S521A 4.6 ± 2.3 96.6 ± 1.5  C613A NA NA 
T522A 2.3 ± 2.3 92.7 ± 3.6  D632A NA NA 
V523A 1.1 ± 1.1 96.4 ± 0.4  C635A NA NA 
S524A 3.4 ± 1.9 96.3 ± 0.4  P638A NA NA 
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2. Unfolding of Single Alanine Mutants 
 
All trimeric mutant tailspikes consistently dissociated to monomeric 
SDS/polypeptide chain complexes when heated to 90ºC (Figure 3-2). All of these chains 
partially denatured similarly to wild-type when subjected to 80ºC, except for F394A. 
F394A consistently and completely dissociated to SDS-sensitive chains when subjected 
to 80ºC (Figure 3-2; Table 3-1). These results demonstrate that the single alanine mutants 
have melting temperatures within the range of 80ºC to 90ºC in the presence of 2% SDS. 
Therefore, all but one of the alanine mutations did not affect the stability of the trimeric 
native state. 
 
 
D. DISCUSSION 
 
 
1. Alanine Mutants Affect β-helix Folding Intermediates 
 
In these thermostability experiments, mutant chains were exposed to extreme 
environmental conditions. The chains, while being present in a 2% SDS solution, were 
first frozen at -20ºC and then heated to either 80ºC or 90ºC. These settings are far harsher 
than the environment experienced by mutant chains folding within cells at 37ºC. Given 
that the melting temperatures of these chains is greater than 80ºC in the presence of 
detergent, it is clear that the observed folding efficiencies in Chapter 2 are not due to a 
destabilization of the native state, but must be due to a folding defect earlier in the 
productive folding pathway. 
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CHAPTER FOUR: 
 
 
IN VIVO FOLDING OF β-HELIX MUTANTS IN THE 
ISOLATED β-HELIX DOMAIN 
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A. INTRODUCTION 
 
 
1. The Isolated β-helix Domain 
 
Seckler and coworkers constructed and characterized a tailspike fragment 
consisting of only the central β-helix domain (109 – 544) of the P22 tailspike protein 
(Miller et al., 1998a). They demonstrated that the fluorescence and CD signals of the 
isolated β-helix construct closely resemble those of the full length tailspike, indicating 
that the fragment is in a conformation similar to that of the β-helix domain in the native 
trimeric tailspike. This tailspike fragment exists as a monomer at concentrations below 1 
µM, trimerizes at higher protein concentrations, and is capable of binding and cleaving 
tailspike’s endorhamnosidase substrate. Unlike the full length tailspike, the β-helix 
fragment can be reversibly unfolded and refolded under ideal conditions, allowing for the 
calculation of its free energy of folding (-32 kJ/mol) from a two-state model. 
Under non-ideal conditions, such as temperatures above 10ºC, high salt 
concentrations, or the lack of chelating agents, the β-helix fragment readily aggregates 
(Schuler et al., 1999). This aggregation proceeds by a linear polymerization model and 
occurs fastest at denaturant concentrations corresponding to its folding mid-point, 
indicating that aggregation proceeds from a partially folded intermediate. Aggregation 
leads to a number of distinct morphologies, including the formation of amyloid-like 
fibrils. These fibers bind the dye Congo red and display bright green birefringence upon 
excitation with cross-polarized light. Unlike most amyloids, the fibers are an order of 
magnitude larger in diameter and many of the fibers appeared curled or branched. 
2. Mutants G244R (tsf) and A334V (su) 
 
Mutational analysis of the full length tailspike and the isolated β-helix domain 
have allowed for detailed investigations into the sequence control of the folding of the β-
helix. Two particular mutations, G244R and A334V, have been well characterized in 
both constructs under various environmental conditions in vivo and in vitro. 
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The temperature sensitive mutation (tsf) G244R, originally designated tsH304, is 
located in a solvent exposed loop of the dorsal fin. This mutation produces trimeric 
tailspike at temperatures at or below 30ºC with an altered electrophoretic mobility both in 
vivo and in vitro (Goldenberg and King, 1982; Goldenberg et al., 1982; Mitraki et al., 
1993; Yu and King, 1984). At elevated temperatures, such as 37ºC or greater, G244R is 
incapable of forming trimeric tailspikes, even though trimeric G244R tailspikes formed at 
permissive temperatures have a melting temperature of 87.5ºC (Goldenberg and King, 
1981; Smith and King, 1981; Sturtevant et al., 1989). Instead, a destabililzed folding 
intermediate rapidly accumulates into an irreversible aggregate, as is apparent from in 
vitro refolding experiments (Danner and Seckler, 1993). When investigated in the context 
of the isolated β-helix domain, G244R destabilized the structure’s free energy of folding 
by 10 kJ/mol, or 2.4 kCal/mol (Schuler and Seckler, 1998). These observations have led 
to the hypothesis that G244R and other tsf mutants act by globally destabilizing a 
monomeric folding intermediate where the β-helix domain is largely formed. 
The global suppressor mutation (su) A334V is capable of rescuing an intrachain 
G244R folding defect or enhancing the folding yields of wild-type at higher temperatures 
in vitro and in vivo (Danner and Seckler, 1993; Fane et al., 1991; Mitraki et al., 1993). 
Although A334V does not alter the melting temperature of the full length trimer (Mitraki 
et al., 1993), it has been shown to accelerate the unfolding of ∆N and full length tailspike 
(Beissinger et al., 1995; Miller et al., 1998b). The crystal structure of A334V displays a 
root mean square difference of only 0.104 Å in comparison to the wild-type structure, but 
is hindered in its enzymatic activity by 40% (Baxa et al., 1999). This single amino acid 
mutation appears to stabilize the monomeric folding intermediate along the productive 
folding pathway, allowing for more efficient folding (Beissinger et al., 1995). Since 
A334V stabilizes the isolated β-helix domain by 7 kJ/mol, or 1.7 kCal/mol (Schuler and 
Seckler, 1998), it has been proposed that this suppressor mutation globally stabilizes the 
β-helical, monomeric folding intermediate. 
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3. Experimental Design 
 
In previous chapters, it was shown that single alanine mutants of β-helix domain 
residues do not destabilize the native state of the trimeric P22 tailspike protein. Instead, 
mutant chain solubilities indicate the β-helix mutants affect a folding step before 
oligomerization. Do single alanine mutations located in the buried stacks of the tailspike 
β-helix domain prevent tailspike formation by hindering the folding of the β-helix? 
To test the affects of mutations directly on the folding of the β-helix, mutations 
were constructed in the context of the isolated β-helix domain and assayed for their 
ability to fold in vivo at the temperatures previously tested with the full length tailspike. 
The mutations A334V and G244R were included in this study as controls. 
 
 
B. MATERIALS AND METHODS 
 
 
1. Production of Isolated β-helix Construct 
 
pET(∆N), which is a pET11a vector encoding a P22 tailspike protein lacking its 
N-terminal domain (1-108) called ∆N, was a generous gift from Dr. Anne Robinson 
(Gage and Robinson, 2003). Methylated pET(∆N) DNA was purified to act as template 
DNA for mutagenesis from E. coli XL1-Blue cells (Stratagene) using a QIAprep Spin 
MiniPrep kit (QIAGEN). 
The pET(∆N) vector was mutated to a pET(βHX) vector, a pET11a vector 
encoding the isolated β-helix domain (residues 109-544) with a hexahistidyl tag at its C-
terminus (Miller et al., 1998a), through a series of 3 site-directed mutagenesis reactions. 
The first reaction mutated three amino acids at the end of the β-helix domain of ∆N to 
histidines to generate ∆N-L545H-G546H-N547H, which was called ∆N-3H. The second 
reaction further mutated three more residues to hisitidines, generating ∆N-L545H-
G546H-N547H-I548H-R549H-A550H, or ∆N-6H. The final reaction mutated the codons 
encoding residues 551 and 552 to amber and ochre stop codons, respectively, generating 
the βHX construct. 
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At each step of the process, methylated template DNA was mutated through a 
PCR-based QuikChange procedure (Stratagene) that utilized the appropriate mutagenic 
primer (IDT) listed in Table 4-1 and that primer’s exact reverse complement. PCR 
products were transformed into E. coli XL1-Blue cells using a single step protocol 
(Chung et al., 1989). Following clonal growth, methylated plasmid DNA was purified as 
before and used either as a template for further rounds of mutagenesis or for DNA 
sequencing. DNA sequencing of a 400 base pair region (20% of the tailspike gene) 
containing the targeted codon confirmed the generation of ∆N-3H, ∆N-6H, and βHX 
clones (MGH DNA Core, Cambridge, MA). 
 
2. Production of Single Alanine Mutants in the Isolated β-helix 
 
Methylated pET(βHX) DNA was purified to act as template DNA for mutagenesis 
from XL1-Blue cells (Stratagene) as described above. Scanning alanine mutagenesis was 
performed using the PCR-based QuikChange mutagenesis procedure (Stratagene) as 
described in Chapter 2, Section B1. Mutagenic primers used to generate single alanine 
mutants in Chapter 2, Section B1 were used again to introduce the desired six mutations 
[F160A, F308A, F336A, F352A, Q489A, and C496A] individually into the βHX 
construct (Table 2-1). The mutagenic primers (IDT) listed in Table 4-2 and their reverse 
complements were used to generate the control mutations of G244R and A334V in the 
βHX-encoding gene. PCR products were transformed into E. coli XL1-Blue cells as 
described previously. 
Plasmids encoding potentially altered βHX genes were purified from XL1-Blue 
cells and confirmed by sequencing, as described above. Plasmid DNA encoding 
confirmed alanine mutants was transformed into E. coli BL21(DE3) as described above. 
Cultures were selected on individual Luria Broth (LB) plates containing 100 µg/ml 
ampicillin. Cultures were made into 8.3% DMSO freeze stocks after 8 to 11 hours of 
growth in LB containing 100 µg/ml ampicillin at 37ºC. Freeze stocks were stored in dram 
vials at -80ºC. 
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3. Production of G244R and A334V Full Length Tailspike Mutants 
 
The plasmid pET(gene9) was mutated to encode the mutation G244R or A334V 
using the procedures described in Chapter 2, Section B1. The mutagenic primers listed in 
Table 4-2 were used to generate the G244R and A334V mutations. Mutants were 
confirmed by sequencing following transformation into XL1-Blue cells and miniprep of 
clonal cultures as described in Section B2. Confirmed mutant plasmids were transformed 
into E. coli BL21(DE3) cells and stored as 8.3% DMSO freeze stocks at -80ºC, as 
detailed in Chapter 2, Section B2. 
 
4. Expression of β-helix and Full Length Constructs 
 
Freeze stocks of full length tailspike constructs and pET(βHX) strains were 
streaked out on LB plates containing 100 µg/ml ampicillin and grown overnight at 37ºC. 
Clones from these plates or streaks from freeze stocks were used to inoculate 37ºC 
overnight growth cultures in LB containing 100 µg/ml ampicillin. Expression cultures 
were inoculated via 100-fold dilution of the overnight cultures into LB media containing 
0.5% glucose, 50 mM MOPS and 100 µg/ml ampicillin. Cells were grown shaking (225 
rpm) in 500 µl volumes in 96 deep-well plates for approximately 3.25 hours at 37ºC. 
IPTG was added to a final concentration of 1.5 mM to induce protein expression. 
Expression cultures were transferred to 37ºC, 30ºC, 18ºC, or 10ºC and were allowed to 
express protein for approximately 4, 8.5, 22.4 hours, or 24 hours respectively. Cultures 
were harvested via centrifugation for 15 minutes at 4000g and 4ºC. Cells were 
resuspended to 1/10 volume in lysis buffer (50 mM Tris-HCl, pH8.0; 25 mM NaCl; 2 
mM EDTA; 0.1% Triton X-100) and stored at -20ºC. 
 
5. Cell Lysis, Fractionation, and SDS-PAGE 
 
Frozen expression samples were thawed at room temperature and lysis was 
initiated by addition of freshly dissolved lysozyme (1 mg/ml final concentration from 10 
mg/ml aqueous solution) and PMSF (9 mM final concentration from 90 mM stock in 
isopropanol). After 30 min of slow stirring at room temperature and addition of DNase I 
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(Sigma) (10 or 125 µg/ml final concentration from 0.06 or 1 mg/ml stock in glycerol; 1 
M MgSO4), lysates were stirred for an additional 30 min. 
Half of each lysate was removed as a complete lysate sample, while the remaining 
lysate was centrifuged for 30 to 50 min at 4,000g and 4ºC in shallow well plates to 
separate soluble and insoluble fractions. Lysate pellets were resuspended in Buffer B (50 
mM Tris-HCl, pH8.0; 25 mM NaCl; 2 mM EDTA) by gentle agitation. Lysate fractions 
were mixed with 2% SDS sample buffer and run on 7.5% Triple Wide SDS 
polyacrylamide gels as described in Chapter 2, Section B3. Crude lysates, supernatant 
fractions, and insoluble pellet fractions were all analyzed by SDS-PAGE. 
 
6. Optical Densitometry 
 
Coomassie-stained gels were individually scanned at 400ppi and 8-bit gray scale 
via a ScanMaker 9800XL tabletop scanner (Microtek). Optical densitometry of the gel 
images was performed using the GelAnalyzer plugin (Appendix A) for ImageJ (NIH) as 
described in Chapter 2, Section 4. Background subtraction using lanes of expression 
cultures containing pET11a vectors lacking any tailspike or β-helix genes was performed 
separately for crude lysate samples, supernatant fraction samples, and pellet fraction 
samples. 
Folding efficiencies for full length tailspike samples were calculated as described 
in Chapter 2, Section 4. For βHX constructs, the percent folded values were calculated as 
the percent ratio of the optical density of the supernatant fraction’s βHX band versus the 
complete crude lysate’s βHX band, according to the following formula: 
! 
Percent Folded =  
ODSupernatant
ODCrude
"100% 
These folding efficiencies were normalized to the average wild-type β-helix 
efficiency, as in Chapter 2, section 4. 
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C. RESULTS 
 
 
1. Construction of ∆N-3H, ∆N-6H, and β-helix Constructs 
 
Although the β-helix construct had been previously generated in a derivative of 
the pASK40 plasmid (Miller et al., 1998a), it was necessary to reproduce this construct in 
the context of the pET11a vector to achieve expression levels consistent with experiments 
discussed previously in this thesis. The plasmid pET(∆N) was sequentially mutated to 
encode ∆N-3H, ∆N-6H, and, finally, the isolated β-helix (βHX) as detailed in section B1. 
Once sequencing confirmed these three constructs, they were expressed at 37ºC 
and analyzed for their solubility and ability to fold. While expression of βHX 
predominantly produced soluble 48kDa polypeptide chains, ∆N-3H and ∆N-6H produced 
72kDa chains that were found solely in the insoluble fraction of cell lysates. This data 
indicates that histidines in the region of 545 – 550 promote aggregation of the full length 
tailspike, but do not hinder the folding and solubility of the βHX protein when present as 
a C-terminal his-tag. 
Six mutations investigated in the context of the full length tailspike were chosen 
for investigation in the context of the βHX construct: F160A, F308A, F336A, F352A, 
Q489A, and C496A. These mutations represent a diversity of folding phenotypes as 
determined in Chapter 2, of locations in the β-helix, and of amino acid types in the wild-
type sequence (Figure 4-1). In addition to these six mutations, G244R and A334V were 
chosen as folding controls, since these mutations have been previously characterized in 
the full length tailspike protein and in the isolated β-helix, as discussed in Section A2. 
The eight desired mutants were generated in the context of the βHX construct, confirmed 
by sequencing, and subsequently assayed for their affect on the solubility of the βHX 
construct. Since G244R and A334V were not analyzed in Chapter 2, full length tailspike 
mutants were made, confirmed, and assayed for folding.
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Figure 4-1. Mutations investigated in the isolated β-helix. The locations and folding 
phenotypes for the 8 mutations investigated in this chapter are shown on the structure of 
the β-helix domain from the native, trimeric structure (1TYU, (Steinbacher et al., 1996)). 
Folding phenotypes are given as the temperatures at which the mutations are wild-type-
like folders in vivo in the context of the full length tailspike protein, along with a 
corresponding color code. Mutants that cannot fold at any temperatures tested are part of 
the folding spine and are labeled “FS”. Folding temperatures for A334V and G244R are 
from the literature discussed in the main text.  
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2. In Vivo Folding Efficiencies of Full Length Tailspike Mutants 
 
The newly constructed mutants A334V and G244R were over-expressed at all 
four temperatures previously tested in Chapter 2: 37ºC, 30ºC, 18ºC, and 10ºC. Since a 
number of the mutants under examination in this chapter are not in the folding spine and 
were not assayed at 10ºC, all 9 full length tailspike strains under analysis in this chapter 
were over-expressed at 10ºC. When unheated over-expression lysates were examined by 
SDS-PAGE, host protein translational levels were consistent across all samples and full 
length tailspike strains accumulated tailspike polypeptide chains as clearly resolved 
bands. These observations are consistent with those made in previous expression 
experiments in Chapter 2. 
The percent of wild-type folding efficiencies were calculated from three or six 
independent expression samples for each strain at each temperature newly tested. Without 
normalization, the folding efficiency of wild-type chains expressed at 10ºC was 95±3% 
(3 independent expression samples), which is consistent with the previously determined 
value of 93±4%. This consistency was also observed for mutant strains previously 
examined at 10ºC, F308A, F336A, and C496A (Table 2-2, Table 4-3). At most, new and 
old values differed by approximately 9%. 
As had been observed previously, all strains having a folding efficiency less than 
75% of wild-type at 18ºC were folding deficient at 10ºC, while mutants that folded like 
wild-type at 18ºC continued to do so at 10ºC (Table 4-3). As expected from previous 
publications, A334V folded like wild-type or better at all temperatures tested while 
G244R only displayed greater than 75% folding efficiencies at 30ºC or lower 
temperatures. Only 2±2% of G244R tailspike chains reached the native state at 37ºC, 
which is consistent with the original discovery that G244R is a temperature sensitive 
folding mutant. 
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Table 4-3. Folding efficiencies of full length tailspike mutants. The percent of WT 
folding efficiencies for 8 mutants and WT at the four temperatures tested are given as 
averages and standard deviations of multiple expression experiments. Folding deficient 
average values (<75%) are shaded and bolded, while new expression data is starred (*). 
 
Percent of WT folding efficiency 
Sample 
37ºC 30ºC 18ºC 10ºC 
WT 100.0 ± 9.9 100.0 ± 5.7 100.0 ± 1.8 100.0±3.2 * 
F160A 8.8 ± 4.9 77.4 ± 2.7 100.4 ± 0.8 103.6±1.3 * 
G244R 2.2±1.6 * 81.9±5.9 * 102.6±11.6 * 98.7±5.0 * 
F308A 0.0 ± 0.0 0.7 ± 1.0 8.4 ± 10.7 0.7±0.7 * 
A334V 109.9±26.7 * 98.6±3.2 * 105.7±2.4 * 100.9±1.3 * 
F336A 0.0 ± 0.0 0.1 ± 0.1 28.5 ± 32.8 47.1±1.9 * 
F352A 0.6 ± 0.9 11.7 ± 16.1 95.8 ± 4.5 96.4±1.9 * 
Q489A 102.2 ± 11.9 100.7 ± 4.2 92.6 ± 7.2 90.5±3.0 * 
C496A 0.7 ± 1.0 20.4 ± 19.4 58.5 ± 13.4 6.3±2.9 * 
 
 
 
 
Table 4-4. Folding efficiencies of βHX mutants. The percent of WT-βHX folding 
efficiencies for 8 mutants and WT-βHX at the four temperatures tested are given as 
averages and standard deviations of triplicate expression experiments. Folding deficient 
average values (<75%) are shaded and bolded. 
 
Percent of WT-βHX folding efficiency 
Sample 
37ºC 30ºC 18ºC 10ºC 
WT-βHX 100.0±22.1 100.0±18.8 100.0±10.2 100.0±5.9 
F160A-βHX 0.8±0.2 121.8±6.2 102.7±5.0 97.1±3.5 
G244R-βHX 0.5±0.4 79.9±4.6 76.7±5.4 84.9±5.7 
F308A-βHX 0.3±0.1 0.0±0.1 0.0±0.0 0.0±0.1 
A334V-βHX 116.4±3.9 115.0±11.3 84.1±2.5 105.4±6.0 
F336A-βHX 0.0±0.0 0.1±0.1 8.6±3.1 49.0±8.5 
F352A-βHX 0.1±0.1 0.0±0.0 67.4±6.4 85.2±9.9 
Q489A-βHX 119.3±5.4 119.1±12.2 107.2±14.5 89.5±1.6 
C496A-βHX 0.0±0.0 2.7±2.2 96.3±1.0 12.0±3.8 
 107 
3. In Vivo Expression of β-helix Mutants 
 
Mutant and wild-type βHX proteins were expressed in E. coli cultures at 37ºC, 
30ºC, 18ºC, and 10ºC in a manner identical to the full length tailspike proteins. As 
observed with the full length tailspike samples, host protein translational levels were 
consistent across all samples when examined by SDS-PAGE (Figure 4-2). The SDS-
sensitive βHX protein band had a mobililty corresponding to its 48kDa molecular weight 
and could be identified in all samples by comparison with a pET11a expression sample, 
which lacked any tailspike or β-helix genes (Figure 4-2A). Examination of the crude 
lysates of all expression samples indicated that the βHX protein was expressed in a 
consistent manner and was not degraded by host proteases at any of the temperatures 
tested. 
When crude lysates were fractionated by low speed centrifugation, βHX proteins 
partitioned between the soluble supernatant fraction and the insoluble pellet fraction. 
Based on previously published fluorescence and CD spectroscopy, oligosaccharide 
binding, and enzymatic activity of purified, soluble β-helix constructs expressed at 30ºC, 
which include wild-type, G244R, and A334V, it is assumed that solubility is a measure of 
folding in vivo (Miller et al., 1998a; Schuler and Seckler, 1998). The observed 
partitioning and consistent expression levels allowed for the quantitation of folding 
efficiencies for all isolated β-helices. The most reliable method for calculating the 
percent of βHX chains folded proved to be a ratio of the supernatant chains to crude 
lysate chains, due to concentration changes that occur in resolubilizing the pelleted 
fraction. Since this calculation requires the comparison of two distinct gel electrophoresis 
samples while the calculation for full length tailspike relies only on a single crude lysate 
sample, this method inherently introduces more potential sources of error. In spite of this 
potential error, the calculated folding efficiencies proved to be both precise and 
consistent with previous experiments (Table 4-4, Table 4-3). 
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4. Wild-type, G244R, and A334V Folding Efficiencies 
 
The calculated folding yields for the wild-type isolated β-helix proteins 
demonstrate some of the errors in calculating folding yields from multiple samples. For 
example, when wild-type βHX was expressed at 18ºC in three independent expression 
cultures, the folding yield was 127±13%. Folding yields significantly greater than 100% 
are indicative of some error in fractionation or pipetting. The calculated folding yields of 
expression at 37ºC, 30ºC, and 10ºC, 105±23%, 88±17%, and 88±5% respectively, did not 
appear to suffer from these errors, and it can be observed that the wild-type β-helix 
consistently produced high folding yields at all temperatures tested. 
Normalization of mutant folding yields to the wild-type βHX folding yields at 
each temperature generated folding efficiencies for A334V and G244R that are consistent 
with the folding efficiencies of full length tailspike expression cultures (Figure 4-3) and 
previously published data. A334V-βHX was able to fold like wild-type or better at all 
temperatures tested (Table 4-4), consistent with the folding efficiencies observed for the 
full length A334V tailspike (Table 4-3). Although the folding efficiencies of A334V-
βHX do not always overlap with those of full length A334V, they are never more than 
22% apart (Figure 4-3). 
G244R-βHX accumulated in the pelleted fraction of the lysate when expressed at 
37ºC, yielding a relative folding efficiency of 0.5±0.4%. Below 37ºC, G244R-βHX 
folded with wild-type-like folding efficiencies (Table 4-4). This temperature sensitivity is 
consistent with folding efficiencies obtained with the full length G244R tailspike (Table 
4-3, Figure 4-3). The wild-type-like folding of G244R-βHX at 30ºC reflects previously 
published data, where this construct was expressed at 30ºC in generating soluble protein 
for purification (Schuler and Seckler, 1998). 
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Figure 4-3. Quantitative comparison of β-helix and tailspike in vivo folding. Average 
percent of wild-type folding efficiencies are shown for full length tailspike (blue) and 
βHX (green) mutants at the four temperatures tested. Darker color lines indicate the 
standard deviations of triplicate experiments. The 75% threshold delineating wild-type-
like folders and folding deficient samples is shown as a dashed line. 
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5. Single Alanine Mutant βHX Folding Efficiencies 
 
The folding efficiencies for single alanine mutations of the isolated β-helix reflect 
the observations made with A334V and G244R that the solubility of βHX constructs 
matches the folding efficiencies of full length tailspike mutants. At 37ºC, the only alanine 
mutant that is capable of folding with wild-type-like folding efficiencies is Q489A-βHX 
(Table 4-4). All other alanine mutants are completely incapable of yielding soluble βHX 
proteins. This is identical to the observed folding efficiencies of full length constructs at 
37ºC (Figure 4-3). 
When expressed at 30ºC, F160A was the only alanine mutant incapable of folding 
at 37ºC that was rescued to a wild-type-like folding efficiency. As observed with the full 
length tailspike proteins, all other alanine mutants failed to fold and accumulated in the 
pelleted fractions of the cellular lysates. 
At 18ºC, F160A-βHX, Q489A-βHX, and C496A-BHX folded with wild-type-like 
efficiencies, while F308A-βHX, F352A-βHX, and F336A-βHX were folding deficient. 
The folding efficiencies of F160A, F308A, and F336A are nearly identical to those 
calculated for the full length tailspike protein (Table 4-3, Table 4-4, Figure 4-3). For 
Q489A, both full length and βHX proteins are wild-type-like in folding but show a 14.6% 
difference. F352A-βHX is folding deficient with a folding efficiency of 67±6% while 
F352A full length is classified as a wild-type-like folder with a folding efficiency that is 
28% higher than the βHX construct. Although there is a discrepancy in the folding 
efficiencies of the full length and βHX F352A, it is clear that F352A-βHX is capable of 
generating a substantial amount of soluble proteins. The same is true for C496A, where 
the full length tailspike is folding deficient at 18ºC, but C496A-βHX displays a wild-
type-like folding efficiency 37.8% greater than its full length counterpart. 
Isolated β-helix mutants F308A, F336A, and C496A were folding deficient when 
folded in vivo at 10ºC. The calculated folding efficiencies for these mutants are nearly 
identical to those observed for their corresponding full length tailspike mutants. This is 
also the case for F160A, F352A, and Q489A, which are wild-type-like folders in the 
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context of the isolated β-helix and in the full length tailspike protein. It is interesting to 
note that C496A, both in the isolated β-helix domain and in the full length protein, is 
capable of producing a substantial amount of folded protein at 18ºC but is nearly 
completely blocked in folding at 10ºC. 
 
 
D. DISCUSSION 
 
 
1. Alanine Mutants Affect the Folding of the β-helix 
 
Seckler and coworkers were able to purify and characterize wild-type and mutant 
isolated β-helix domain proteins from the soluble fractions of 30ºC expression cultures. 
Based on a number of biophysical methods, they concluded that these proteins were in a 
β-helical confirmation that is very close to the native β-helix conformation observed in 
the full length protein (Miller et al., 1998a; Schuler and Seckler, 1998). In the 
experiments presented here, the in vivo solubilities of mutant and wild-type βHX proteins 
mirrored the corresponding full length tailspike sequences’ abilities to produce native, 
SDS-resistant trimers in the cellular environment. Taken together, these observations 
support the notion that solubility is a measure of the folding of the βHX domain in vivo. 
Overall, the folding phenotypes observed here for the isolated β-helix domain 
reasonably replicate the folding efficiencies observed for the full length tailspike mutants. 
Two mutants did not follow this general observation at one temperature, 18ºC. Although 
these βHX mutants crossed the 75% delineation between folding deficiency and wild-
type-like folding with respect to their corresponding full length constructs, both full 
length and βHX constructs produced substantial amounts of folded protein. In contrast, 
mutant F308A was never able to produce any folded protein at any temperature in either 
the full length protein or the isolated β-helix domain. The data for all mutants across all 
four temperatures suggests that the single alanine mutants affect the ability of the isolated 
β-helix to fold. This in turn demonstrates that the alanine mutants in the buried core of 
the β-helix domain of the P22 tailspike protein prevent the full length tailspike from 
folding by preventing the β-helix domain from folding. 
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2. Multiple Pathways of Aggregation 
 
In constructing the pET(βHX) construct, it was noted that ∆N-3H and ∆N-6H 
were completely blocked in forming any native, trimeric tailspike proteins and instead 
accumulated in the insoluble fraction of the cellular lysate. In contrast, βHX 
predominantly accumulated in the soluble fraction, indicating that it was folded as 
investigated by Seckler and co-workers (Miller et al., 1998a). Since ∆N-6H and βHX 
differ from each other by the presence of the C-terminus of the tailspike protein (residues 
551 – 666), this region of the protein must be responsible for the aggregation observed 
with the ∆N-6H construct. 
Various mutants of βHX accumulated in the pelleted fraction of crude lysates in a 
temperature dependent manner. One particular mutant, F308A, was never capable of 
producing any soluble βHX proteins at any temperatures and consistently produced 
insoluble aggregated protein. Previous investigations into the aggregation of the isolated 
β-helix domain have shown that this protein fragment is not a well-behaved protein and 
readily aggregates (Miller et al., 1998a; Schuler et al., 1999). 
The aggregation of the ∆N-6H and the aggregation of the isolated β-helix domain 
depend upon different parts of the full length tailspike protein. Previous investigations 
into the aggregation pathway and inclusion body formation of tailspike proteins indicate 
that aggregation proceeds from a partially folded or misfolded β-helical intermediate that 
is aggregation prone (Haase-Pettingell and King, 1988; King et al., 1996; Schuler et al., 
1999). The results described here demonstrate that multiple pathways of aggregation exist 
for the P22 tailspike protein (Figure 4-4). One pathway utilizes the C-terminal, 
oligomerization domain while the second involves the β-helix domain. It is unclear why 
these distinct pathways have not been detected before, but it may be postulated that the 
process of evolution optimized the C-terminal region for folding, assembly, and stability, 
while it has been previously demonstrated that the β-helix domain has been optimized for 
oligosaccharide binding rather than folding and stability (Seckler, 1998). Hence, in the 
full length protein, the region less optimized for folding is more likely to cause 
aggregation.
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Figure 4-4. βH
X
 and ∆N
-6H
 aggregate through different pathw
ays. W
hen released from
 the ribosom
e, ∆N
-6H
 likely folds to an 
interm
ediate structure w
here the β-helix dom
ain is folded, but the C
-term
inal part of the protein is not. Since the hexahistidyl internal 
tag (cyan) of ∆N
-6H
 appears to block folding, this protein proceeds to inclusion body accum
ulation through aggregation of the C
-
term
inal tails of ∆N
-6H
 proteins. In contrast, the βH
X
 construct likely folds into a partially folded interm
ediate at high tem
peratures or 
in the presence of folding defective m
utants. This aggregation prone interm
ediate oligom
erizes and accum
ulates into the inclusion 
body. 
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CHAPTER FIVE: 
 
 
IN VITRO REFOLDING OF TAILSPIKE MUTANTS 
 
 
 
 
 116 
A. INTRODUCTION 
 
 
1. In vitro refolding of P22 Tailspike 
 
In vitro refolding of the tailspike protein has shown that the protein is capable of 
refolding without the presence of the ribosome or other cellular factors and that in vitro 
refolding closely resembles the intracellular maturation pathway (Fuchs et al., 1991). 
Therefore, cellular components are not necessary for the folding of the protein and the 
amino acid sequence is sufficient to encode the folding and assembly of the protein to its 
native, trimeric state. 
Tailspike folding in vitro is rarely as efficient as in vivo. For example, folding 
yields as high as 60% have been reported for in vitro refolding of the wild-type tailspike 
at 10ºC (Fuchs et al., 1991; Seckler et al., 1989), while a 10ºC in vivo folding yield of 
93% was achieved in Chapter 2 of this thesis. One difference between the in vitro and in 
vivo refolding pathways that may account for this lower yield in vitro is that nascent 
polypeptide chains on the ribosome exhibit a β-helical conformation, as determined by 
antibody binding studies, that is not present at early times when tailspike is refolded in 
vitro (Clark and King, 2001). This observation has led to the suggestion that interaction 
with the ribosome or other cellular factors assists the tailspike chain in reaching these 
productive folding conformations more quickly than upon refolding in vitro. 
 
2. Chaperones and the P22 Tailspike 
 
In the cell, tailspike protein folding intermediates are recognized and bound by 
GroEL, but folding defects are not rescued by the presence of the chaperone (Gordon et 
al., 1994). In vitro studies showed that although GroEL can bind refolding tailspike, the 
tailspike protein is not released in an efficient manner and can thereby be trapped when 
ATP is not present (Brunschier et al., 1993). In contrast, the coat protein of the P22 phage 
has been shown to interact with GroEL to suppress aggregation (Doyle et al., 2004). 
Secondary-site suppressors of temperature sensitive folding mutants in the coat protein 
suppress aggregation by enhancing interactions between folding intermediates of the coat 
protein and the chaperone system (Parent et al., 2004). 
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Although the tailspike does not utilize the GroEL chaperone, the nascent chain 
displaying β-helical conformation does associate with the 30S ribosomal subunit (Clark 
and King, 2001). Since the ribosome-associated chaperone trigger factor and other 
chaperones such as the signal recognition particle dock to the 50S subunit near the 
polypeptide exit tunnel (Kramer et al., 2002; Schaffitzel et al., 2006), it is unlikely that 
these factors direct the folding of this 30S bound conformer. It has been suggested that 
co-translational interactions with the ribosome may favor β-helix formation. 
 
3. Experimental Design 
 
The results presented in previous chapters demonstrate that alanine mutations in 
the buried core hinder the folding of the β-helix domain in a temperature-sensitive 
manner. Do these residues affect intermolecular interactions, such as with the ribosome 
or chaperones, that favor the folding of the β-helix, or are the wild-type residues 
sufficient for encoding the folding of the β-helix domain? 
To investigate if the amino acid substitutions investigated in Chapter 4 are 
sufficient for producing the observed in vivo folding defects documented in Chapter 2, 
full length tailspike mutant polypeptide chains that had been investigated in the context 
of the isolated β-helix were purified, chemically denatured, and assessed for their ability 
to refold in vitro. Since mutant polypeptide chains completely incapable of reaching the 
native state at all temperatures were amongst those to be isolated, methods for purifying 
native tailspike trimers could not be utilized. Although his-tagged, full length tailspike 
proteins were constructed and purified, the additional amino acids present in the tag 
interfered with wild-type tailspike refolding (see Appendix B). Therefore, inclusion 
bodies from over-expressing cultures of full length tailspike sequences were purified and 
chemically denatured. Polypeptide chains were refolded in vitro to determine how alanine 
mutants in the β-helix domain affect the refolding of tailspike trimers. 
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B. MATERIALS AND METHODS 
 
 
1. Production of Inclusion Bodies of Full Length Tailspike Mutants 
 
Freeze stocks of full length tailspike constructs, which were generated as detailed 
in Chapter 2 and above, were streaked out on LB plates containing 100 µg/ml ampicillin 
and grown overnight at 37ºC. Clones from these plates were used to inoculate 37ºC 
overnight growth cultures in Super Broth containing 100 µg/ml ampicillin. Expression 
cultures were inoculated via 200-fold dilution of the overnight cultures into 1 liter Super 
Broth media containing 100 µg/ml ampicillin. Cells were grown shaking (225 rpm) for 
approximately 3 hours at 37ºC. Isopropyl-β-D-thiogalactopyranoside (IPTG) was added 
to a final concentration of 1 mM to induce protein expression. Expression cultures were 
transferred to 42ºC water baths and were allowed to express protein for 5 hours. Cultures 
were harvested via centrifugation for 15 minutes at 4000g. Cell pellets were resuspended 
in 10 ml of lysis buffer (50 mM Tris-HCl, pH8.0; 25 mM NaCl; 2 mM EDTA; 0.1% 
Triton X-100) and stored at -80ºC. 
Frozen expression cultures were thawed at room temperature and lysed at 4ºC and 
18,000 psi via French press. Samples were pressed three times each before adding PMSF 
(0.9 mM final concentration from 90 mM stock in isopropanol). Inclusion bodies were 
harvested by centrifugation at 5,800g for 40 minutes. Pelleted inclusion bodies were 
washed twice with 25 ml of lysis buffer for over an hour at 4ºC after being resuspended 
by scraping with a glass rod. Washed samples were pelleted by centrifugation at 15,000g 
for 10 minutes at 4ºC. Purified inclusion bodies were resuspended in 25 ml of Buffer B 
(50 mM Tris-HCl, pH8.0; 25 mM NaCl; 2 mM EDTA) and stored at 4ºC for up to four 
months. 
Inclusion body samples were analyzed by SDS-PAGE to observe their purity and 
to estimate the concentration of tailspike protein in each sample via optical densitometry. 
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2. Unfolding and Refolding of Inclusion Bodies 
 
Inclusion body samples containing approximately 40 µg of tailspike protein were 
pelleted via centrifugation for 10 minutes at 10,000g at room temperature. Pellets were 
resuspended in unfolding buffer (6 M urea, 10 mM DTT, 50 mM Tris-HCl, 25 mM NaCl, 
2 mM EDTA, pH 7.6) to an estimated concentration of 2mg/ml and incubated for 1 hour 
at room temperature. 
Unfolded samples were rapidly diluted 1:20 with ice cold refolding buffer (50 
mM Tris, 2 mM EDTA, pH7.6) to initiate refolding with an approximate tailspike 
concentration of 100 µg/ml. Samples were placed on ice for 30 minutes before being 
moved to a water bath at the desired testing temperature, either 37ºC, 30ºC, 18ºC, or 
10ºC. After specified time points, aliquots were removed from the refolding sample and 
mixed with 2% SDS sample buffer and stored at 4ºC until all time point samples were 
taken and could be analyzed by gel electrophoresis. 
3. SDS-PAGE and Optical Densitometry of Refolding Samples 
 
Time point samples were electrophoresed through 7.5% polyacrylamide gels as 
described in Chapter 2, Section B3. Gels were fixed with 10% acetic acid and 30% 
ethanol for over one hour and then stained with SYPRO® Ruby stain (Invitrogen) 
overnight. Gels were visualized using the Typhoon 9400 variable mode imager 
(Amersham Biosciences) with a fluorescence excitation of 457 nm, an emission filter of 
610 nm, and a photomultiplier value of 750 – 800. Gels were scanned at a resolution of 
100 microns. 
Optical densitometry of the gel image was performed using the GelAnalyzer 
plugin (Appendix A) for ImageJ (NIH). Images were calibrated using ImageJ’s 
Uncalibrated OD correlation function. Profile plots calculated for sample lanes were not 
corrected by a background lane, but were corrected by an average baseline value. As 
described in Chapter 2, Section B4, integration of the positive area of peaks 
corresponding to tailspike bands yielded relative protein amounts. A percent folded was 
calculated for each time point as the percent of tailspike chains present in the native, 
trimeric tailspike band, as detailed in Chapter 2, Section B4. 
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4. Kinetic Fits of Time Course Data 
 
Average percent folded time course data were fit to a single exponential rise 
function using the curve fitting feature of Kaleidagraph. This particular fit has the 
following formula, where t is time and A, B, and C are fitting variables: 
! 
Percent Folded = A +B(1- e
(-C*t)
)  
Each average percent folded value, calculated from triplicate independent experiments, 
was weighted by one over the square of the calculated standard deviations of triplicate 
experiments. Kaleidagraph provides data weighting as an option for curve fitting. 
 
C. RESULTS 
 
 
1. Inclusion Body Production 
 
Full-length tailspike mutants that had been examined at 10ºC in Chapter 4 (Figure 
4-1) were over-expressed at 42ºC, a temperature at which even the suppressor mutation 
A334V accumulates into inclusion bodies rather than folding or undergoing intracellular 
degradation. Inclusion bodies were washed and purified via several rounds of low speed 
centrifugation. Purified inclusion body samples were stable at 4ºC for several months 
with no signs of proteolysis.  
All tailspike sequences produced inclusion bodies whose composition was 70 – 
75% SDS-sensitive tailspike protein (Figure 5-1). In contrast, a pET11a lacking any 
tailspike genes was induced for expression but yielded no inclusion body proteins. 
Although some samples, such as A334V, still produced some native trimers at 42ºC, 
these trimers were removed in the process of purifying the inclusion bodies. 
 
2. Inclusion Body Refolding 
 
Pelleted inclusion body samples were chemically denatured at neutral pH in 6 M 
urea. Although these conditions are not strong enough to denature the natively folded, 
trimeric tailspike (Seckler et al., 1989), they were sufficient for solubilizing the inclusion
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body pellets. After one hour of unfolding at room temperature, samples were diluted with 
ice cold refolding buffer and incubated for 30 minutes on ice. This ice step has been 
shown to suppress in vitro aggregation of folding intermediates and produce folding 
yields in excess of 80% at 20ºC (Betts and King, 1998). Since tailspike in vitro refolding 
yields are typically much lower than in vivo, and since a number of the mutations 
examined in this study have already proven to be highly aggregative and defective in 
folding, we wanted to refold under optimal conditions for productive refolding. After the 
incubation on ice, refolding time courses were monitored for wild-type and all mutant 
samples in triplicate at three different temperatures: 10ºC, 18ºC, and 30ºC. SDS gels of 
18ºC refolding samples for wild-type, G244R, and F308A are shown in Figure 5-2. 
As can be seen in Figure 5-2, all tailspike chains were in an SDS-sensitive state 
upon being moved from ice to a heated water bath. With increasing time of incubation, 
wild-type and G244R tailspike chains trimerized and became SDS-resistant. This was the 
case for a number of other mutants, as will be discussed below. As expected, the G244R 
trimer exhibited an altered electrophoretic mobility with respect to wild-type trimers. 
While WT and G244R accumulated as trimers, the density of the SDS-sensitive band (U) 
diminished with time, as is most obvious in the case of WT. In contrast to the ability of 
wild-type and G244R polypeptide chains to reach the native state, F308A chains were 
completely incompetent for folding and remained in the SDS-sensitive band throughout 
the refolding time course. 
Except for two bands, marked by a question mark in Figure 5-2, bands 
representing other proteins in the inclusion bodies did not increase or decrease in density 
through the course of the experiment. The marked bands, however, increased sharply 
after the ice incubation and decreased with time. These bands appear to be tailspike 
specific, as they are not present in the refolding time course of the folding defective 
mutant F308A. The unknown band in the G244R sample is electrophoretically altered 
with respect to the unknown band in the wild-type sample, as would be expected if these 
bands were tailspike specific. Although these bands may be tailspike fragments, such as 
∆N tailspike chains that are known to be produced by proteolysis of partially unfolded 
intermediates (Chen and King, 1991), the fact that their density decreases with time 
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suggests that they are previously unidentified, SDS-resistant trimeric folding 
intermediates. However, since it is not known if these bands represent full length 
tailspike proteins, the calculation of percent folded values at each time point did not 
include these bands. 
 
3. Refolding Time Courses 
 
Refolding data acquired from the SDS-PAGE analysis of refolding time points 
demonstrated that the mutations investigated here significantly affect the refolding of 
tailspike chains to the SDS-resistant trimer state. This is most readily apparent from the 
refolding time courses of C496A, F336A and F308A. These full length tailspike mutants 
were completely incapable of producing substantial SDS-resistant tailspike proteins 
above the values calculated at the zero hour time point, independent of the refolding 
temperature (Figure 5-3). 
In contrast, the wild-type protein was capable of reaching refolding yields of 
26±2% at 30ºC, 43±4% at 18ºC, and 29±1% at 10ºC. The time courses observed in 
Figure 5-3 could be fit by a single exponential rise function. For wild-type, the resulting 
fits had coefficients of determination (R2) of 0.98 at 30ºC, 0.98 at 18ºC, and 0.99 at 10ºC, 
indicating the goodness of the fits. These fits were used to determine the half-times of 
refolding, which are shown for all time courses in Table 5-1. For the wild-type tailspike, 
the calculated half times of refolding, 12 minutes at 30ºC, 85 minutes at 18ºC, and over 4 
hours at 10ºC are generally in agreement with previously published data, which cites the 
refolding half-times of wild-type tailspike as 7 minutes at 30ºC, 60 minutes at 20ºC, and 
10 hours at 10ºC (Danner et al., 1993; Danner and Seckler, 1993). Given that the 
previously published experiments were performed without the initial ice step and were 
performed using different concentrations of proteins, the fact that the published values 
and those estimated here are on the same order of magnitude for all three temperatures 
indicates that the refolding of wild-type tailspike chains from inclusion bodies mimics the 
refolding of natively purified tailspike protein. 
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Figure 5-3. Kinetics of inclusion body refolding. For each time point, the percent of 
tailspike chains folded into SDS-resistant trimers was calculated. Colored symbols, as 
detailed in the legend in the upper left, represent averages of triplicate independent 
refolding experiments with vertical bars representing the standard deviations of these 
experiments. Colored curves are single exponential fits to the data, weighted by standard 
errors. 
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Table 5-1. Folding half-times of inclusion body refolding samples. The single 
exponential fits shown in Figure 5-3 were used to estimate the half-times of refolding. 
These values were calculated as the amount of time required for 50% of the fit’s 
maximum yield to fold into a native, SDS-resistant trimer. Negative values, which are 
shaded and bolded, represent time courses that could not produce native tailspike. 
 
In Vitro Trimer Refolding Half-Times (min) 
Sample 
37ºC 30ºC 18ºC 10ºC 
WT NA 12 85 256 
F160A NA 44 69 208 
G244R NA 20 71 212 
F308A NA -51 -245 -2220 
A334V NA 24 76 215 
F336A NA -1269 -456 -3999 
F352A NA -82 58 144 
Q489A NA 24 75 219 
C496A NA -1763 -278 -1674 
 
Table 5-2. In vitro folding efficiencies of full length tailspike mutants. The percent of 
WT folding yields for 8 mutants and WT at the various refolding temperatures tested are 
given as averages and standard deviations of the final yields of multiple refolding 
experiments. Folding deficient average values (<75%) are shaded and bolded, while 
heavily defective values (<25%) are colored red. 
 
In Vitro End-Point Percent of WT folding yields 
Sample 
37ºC 30ºC 18ºC 10ºC 
WT NA 100.0±6.4 100.0±8.6 100.0±2.7 
F160A NA 60.8±0.2 71.4±10.3 74.5±6.1 
G244R NA 69.3±2.5 78.7±9.8 92.7±6.0 
F308A NA 13.5±3.0 10.8±3.2 14.9±1.1 
A334V NA 82.1±2.6 88.6±14.0 79.0±4.0 
F336A NA 13.3±2.8 13.4±5.1 14.7±0.9 
F352A NA 15.3±0.6 35.1±9.5 41.2±7.0 
Q489A NA 100.4±4.7 88.0±14.0 94.3±11.2 
C496A NA 15.5±1.1 16.6±10.3 20.6±5.3 
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A number of mutants were able to refold to a native, trimeric state with kinetics 
similar to the wild-type full length tailspike protein. A334V, G244R, Q489A, and F160A 
were capable of producing detectable native trimer bands at all temperatures tested. As 
can be observed in Figure 5-3, although the final yields of these four mutants and wild-
type tailspike were often significantly different, the time courses of these mutants tended 
to cluster with that of wild-type, as opposed to the time courses of F352A, C496A, 
F308A, and F336A. At 30ºC, the half-times of mutants A334V, G244R, and Q489A were 
approximately twice that of wild-type, while F160A had a refolding half time nearly 4 
times that of wild-type. Though this difference may be significant, these values are still 
on the same order of magnitude. When refolded at 18ºC and 10ºC, these four mutants 
fold with half-times nearly identical to that of the wild-type sequence.  
The single alanine mutant F352A displayed significantly lowered folding yields at 
18ºC and 10ºC, and was completely blocked from folding at 30ºC (Figure 5-3). The fact 
that this mutation is capable of refolding back to its native conformation at 18ºC and 
10ºC, but not at 30ºC, mirrors its in vivo folding phenotypes at these temperatures (Table 
4-3). It is unclear why the folding yields for F352A are so much lower than the other 
refolding samples. When the half-time of refolding was calculated for F352A at 30ºC, a 
negative value was obtained (Table 5-1). This proved to be the case for all the other 
mutants incapable of producing native tailspike and is likely an indicator of the inability 
of these chains to fold to the native conformation. Positive values were obtained for 
F352A at 18ºC and 10ºC, and these values were higher than, but still on the same order, 
as those observed for wild-type and the other mutants capable of refolding. 
 
4. A Comparison of In Vivo and In Vitro Data 
 
A simple comparison of the temperature dependence of the in vivo folding of 
tailspike sequences (Table 4-3) and their ability to refold in vitro (Table 5-1) 
demonstrates that in vitro refolding data recapitulates the in vivo folding phenotypes, as 
previously highlighted with F352A. Some differences can be observed, however, when 
the end point folding yields of in vitro refolding experiments (Table 5-2) are compared 
with in vivo folding efficiencies (Figure 5-4). 
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Figure 5-4. Quantitative comparison of in vivo and in vitro tailspike folding. Average 
percent of wild-type folding efficiencies are shown for the in vivo expression (blue) and 
in vitro refolding (green) of full length tailspike mutants at the three temperatures tested. 
Darker color lines indicate the standard deviations of triplicate experiments. The 75% 
threshold delineating wild-type-like folders and folding deficient samples is shown as a 
dashed line. 
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In comparing the in vitro and in vivo percent of wild-type folding efficiencies, a 
number of mutants displayed folding deficient values when refolded from inclusion 
bodies that did not display these values when folded in the environment of the cell. These 
inconsistencies, colored pink in Table 5-2, highlight F160A at all temperatures, F352A at 
lower temperatures, and G244R at 30ºC. Although these mutant samples would not have 
been classified as wild-type-like folders in the in vivo assay performed in Chapter 2, they 
do produce significant amounts of native tailspike, as is observed in Figure 5-3. 
Therefore, the ability to form native tailspike is consistent from in vivo expressions to in 
vitro refoldings. 
Nonetheless, large differences between in vivo and in vitro conditions were 
observed for F352A at 18ºC and 10ºC, C496A at 18ºC, and F336A at 10ºC (Figure 5-4). 
The reason for these differences is unclear, but it is important to note that C496A, for 
example, is able to generate some SDS-resistant trimers in vivo, but was completely 
incapable of doing so in vitro. Many factors, such as the oxidation state of the refolding 
environment or the presence of other proteins in the inclusion body samples may affect 
the folding of these chains. 
 
D. DISCUSSION 
 
 
1. Single Alanine Mutations Block Refolding 
 
Although some differences are apparent between the folding of full length mutant 
chains in vivo and in vitro, the temperature sensitivity displayed by mutant chains 
refolding from chemically denatured inclusion body pellets is consistent with their ability 
to fold de novo in the cell. In particular, F352A was capable of refolding at 18ºC and 
10ºC, but was not able to refold at 30ºC. This mutant displays the same temperature 
sensitive folding phenotype when expressed in E. coli. Given that the refolding 
environment tested here is substantially different from the environment a nascent chain 
experiences inside the cell, the observed consistency of folding phenotypes supports the 
notion that the inability of these mutant chains to fold is due solely to the introduced 
alanine mutation. 
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Not only is it apparent that the single alanine mutations affect the folding and 
refolding of tailspike chains in a temperature sensitive manner, it is surprising that some 
mutations, such as F308A, are able to completely block the folding of the tailspike 
protein under all conditions so far tested. In the case of F308A, the deletion of a single 
side chain from a 666 amino acid polypeptide chain completely prevents the protein from 
folding in the cell, completely blocks inclusion body purified polypeptide chains from 
folding in the test tube, and bars βHX proteins from folding in vivo. 
 
2. Sequence, not Ribosomal Interactions, Control Folding of β-helix 
 
Mutants capable of folding upon expression in vivo were also able to fold into 
trimeric tailspike proteins upon renaturation from denatured inclusion bodies. This 
demonstrates that the observed folding phenotypes are not a product of cotranslational 
folding or the environment that the nascent chain experiences upon emergence from the 
ribosome exit tunnel. Instead, this is a product of the sequence itself. 
The inclusion body samples were only approximately 70 – 75 % pure. Although 
this purity is consistent with a previously published purity of 68% for inclusion bodies 
generated with β-lactamase at 42ºC (Valax and Georgiou, 1993), it is clear that 
contaminants are present in the samples. It is possible that chaperones or ribosomal 
components may exist amongst those contaminants, as inclusion bodies have been 
observed to contain the heat-shock chaperone DnaK and ribosomal RNAs (Hartley and 
Kane, 1988; Rinas et al., 2007). These contaminants may assist or hinder the refolding of 
tailspike chains in a sequence specific manner. The fact that the observed kinetics of 
refolding of tailspike chains from inclusion bodies are consistent with the published 
values for the natively purified tailspike protein indicates that inclusion body 
contaminants do not significantly affect the rate of refolding. The unexpectedly low 
folding yields for all sequences tested may indicate that these contaminants do affect the 
relative rates of aggregation. This has been previously noted in the case of the refolding 
of hen egg white lysozyme from inclusion bodies, where contaminants affected the rate 
of aggregation, and hence folding yields, but did not disturb the rate of folding 
(Maachupalli-Reddy et al., 1997). 
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IN VITRO REFOLDING OF β-HELIX MUTANT IN THE 
ISOLATED β-HELIX DOMAIN 
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A. INTRODUCTION 
 
 
1. Fluorescence Studies on the Isolated β-helix Domain 
 
Fluorescence intensity experiments have been utilized to characterize the 
reversible folding of the isolated β-helix domain and the affects that mutations have on 
this process (Miller et al., 1998a; Schuler and Seckler, 1998). An apparently two-state 
fluorescence transition has been demonstrated for the urea induced equilibrium unfolding 
and refolding of the β-helix domain that is similar to the unfolding and refolding 
transitions of the trimeric ∆N tailspike protein. The fluorescence kinetics of refolding are 
identical to that of ∆N tailspike, indicating that the isolated β-helix domain adopts a 
tertiary structure that resembles that of the β-helix domain in the full length protein. 
Although the reversible folding of the isolated β-helix domain has allowed for the 
calculation of differences in free energies of folding for the wild-type sequence and 
various mutations, these experiments were performed under conditions that suppressed 
aggregation. When equilibrium studies were performed under strong ionic conditions, 
such as in the presence of guanidinium or urea with added sodium chloride, the 
fluorescence transition was no longer two-state but showed a plateau region in the 
equilibrium curve at 1 M guanidine or between 2 M and 4 M urea in the presence of 0.5 
M salt (Schuler et al., 1999). This plateau matched a similar plateau observed in the 
refolding fluorescence of the full length tailspike protein (Fuchs et al., 1991). In the urea 
induced unfolding and refolding experiments, the transition region at 4 M urea from this 
plateau to the unfolded state was congruent with an apparently two-state acquisition of 
secondary structure, as measured by circular dichroism.  
When high ionic strength equilibrium unfolding and refolding samples were 
allowed to incubate for extended times at 10ºC, it became apparent that conformations 
associated with the 2 M fluorescence transition and the plateau region were highly 
aggregation prone. The resulting aggregated protein exhibited multiple morphologies, 
including an amyloid-like fibril. When the affect of mutations was investigated on these 
aggregation processes, Seckler and coworkers observed that the temperature sensitive 
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folding mutant G244R substantially deviated from two-state fluorescence behavior at 
18ºC, yielding a fluorescence intensity 33% lower than wild-type at low urea 
concentrations. Under these same conditions, the suppressor V331G displayed near two 
state behavior, but showed a dip in fluorescence intensity at 1.5 M urea. These data 
suggest that the β-helix domain folds through an aggregation prone intermediate that is 
more readily populated by the temperature sensitive folding mutant G244R. 
 
2. Experimental Design 
 
In Chapter 5, refolding experiments using purified inclusion bodies demonstrated 
that the buried core alanine mutants affected the refolding of the full length tailspike 
protein in a sequence specific and temperature sensitive manner that mirrored the in vivo 
folding phenotypes characterized in Chapter 2. This observation, in combination with the 
in vivo folding phenotypes of isolated β-helix domain mutants described in Chapter 4, 
supports the notion that single amino acid changes block the folding of the entire trimeric 
210 kDa protein by altering the necessary information for encoding the folding of the β-
helix domain. Can this effect be more directly demonstrated if isolated β-helix domain 
mutants are purified and refolded in vitro? 
The answer to this question was investigated directly by purifying the wild-type 
isolated β-helix domain and the single alanine mutant F308A-βHX. Because the F308A 
mutation has proven to be completely blocked under all expression conditions tested, 
both constructs were purified under denaturing conditions and subsequently assayed for 
their ability to refold by fluorescence spectroscopy. 
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B. MATERIALS AND METHODS 
 
 
1. Production and Purification of Isolated β-helix Constructs 
 
Wild-type and F308A mutant pET(βHX) constructs were previously generated 
and transformed into E. coli BL21(DE3) as described in Chapter 4. Freeze stocks of βHX 
were streaked out on LB plates containing 100 µg/ml ampicillin and grown overnight at 
37ºC. Clones from these plates were used to inoculate 37ºC overnight growth cultures in 
LB containing 100 µg/ml ampicillin. Expression cultures were inoculated via 200-fold 
dilution of the overnight cultures into 1 liter LB media containing 100 µg/ml ampicillin. 
Cells were grown shaking (225 rpm) for approximately 2.5 hours at 37ºC until cultures 
reached an OD600 between 0.6 and 0.7. Isopropyl-β-D-thiogalactopyranoside (IPTG) was 
added to a final concentration of 1 mM to induce protein expression. Expression cultures 
were allowed to express protein for 7.5 hours at 37ºC. Cultures were harvested via 
centrifugation for 15 minutes at 4000g. Cell pellets were frozen and stored at -80ºC. 
Frozen expression culture pellets were thawed at room temperature and lysed by 
mixture with 5 ml of denaturing lysis buffer (100 mM NaH2PO4, 10 mM Tris base, 8 M 
urea, pH 8.0) per gram of cell pellet for one hour at room temperature. Cellular debris 
was removed by centrifugation of lysates for 30 min at 10,000g. The resulting 
supernatant was mixed with Ni-NTA resin (Qiagen) and purified by gravity flow affinity 
chromatography. The Ni-NTA and lysate column was washed with denaturing lysis 
buffer and subsequently washed with denaturing wash buffer (100 mM NaH2PO4, 10 mM 
Tris base, 8 M urea, pH 6.3). His-tagged proteins were eluted with denaturing elution 
buffer (100 mM NaH2PO4, 10 mM Tris base, 8 M urea, pH 4.5). Elution fractions were 
pooled and concentrated using Amicon Ultra-15 centrifugal filters (Millipore). 
Protein concentrations were determined by measuring absorbance at 280 nm of 
unfolded proteins, according to the Edelhoch method (Edelhoch, 1967). Extinction 
coefficients, 1.1872 (mg/ml)-1cm-1 for WT-βHX and 1.1891 (mg/ml)-1cm-1 for F308A-
βHX, were calculated based on the protein sequence (Gill and von Hippel, 1989). 
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2. Equilibrium Refolding of the Isolated β-helix 
 
βHX proteins were unfolded in 6 M urea (pH 7), 45 mM sodium phosphate, 0.9 
mM EDTA, and 4.5 mM DTT at a concentration of 100 µg/ml for one hour at room 
temperature. These unfolding reactions were then diluted 10-fold into varying 
concentrations of urea solution (0 M – 6.5 M), giving a lowest final urea concentration of 
0.6 M. Refolding samples were allowed to equilibrate for up to 5 days at 10ºC. The exact 
urea concentration of each sample was determined by measuring the refractive indexes of 
samples and applying the following equation: 
[Urea] = 117.66*∆N + 29.753*∆N2 + 185.56*∆N3 
where ∆N is the refractive index of the sample minus the refractive index of buffer 
lacking any urea. 
 
3. Fluorescence Spectroscopy 
 
Fluorescence emission spectra were taken using a Hitachi F-4500 fluorimeter 
equipped with a temperature control circulating water bath to maintain a constant 
temperature of 10ºC. The fluorimeter parameters included a slit width of 10 nm for 
excitation monochromators and 5 nm for emission monochromators. Samples were 
excited at 280 nm and the emission fluorescence was recorded for the wavelength range 
of 300 – 400 nm. All spectra were corrected for buffer. 
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C. RESULTS 
 
 
1. Fluorescence of the Unfolded and Refolded States of βHX 
 
Both wild-type βHX and F308A-βHX were purified by metal affinity 
chromatography to >90% homogeneity. Purified proteins were chemically denatured at 
neutral pH and refolded into varying concentrations of urea. To acquire the data shown 
here, DTT was required in the unfolding buffer. The range of urea that βHX chains 
experienced was 0.6 M to 6.4 M. Refolding reactions were allowed to equilibrate via 
incubation at 10ºC for 5 days. Equilibrium samples were then assayed for folding by 
fluorescence spectroscopy. 
Completely unfolded samples mixed with 6.4 M urea were excited at 280 nm and 
monitored for fluorescence across a range of wavelengths from 300 nm to 440 nm. Both 
WT-βHX and F308A-βHX samples displayed nearly overlapping curves, with peaks at 
350 nm for both samples (Figure 6-1). The WT-βHX sample equilibrating at the lowest 
concentration of urea, 0.6 M, showed a peak shift to 340 nm and a large increase in 
fluorescence intensity. The observed peaks and intensity changes are consistent with 
previously published fluorescence data on the WT-βHX protein (Miller et al., 1998a). 
This intensity increase was not observed if the unfolding buffer lacked DTT. 
The F308A-βHX sample equilibrated at 0.6 M urea displayed a peak shift to 340 
nm, but did not display a large intensity change (Figure 6-1). This is indicative that the 
conformation of this protein at low denaturant concentrations is not in the same folding 
state as the natively folded WT-βHX protein, nor is it in the completely unfolded state 
observed at high urea concentrations. The F308A-βHX protein appears to go into a third 
conformational state at low urea concentrations where some partial burial of tryptophans 
likely account for the peak shift and slight increase in fluorescence intensity. 
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2. Equilibrium Refolding Fluorescence 
 
The above fluorescence analysis and previously published data indicates that the 
fluorescence intensity of the β-helix domain at 340 nm is an indicator of the native folded 
state of the protein. Fluorescence emissions at this wavelength was observed for WT-
βHX and F308A-βHX samples that had been refolding for five days in a range of urea 
concentrations  
The WT-βHX protein displayed near two-state behavior, showing a clear 
transition between the unfolded state at high urea concentrations and the highly 
fluorescent native state at low urea concentrations. The midpoint of this transition 
occurred at approximately 2.5 M urea, which is in agreement with previously published 
data (Miller et al., 1998a; Schuler and Seckler, 1998). The only deviation from this two-
state refolding was a dip in fluorescence intensity centered around 1.5 M urea. This is the 
concentration of urea at which refolding experiments that include high amounts of salt 
show a folding transition from an intermediate plateau to the native state (Schuler et al., 
1999). This is also the concentration at which a similar dip in fluorescence can be 
observed in the 18ºC incubation of the suppressor mutation V331G. This dip in 
fluorescence may indicate a range of urea concentrations where the WT-βHX protein 
populates a partially folded, aggregation prone state. Although the aggregation of these 
samples was analyzed by absorbance at 360 nm, which measures light scattering due to 
high molecular weight species, turbidity measurements did not show any signal of 
aggregation. This is likely due to the fact that the 10 µg/ml concentration of proteins in 
the refolding samples was below the detection limit of the spectrophotometer. 
F308A-βHX showed a clear deviation from two-state behavior (Figure 6-2). This 
deviation is nearly identical to that of G244R-βHX when it was incubated in high salt 
concentrations at 18ºC. The deviation is not only similar in the shape of the resulting 
equilibrium curve, but in the magnitude of the fluorescence signal as compared with the 
wild-type isolated β-helix domain. At the lowest tested urea concentration, the 
fluorescence of F308A-βHX was 44% less than that observed for WT-βHX. 
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D. DISCUSSION 
 
 
1. Mutant β-helix Folding Phenotypes are due to Sequence Alone 
 
WT-βHX and F38A-βHX protein were purified under denaturing conditions to a 
high degree of homogeneity. When assayed for their ability to refold, the WT-βHX 
folded to its native state, as assayed by fluorescence, while the F308A-βHX protein could 
not reach the same conformation. These experiments indicate that it is the polypeptide 
chain sequence of the single alanine mutation F308A that prevents the folding of the β-
helix domain. 
This single change appears to hinder the 42 kDa tailspike fragment from fully 
folding. Instead, the observed peak shift and partial fluorescence recovery indicate that 
the F308A-containing polypeptide chain goes into a partially folded conformation that is 
aggregation prone. The partial increase in fluorescence intensity and the peak shift 
observed at low urea concentrations indicate that some of the tryptophans of the β-helix 
protein may become partially buried, though not to the extent observed in the native 
structure. Though this burial may be due to aggregation, it is important to note that this 
altered burial is due to amino acid changes that do not necessarily contact any of the six 
tryptophans present on the surface of the β-helix domain (Figure 6-3).  
Based upon the published CD spectra of the wild-type sequence under conditions 
of high salt, the β-helix appears capable of attaining its high degree of β-sheet content at 
urea concentrations much higher than the fluorescence transitions observed here (Schuler 
et al., 1999). Although it is unclear how the F308A mutation affects β-sheet formation, 
this data would argue that the F308A mutant populates a partially folded state that likely 
has β-sheet content but lacks proper tertiary structure. The structure of such a partially 
folded conformer may be a β-helical topology where strands are improperly registered or 
a nucleus for folding cannot form. In such a collapsed structure, tryptophans could be 
partially buried but not folded into a native structure, while exposed hydrophobic 
sequences would be particularly prone to aggregation. 
 141 
 
 
 
Figure 6-3. Locations of tryptophan residues in the tailspike β-helix domain. Six 
tryptophans, shown in blue, are located in the β-helix domain of the P22 tailspike. All are 
located on the surface of the protein. Three of these tryptophans (W202, W207, and 
W213) are located in the dorsal fin, while the other three (W315, W365, and W391) are 
on the surface of the β-helix. Residues A334 (green), F308 (red), and G244 (magenta) are 
shown for reference.
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CHAPTER SEVEN: 
 
 
DOUBLE MUTANT ANALYSIS REVEALS A NUCLEUS 
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A. INTRODUCTION 
 
 
1. The Global Suppressors 
 
Suppressor mutations of temperature sensitive folding mutations were repeatedly 
isolated in genetic screens at two positions in the P22 tailspike protein: V331 and A334 
(Fane and King, 1991; Fane et al., 1991). Because these mutants intragenically rescued 
the temperature sensitivity of all mutants they were tested against, regardless of amino 
acid change or position, it was claimed that these suppressors acted in a global, or generic 
manner. Investigations of these mutants in the context of the isolated β-helix domain 
indicated that this global mechanism of suppression is likely via thermodynamic 
stabilization of a β-helical folding intermediate (Schuler and Seckler, 1998). 
 
2. Experimental Design 
 
The folding spine positions discovered in Chapter 2 represent the minimal 
required code for folding the β-helix domain. These mutations are incapable of folding 
like wild-type at all temperatures when expressed in the full length tailspike in vivo. For a 
small set of these mutants, it has been demonstrated that these alanine mutations block 
folding of the isolated β-helix domain (Chapter 4), block in vitro refolding of the full 
length protein (Chapter 5), and block the in vitro folding of the β-helix domain (Chapter 
6). Can the global suppressor rescue these highly defective sequences? 
If the global suppressor does rescue folding spine mutants, will the resulting 
folding efficiencies indicate which part of the β-helix domain folds first? After all, the 
central model of this thesis is that the β-helix domain of P22 tailspike folds via a 
nucleation-elongation mechanism. The folding spine does not appear to highlight a 
particular nucleus for folding. Does a specific region of the β-helix domain nucleate 
folding and, if so, where is it located? 
To address these questions, double mutants of the single alanine folding spine 
mutations were made by introducing A334V into each single folding spine mutant 
sequence. The global suppressor A334V was chosen over other suppressor mutations 
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because the wild-type alanine side chain points into the core of the β-helix and because 
this mutant has been analyzed in a number of contexts relevant to this thesis (Baxa et al., 
1999; Beissinger et al., 1995; Danner et al., 1993; Miller et al., 1998b; Mitraki et al., 
1993; Mitraki et al., 1991; Schuler and Seckler, 1998). The C-terminal cysteine annulus 
mutations investigated in Chapter 2 were included in this investigation to control for the 
location of the mutants. Double mutants of G244R, ∆N, and ∆N-G244R were constructed 
to provide positive controls for rescue by A334V. These new double mutants were tested 
for their ability to fold in vivo at four temperatures: 37ºC, 30ºC, 18ºC, and 10ºC. 
 
 
B. MATERIALS AND METHODS 
 
 
1. Production of Double Mutants 
 
Purified, methylated plasmids encoding confirmed single alanine mutants, the 
wild-type tailspike, the ∆N tailspike, and the mutated G244R tailspike were previously 
isolated from NovaBlue(DE3) cells (Novagen) or XL1-Blue cells as described in Chapter 
2 and Chapter 5, Section B1. These plasmids were used as templates for introducing the 
A334V mutation via the PCR-based QuikChange mutagenesis procedure (Stratagene). 
The A334V mutagenic primer listed in Table 4-2 and its reverse complement were used 
to introduce this mutation in all but two of the single alanine mutant constructs. Since the 
codons encoding the G329A and F336A mutants are located in the region of the A334V 
mutagenic primer, new primers were designed to maintain these single alanine mutations 
while introducing the A334V mutation. The sequences of these primers (IDT) are listed 
in Table 7-1. Mutagenesis reactions were performed in parallel in 96 well plates and 
utilized multi-channel pipeting to achieve high-throughput processing. 
PCR products were transformed into E. coli BL21(DE3) cells as described in 
Chapter 2, Section B2. Plasmid DNA was purified using QIAprep Spin MiniPrep kits 
(QIAGEN). Purified plasmids were also submitted for DNA sequencing of a 400 base 
pair region (20% of the tailspike gene) containing the targeted codon. Sequencing 
confirmed the double mutant clones (MGH DNA Core, Cambridge, MA). 
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2. Expression of Double Mutant Constructs 
 
Clonal E. coli BL21(DE3) cultures of double mutants and the A334V single 
mutant were made into 40% glycerol working stocks and 8.3% DMSO freeze stocks after 
8 hours of growth in LB containing 100 µg/ml ampicilllin at 37ºC. Working stocks were 
stored at -20ºC in 96 deep-well plates while freeze stocks were stored at -80ºC in dram 
vials. Overnight growth cultures were inoculated via 100-fold dilution of the working 
stocks into LB media containing 100 µg/ml ampicillin in preparation for inoculation of 
expression cultures. In the case of mutants with the F381A mutation, proper expression 
required that these cultures be freshly transformed into BL21(DE3) cells as described 
above and that the resulting transformant clones be used to inoculate overnight growth 
cultures. 
Expression cultures were inoculated via 100-fold dilution of the overnight or the 
working stock cultures into LB media containing 0.5% glucose, 50 mM 3-[N-
morpholino]-propanesulfonic acid (MOPS) and 100 µg/ml ampicillin. Cells were grown 
shaking (225 rpm) in 500 µl volumes in 96 deep-well plates for approximately 4.25 to 4.5 
hours at 30ºC. Isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final 
concentration of 1.5 mM to induce protein expression. Cultures were transferred to 37ºC, 
30ºC, 18ºC, or 10ºC and were allowed to express protein for approximately 4, 6.25, 18.3 
hours, or over 30.5 hours respectively. Cultures were harvested via centrifugation for 15 
minutes at 4000g and 4ºC. Cells were resuspended to 1/10 volume in lysis buffer (50 mM 
Tris-HCl, pH8.0; 25 mM NaCl; 2 mM EDTA; 0.1% Triton X-100) and stored at -20ºC. 
 
3. Cell Lysis, Fractionation, and SDS-PAGE 
 
Frozen expression samples were thawed at room temperature and lysed as 
described in Chapter 2, Section B3. Complete crude lysates, supernatant fractions, and 
pellet fractions were analyzed by SDS-PAGE as described in Chapter 2, Section B3. 
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4. Optical Densitometry 
 
Optical densitometry was performed on coomassie stained gels and normalized 
folding efficiencies were calculated from complete crude lysate samples as described in 
Chapter 2, Section 4. 
The amount of rescue conferred by the presence of A334V was calculated as the 
difference between the normalized folding efficiency of the A334V containing mutant 
and the normalized folding efficiency of the mutant lacking A334V. Standard deviations 
of this measure were calculated as the standard error of this difference: 
! 
Standard Error of Difference =  
SD
Mut( )
2
N
Mut
+
SD
Mut +A334V( )
2
N
Mut +A334V
 
The above equation utilizes the standard deviation (SD) calculated for the single mutation 
(Mut) and its corresponding double mutant (Mut+A334V), as well as the number of 
independent expression samples (N) used in calculating the standard deviations. 
 
 
C. RESULTS 
 
 
1. In Vivo Expression of Double Mutants 
 
All double mutants and single mutants not previously characterized, such as ∆N-
G244R, were individually over-expressed from a pET plasmid in Escherichia coli 
cultures incubated at 37ºC, 30ºC, 18ºC and 10ºC in order to assess the affect of the 
A334V suppressor on previously characterized folding phenotypes. As was observed 
previously, all strains accumulated tailspike polypeptide chains as clearly resolved bands, 
indicating that the mutations did not recruit proteases. Host protein translational levels 
were consistent across samples, allowing for appropriate background subtraction so that 
the folding efficiencies of new expression cultures could be calculated accurately in the 
manner performed in Chapter 2. Folding efficiency values for strains not previously 
characterized were normalized to wild-type folding efficiencies. These newly calculated 
values are listed in Table 7-2.
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Table 7-2. Folding efficiencies of new double mutants. The percent of wild-type 
folding efficiencies for double mutants at the four temperatures tested are given as 
averages and standard deviations of triplicate or sextuplicate independent expression 
experiments. Folding deficient average values (<75%) are shaded and bolded. 
 
Percent of WT folding efficiency 
Sample 
37ºC 30ºC 18ºC 10ºC 
∆N-A334V 134.3±7.0 99.9±2.5 109.0±2.9 105.0±0.6 
G244R-A334V  64.6±32.1 97.3±5.9 107.3±3.5 103.6±1.2 
∆N-G244R 6.3±2.5 73.1±8.1 107.3±3.4 105.0±1.5 
∆N-G244R-A334V  73.9±22.0 97.0±3.1 109.9±1.8 105.6±1.1 
V141A-A334V  8.7±7.0 16.6±7.7 62.5±9.0 52.9±7.8 
L144A-A334V  0.7±0.5 1.3±1.1 28.7±8.8 29.7±13.4 
F152A-A334V  6.6±4.9 0.0±0.0 11.5±9.1 13.8±3.9 
I167A-A334V  0.2±0.2 0.0±0.0 32.6±10.7 46.8±15.4 
L179A-A334V  0.1±0.1 0.0±0.0 21.9±9.0 49.6±16.1 
M195A-A334V  0.1±0.1 0.1±0.0 43.7±17.8 72.9±10.9 
L262A-A334V  0.3±0.4 0.5±0.5 16.8±5.0 35.2±14.6 
G277A-A334V  0.3±0.4 0.2±0.2 7.2±1.4 20.6±6.5 
F282A-A334V  1.0±0.9 0.3±0.1 79.6±18.3 90.4±6.3 
F284A-A334V  0.1±0.1 0.0±0.0 42.2±8.8 75.7±1.7 
G300A-A334V  0.4±0.4 1.2±0.3 101.7±3.0 102.0±3.6 
F308A-A334V  0.0±0.0 0.0±0.0 5.8±3.1 25.2±9.7 
N310A-A334V  0.2±0.2 0.0±0.0 67.2±8.7 90.6±5.9 
N319A-A334V  0.1±0.1 0.0±0.1 89.6±6.0 99.3±3.6 
G324A-A334V  0.1±0.1 0.8±1.0 99.3±5.9 100.2±2.3 
G329A-A334V  0.4±0.5 8.5±3.1 108.5±3.7 98.0±1.3 
F336A-A334V  0.3±0.4 0.5±0.5 101.2±7.5 90.9±9.3 
L379A-A334V  0.2±0.2 0.0±0.0 2.4±2.2 3.8±2.1 
F381A-A334V  0.0±0.0 0.0±0.0 0.0±0.0 0.1±0.0 
G393A-A334V  0.6±0.7 0.1±0.0 0.8±0.9 2.3±1.1 
L396A-A334V  0.1±0.1 0.0±0.0 0.2±0.2 1.3±1.0 
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Sample 37ºC 30ºC 18ºC 10ºC 
L424A-A334V  0.4±0.3 3.9±1.7 16.4±3.6 31.8±12.9 
H426A-A334V  0.1±0.1 0.8±1.1 1.2±1.1 1.7±1.6 
F441A-A334V  0.6±0.6 0.1±0.1 0.4±0.5 0.0±0.0 
G445A-A334V  0.8±0.6 0.0±0.0 0.5±0.6 0.0±0.0 
I453A-A334V  0.5±0.7 0.4±0.5 0.0±0.1 0.0±0.0 
F472A-A334V  1.0±0.7 0.1±0.1 1.2±1.0 1.5±1.0 
I475A-A334V  0.6±0.6 0.3±0.3 0.6±0.5 0.3±0.3 
I492A-A334V  0.8±0.6 0.7±0.5 0.8±0.3 2.0±1.2 
C496A-A334V  0.4±0.2 0.3±0.4 0.1±0.1 0.0±0.1 
V537A-A334V  49.5±33.7 63.3±9.6 60.1±9.3 54.9±17.0 
H610A-A334V  0.2±0.3 0.2±0.2 0.0±0.0 0.0±0.0 
C613A-A334V  0.4±0.2 0.2±0.1 0.0±0.0 0.1±0.1 
D632A-A334V  1.3±0.6 0.1±0.1 0.2±0.2 0.4±0.3 
C635A-A334V  1.9±0.7 2.7±1.1 3.7±2.1 4.6±2.0 
P638A-A334V  2.6±0.7 1.9±1.0 9.2±0.2 29.4±5.4 
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2. Mutant Folding Efficiencies at 37ºC and 30ºC 
 
Folding spine mutants, as well as single alanine mutations in the cysteine annulus 
of the P22 tailspike, were previously shown to be deficient in folding at both 37ºC and 
30ºC. This proved to be the case despite the presence of the A334V suppressor mutation 
(Figure 7-1). The suppressor mutant was completely incapable of rescuing any folding 
spine or cysteine annulus mutant back to wild-type-like folding efficiencies at 37ºC and 
30ºC. For mutants that produced some amount of trimeric tailspike at these temperatures, 
the presence of the A334V suppressor did not significantly alter the folding of the 
mutant. This can be best seen with the mutation V537A, where the average folding 
efficiency of the single mutant was within a single standard deviation of its 
corresponding double mutant. 
Although A334V did not significantly rescue any of the folding spine mutants, it 
did significantly hinder the folding of at least one of these mutants at 30ºC, V141A. As a 
single alanine mutant, this position displays a folding efficiency of 40±12%, but in 
conjuncation with the A334V mutation this mutant displays a folding efficiency of 
17±8%. These values do not statistically overlap, demonstrating the unexpected result 
that the A334V suppressor might actually enhance folding deficient phenotypes, rather 
than cure them. 
In contrast to the fact that A334V could not rescue the folding of any of the single 
alanine mutations, it was capable of significantly improving the folding of the G244R and 
∆N-G244R control mutations at 37ºC and at 30ºC (Figure 7-1, left side). Although such 
rescue was expected at 37ºC, based on tailspike literature (Danner and Seckler, 1993; 
Fane et al., 1991; Mitraki et al., 1993), the fact that A334V could continue to enhance 
folding efficiencies of G244R mutants at 30ºC was an interesting result. A334V was also 
able to significantly improve the folding of the ∆N tailspike protein at 37ºC, but appeared 
to slightly hinder the folding of ∆N at 30ºC. 
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Figure 7-1. Folding efficiencies of single and double m
utants at 37ºC
 and 30ºC
. The average folding efficiencies of strains lacking 
the A
334V
 suppressor m
utation are represented by colored dots w
ith their corresponding colored standard deviations. A
verage folding 
efficiencies and standard deviations of m
utants containing A
334V
 are show
n as black diam
onds and black bars respectively. C
ontrol 
strains are show
n on the left of the vertical black bar, w
hile alanine m
utants are plotted on the right according to their position in the 
polypeptide sequence. A
 dashed cyan line is draw
n at 75%
 folding efficiency. 
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3. Mutant Folding Efficiencies at 18ºC and 10ºC 
 
At 18ºC and 10ºC, the presence of the A334V suppressor mutation did not 
significantly alter the folding efficiencies of the control mutations tested here, as all of 
these strains appeared to be at their maximal folding yields (Figure 7-2, left side). 
In contrast, the presence of the suppressor mutation rescued a handful of folding 
spine mutations back to wild-type-like folding efficiencies (Figure 7-2, Table 7-2). The 
positions of the mutants rescued by A334V at 10ºC lie between residues number 282 and 
336, and include the single alanine mutations F282A, F284A, G300A, N310A, N319A, 
G324A, G329A, and F336A. Of these mutants, only F284A and N310A were not rescued 
back to wild-type-like folding efficiencies at 18ºC, but were still significantly improved 
in their folding by the intragenic presence of A334V at this temperature. 
Rescued alanine mutants are located close in sequence to the suppressor mutation. 
Some positions farther in sequence from the suppressor were also significantly improved 
in folding efficiency, though not enough to be classified as wild-type-like folders. These 
mutations include M195A at 10ºC, V537A at 18ºC and 10ºC, and P638A at 10ºC. 
A number of mutations were significantly hindered in folding by the presence of 
the A334V mutant, particularly when expressed at 18ºC. These include I167A, L179A, 
G393A, L424A, I453A, I492A, C496A, and P638A. 
 
4. A Region of Rescue 
 
A334V rescues a handful of positions located close in sequence to itself at 18ºC 
and 10ºC. Although this can be seen in a general comparison of the folding efficiencies of 
single alanine mutants and their double mutant counterparts (Figure 7-2), the effects of 
the secondary-site mutation are most obvious when the exact percentage difference in 
folding efficiencies are calculated (Figure 7-3). For example, these differences highlight 
the rescue that A334V affords the G244R mutant in the full length and ∆N constructs. At 
37ºC, A334V rescues G244R by 60 to 70%, while this rescue is only 15 to 25% at 30ºC. 
When these constructs are expressed at 18ºC and 10ºC, rescue drops to nil.
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Figure 7-2. Folding efficiencies of single and double m
utants at 18ºC
 and 10ºC
. The average folding efficiencies of strains lacking 
the A
334V
 suppressor m
utation are represented by colored dots w
ith their corresponding colored standard deviations. A
verage folding 
efficiencies and standard deviations of m
utants containing A
334V
 are show
n as black diam
onds and black bars respectively. C
ontrol 
strains are show
n on the left of the vertical black bar, w
hile alanine m
utants are plotted on the right according to their position in the 
polypeptide sequence. A
 dashed cyan line is draw
n at 75%
 folding efficiency. 
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For the single alanine mutants, 18ºC and 10ºC rescue values highlight the region 
just N-terminal to the position of the global suppressor (Figure 7-3). These positions not 
only include the mutants that became wild-type-like folders in the presence of A334V, 
but also include a number of other mutants that are significantly rescued by the 
suppressor, including M195A which displays a significant rescue value of 30% at 10ºC. 
When the positions that are rescued by the A334V suppressor mutation back to 
wild-type-like levels, or alternatively are rescued by 50% or more at either 18ºC or 10ºC, 
are analyzed, the positions highlight a cluster of residues in rungs 4, 5 and 6 (Figure 7-4). 
Although these positions are in the general vicinity of the suppressor mutation, only one 
of these positions, F336, directly contacts the alanine at position 334 in the wild-type 
structure. Amongst the folding spine residues, the second closest position in space to 
alanine 334 is F308, whose alanine mutant cannot be rescued by the suppressor or by any 
temperature. Figure 7-4 also shows the positions of temperature sensitive mutants that 
were listed in the literature as being rescued by the global suppressor. These positions 
highlight the same region that the rescued folding spine positions highlight, as well as the 
dorsal fin. Folding mutants in this central portion of the β-helix appear to be rescueable 
by the A334V suppressor mutation. 
 
5. A334V Hinders Folding of Distant Folding Spine Residues 
 
Single alanine mutants outside the central rungs (4 – 6) of the β-helix have a 
greater tendency to be hindered by the presence of the suppressor mutation rather than be 
rescued by A334V (Figure 7-3). At 30ºC, 18ºC, and 10ºC, rescue values indicate that a 
number of single alanine mutations are significantly hindered by the presence of the 
suppressor mutation. These mutants, such as V141A at 30ºC, have negative rescue values 
that are significantly different from zero. The majority of these hindered positions are 
distantly C-terminal to the suppressor position. Many of these positions were hindered 
between 40 and 60% by the presence of the suppressor mutation. These are significant 
values, given that A334V rescues G244R by 60% at 37ºC. 
 
 157 
 
 
Figure 7-4. Locations of A334V rescued mutants. The native positions of folding spine 
mutants that are rescued back to wild-type-like folding efficiencies (>75%) by the 
presence of A334V (green) are shown in cyan, while the positions of other alanine 
mutants that are not rescued by A334V are colored red. Positions colored blue represent 
temperature sensitive mutations that have been previously published as being rescued by 
the suppressor mutation A334V. 
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D. DISCUSSION 
 
 
1. A334V is Not a Global Suppressor 
 
A334V and other suppressors of temperature sensitive folding defects were 
originally classified as global suppressors because they appeared to rescue the folding 
defects of all mutants tested via a general mechanism of suppression. Since the 
suppressor mutants thermodynamically stabilized the isolated β-helix domain, it was 
suggested that the generic mechanism of suppression was through a stabilization of the β-
helical folding domain (Schuler and Seckler, 1998). 
The results presented here demonstrate that the suppressor mutation A334V is not 
a global suppressor. This mutant is not capable of rescuing a number of alanine mutations 
located in the core of the β-helix that block the folding of the tailspike protein. In fact, 
A334V’s pattern of suppression of folding spine mutations is position specific and is 
isolated to a specific region of the β-helix between rungs 4 and 6. This suggests that the 
mechanism by which A334V rescues folding defects is not by stabilizing the entire β-
helix domain. If suppression occurred through enhanced thermostability of the β-helix 
domain, one would expect the suppressor to rescue positions in a manner more consistent 
with the type of mutations that are generated, rather than by location in the structure. 
A number of folding defective alanine mutations are further hindered in folding 
by the presence of A334V. Since A334V has been shown to stabilize the β-helix, these 
results demonstrate non-additivity in the folding of the double mutant tailspike protein 
sequences. This precludes the possibility that the partitioning between productive folding 
and aggregation is dependent on the thermostability of the β-helical folding intermediate. 
 
2. A Nucleus for Folding 
 
If the suppressor mutation does not enhance productive protein folding through 
the thermodynamic stabilization of a β-helical folding intermediate, then perhaps it acts 
by stabilizing an earlier folding intermediate or a particular kinetic transition in the 
folding of the β-helix domain. Based on the nucleation-elongation mechanism proposed 
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in Chapter 2, the A334V mutant may be stabilizing a nucleus for folding or rescue only 
those mutations that disrupt the folding of the nucleus. The central region of the β-helix 
between rungs 4 and 6, where the suppressor mutation rescues folding spine mutations, 
most likely highlights this nucleus for folding. 
If it is true that the A334V mutation acts by stabilizing a folding nucleus, then the 
non-additivity observed for mutations C-terminal to the suppressor is likely the result of 
the formation of a structure with a stable nucleus that is hindered in elongation by the 
folding spine alanine mutant. Such a combination of mutations would cause polypeptide 
chains to populate a conformation that is partially folded in the central part of the β-helix, 
likely exposes hydrophobic regions, and is highly prone to aggregation. 
How does the suppressor mutation stabilize a nucleus for folding? Seckler has 
suggested that the substitution of valine for alanine at position 334 improves an internal 
hydrophobic stack, given that A334 is sandwiched between I306 and V362 in a buried 
core stack. The existence of the folding spine highlights the importance of key stacking 
positions for registration of one β-strand against the next in the β-helix topology. The 
A334V substitution may rescue folding spine alanine mutations in the nucleation region 
by stabilizing the proper registration of β-strands in the nucleus region. Alternatively, 
alanine mutations remove the necessary information for registering rungs against each 
other while the valine substitution at position 334 provides alternative information for β-
sheet registration. 
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CHAPTER EIGHT: 
 
 
FINAL DISCUSSION 
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A. SUMMARY OF CHAPTERS 
 
Side chain stacking is a structural phenomenon that is a prominent component of 
protein structures, such as amyloid fibers and the β-helix fold, that are involved in a 
number of human illnesses. Neurodegenerative diseases such as Alzheimer’s, 
Huntington’s, and Parkinson’s disease are coincident with the formation and 
accumulation of amyloid fibers at the sites of neuronal loss. Some allergies are the result 
of an immune response to the β-helix structure of antigens. The toxins responsible for 
whooping cough are β-helical in nature. At the end of Chapter 1, the question was posed 
as to how the amino acid sequence involved in side chain stacks directs the folding of 
these proteins. 
 This question was initially investigated in Chapter 1 by reviewing the known 
cases of side chain stacking. β-helix proteins, the amyloid crystal structure, and leucine 
rich repeat proteins all display varying degrees of side chain stacking. In the case of the 
amyloid crystal structure, side chain stacking involved identical residues stacking with 
identical orientations. In contrast, β-helix proteins tend to lack any form of sequence 
repeat between rungs, and β-helix stacks readily tolerate sequence identity mismatches. It 
was further observed that for the right-handed parallel β-helix structures, side chain 
stacking was more highly organized inside the buried cores of the proteins, while external 
side chain stacks were more structurally disorganized. 
To address the question of how the amino acid sequence of buried core residues 
directs the folding of β-helix proteins, scanning alanine mutagenesis was performed on 
the buried core stacks of the P22 tailspike. In Chapter 2, alanine mutants of the buried 
core of the P22 tailspike were assayed for their ability to fold in the context of the cell. 
These experiments demonstrated that the buried core of the tailspike protein is 
surprisingly sensitive to alanine mutations at high expression temperatures. At lower 
temperatures, alanine mutations are tolerated more readily, though a core set of positions 
are completely intolerant to alanine substitution. These positions highlight a network of 
continuously contacting residues called the folding spine. The results of these 
experiments led to the proposal at the end of Chapter 2 that the β-helix domain of P22 
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tailspike folds through a step-wise nucleation-elongation mechanism, where a nucleus of 
a few rungs forms and acts as a template for subsequent rungs to wind up against. In this 
folding mechanism, the folding spine residues represent the necessary information for 
creating key contacts that dock one rung to the next. The remaining chapters of this thesis 
were dedicated to testing this model for the folding pathway of the P22 tailspike β-helix 
domain. 
In Chapter 3, the native state stabilities of mutant tailspike proteins were assayed 
to determine if the alanine mutants investigated in Chapter 2 failed to accumulate native, 
trimeric tailspike proteins at various in vivo expression temperatures because the 
mutations destabilized the native state. A general thermostability assay demonstrated that 
all but one of the mutant proteins carrying alanine substitutions had melting temperatures 
between 80ºC and 90ºC in the presence of 2% SDS. Since these conditions are much 
harsher than that experienced by nascent chains folding in cells at the temperatures tested, 
the results established that the folding defects caused by single alanine mutations were 
not due to a destabilization of the native state. 
To determine whether the buried core alanine mutants acted at the level of the 
folding of the β-helix domain of the full length tailspike protein, a small subset of 
mutants were investigated in the context of the isolated β-helix domain in vivo. The 
folding of the mutant βHX proteins was assayed by their solubility. The temperature 
sensitive folding phenotypes discovered for mutants in the isolated β-helix was consistent 
with those seen in the full length tailspike proteins. These experiments demonstrated that 
the inability of mutant chains to reach the native trimeric state in Chapter 2 was due to a 
defect in the folding of the β-helix domain. 
Another important observation made in Chapter 4 is that multiple aggregation 
pathways exist for the P22 tailspike. This conclusion was borne out from the generation 
of ∆N-6H and βHX sequences. The ∆N-6H polypeptide chain was highly aggregative 
and was incapable of forming native, SDS-resistant trimers. βHX, which was identical in 
sequence to ∆N-6H except for the lack of the C-terminus of the tailspike protein, was 
able to form soluble, natively folded β-helix proteins. Therefore, in the case of ∆N-6H, 
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the C-terminus of the protein was responsible for aggregation while another aggregation 
pathway must be present for folding defective βHX mutants. 
In Chapter 5, the in vitro refolding of full length tailspike mutants was assayed to 
determine if the sequence of these mutants alone is sufficient to cause the observed 
folding defects. Inclusion bodies were purified and denatured tailspike chains were 
investigated for their ability to refold to the native state. The competence of tailspike 
mutants to refold in vitro was consistent with in vivo folding phenotypes. The kinetics of 
refolding was also consistent with previously published half-times. Although in vitro 
folding yields were often reduced in comparison to the calculated in vivo folding 
efficiencies, the kinetics of refolding demonstrated that possible inclusion body 
contaminants did not have a significant effect on the folding of the tailspike. This 
indicates that the amino acid sequence of the tailspike polypeptide chains alone is 
sufficient to encode the folding of the protein. Further, the refolding experiments 
demonstrated that single alanine substitutions are sufficient for blocking the folding 
pathway. 
In vitro refolding experiments were extended to the refolding of wild-type βHX 
and F308A-βHX proteins. These species were purified under denaturing conditions in 
Chapter 6 and equilibrium refolding experiments were monitored by fluorescence. The 
observed fluorescence signals indicated that the F308A mutation does in fact block the 
folding of this domain. However, the observed fluorescence values for F308A-βHX at 
low denaturant concentrations indicated that some burial of tryptophans occurs at low 
urea concentrations. This likely implies that the mutation F308A partially folds or 
collapses into an aggregation prone conformation. 
The final test of the nucleation-elongation model was to ask whether the global 
suppressor mutation A334V could rescue folding spine mutations and demonstrate the 
existence of a folding nucleus. In Chapter 7, double mutants of the full length tailspike 
sequence were expressed in vivo and analyzed for the ability to form native trimers. 
Comparing the folding of single alanine mutations with the folding of double mutants 
containing A334V highlighted a region of residues in rungs 4, 5, and 6 that were rescued 
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by the suppressor mutation at 18ºC or 10ºC. I propose that this region represents a 
nucleus for the earliest of folding events in the β-helix domain. 
Other folding spine residues could not be rescued by A334V and a number of 
mutants had significantly hindered folding efficiencies upon the introduction of the 
A334V mutant. The fact that A334V cannot rescue all mutations demonstrates that this 
mutant is not in fact a global suppressor. Although it has been previously demonstrated 
that A334V thermodynamically stabilizes the β-helix, the non-additivity of folding 
phenotypes of A334V and folding spine double mutants indicates that the 
thermodynamics of a native-like β-helix folding intermediate is not the primary controller 
of the folding of the β-helix domain. Instead, it appears that A334V stabilizes or 
kinetically enhances the population of a nucleus for β-helix folding. 
 
 
B. MEDICAL IMPLICATIONS 
 
As we come to better understand the basic principles behind misfolding and 
aggregation, we can begin to design therapeutics that aim to cure protein misfolding 
diseases. Already, a number of methods are utilized to combat these diseases. These 
methods fall into two categories: rational design and chemical library screening. 
For example, a number of nonsteroidal anti-inflammatory drugs have been 
developed that specifically stabilize the native, tetrameric state of transthyretin (Miller et 
al., 2004). Stabilization of the native state prevents dissociation of the tetramer, which is 
a necessary step towards the progression of amyloid formation (Colon and Kelly, 1992). 
In the case of serpin polymerization, small peptides have been designed to bind into the 
middle strand position of β-sheet A, thereby blocking mobile loops of other proteins from 
intermolecular binding in that position and proceeding towards polymerization (Zhou et 
al., 2004). These two methods of therapeutics design are successful because they target 
native structures and prevent the disruption of that structure by aggregative processes. 
The alternative discovery method has been applied to finding chemicals that can 
disaggregate amyloid fibrils associated with Alzhiemer’s disease. This process resulted in 
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the discovery of 4,5-dianilinophthalimide (DAPH) which is capable of reversing Aβ(1-
42) fiber formation, though the mechanism of action is currently unknown (Blanchard et 
al., 2004). Alternatively, this type of drug discovery process was used to find small 
chemicals that enhance inclusion formation (Bodner et al., 2006). These enhancers of 
aggregation alleviated some of the toxic effects of amyloidgenic Huntingtin protein and 
α-synuclein. It appears that forcing these proteins into inclusions prevents the protein 
from populating toxic species. 
These methods of drug discovery and design have also been used to target 
pathogens, such as pathogenic gram-negative bactera. One example is the discovery of a 
pentadecapeptide that binds and inhibits the β-helical protein LpxA (Williams et al., 
2006). LpxA catalyzes the first step in lipid A biosynthesis and is essential for growth. 
Inhibition of this protein therefore makes this pentadecapeptide a powerful antibiotic. 
As can be seen from these examples of designed and discovered drugs, the main 
focus of modern therapeutics is to target the end states of the folding and aggregation 
processes. Drugs are either designed or screened for their ability bind the native state of a 
protein or to act on formed fibers. In the case of amyloidosis, this may not be ideal if the 
toxic species are small oligomeric species that would become more populated upon fiber 
disaggregation. Instead, a processive folding mechanism provides a new target for drug 
design against a number of diseases associated with β-helical proteins and protein relying 
on side chain stacking. 
For example, it is reasonable that instead of blocking the interactions between an 
infective β-helix and its recognition factor, drugs may be designed to hinder the folding 
process. These may be particularly useful for combating disease-associated 
autotransporter β-helix proteins, whose folding and translocation are coupled (Otto et al., 
2005). Inhibition of the folding process would prevent maturation of toxicity. It is clear 
that the core of the P22 tailspike β-helix is surprisingly sensitive to environmental factors 
and mutational effects, which can cause unrecoverable folding inhibition under 
physiological conditions. The same may be true for the folding of other structures that 
display side chain stacking. Therefore, side chain stacks and their associated folding 
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intermediates may represent an assortment of targets for inhibition of the step-wise 
folding or assembly of these proteins. 
Since the β-helix class of proteins is rare and primarily specific to the microbial 
world, drugs of this type would benefit from specificity towards the infectious agent. 
Drugs capable of inhibiting β-helix formation may offer an effective mechanism for 
preventing selected microbial and viral infections. 
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APPENDIX A. GELANALYZER PLUG-IN FOR IMAGEJ 
 
Commercial 1D gel analysis software is readily available from a number of 
commercial suppliers. These software packages, such as ImageQuant (MD), allow for the 
quantification of optical densities of bands in electrophoresis gels, an activity that proved 
indispensable in this thesis. However, many of these programs suffer from a number of 
limitations that restrict their usefulness, such as operating system dependencies, the 
expense of the software, the inability to correct mistakes, and limits on the number of 
samples that can be analyzed at one time. Many of these software programs are laborious 
and time consuming, particularly when attempting to analyze a 102-lane gel image. 
In order to overcome many of the drawbacks inherent in commercially available 
gel analysis programs, I developed the GelAnalyzer plug-in for the freely available image 
processing software ImageJ (Wayne Rasband, National Institutes of Health, USA). 
Although ImageJ has its own methods for performing optical densitometry analysis, these 
routines suffer from many of the same problems as the commercial software. For example, 
there is currently no way to undo mistakes without having to start the process over entirely. 
ImageJ also only allows for the selection of perfectly rectangular lanes, and does not allow 
for lanes that shift, which is a common occurrence in scanned gel images. GelAnalyzer was 
specifically developed to take advantage of the established framework of the Java-based 
ImageJ program while making the process of gel analysis straight forward, flexible, and 
accurate. 
Like ImageJ, the plug-in was written in the Java programming language, making it 
cross-platform. The plug-in is also freely distributed and can be installed in one step, 
making it readily accessible to any individual interested in performing gel analysis. The 
source code for GelAnalyzer is packaged with the program, allowing software developers 
the option of expanding GelAnalyzer or using its methods as a library for other programs. 
Once a gel image is opened in the ImageJ program, the plug-in can be started 
from ImageJ’s plug-in menu. The plug-in displays a graphical user interface (GUI) for 
the user, which takes the user through the five basic steps of analyzing a gel: orientation 
of the image, calibration of the image, marking lanes, subtracting background, and 
identifying and analyzing band peaks. At any point in the process, the user can save 
whatever progress has been performed on the current image or load progress from a 
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previous analysis run. All selected values for each step of the analysis are saved in the 
text-formatted progress file. 
 
1. Image Orientation 
 
Although the GUI is the main control center for the analysis process, the user can 
still interact with the image using many of the ImageJ tools. This is readily observable in 
the first phase of gel analysis, image orientation. The image orientation panel provides 
two main methods of rotating the image, either by automated detection of features or by 
manual inputting rotation values. 
Two options are currently implemented for automated orientation of the gel 
image. The first is based on the detection of a step tablet, while the second attempts to 
recognize the gel itself. Neither of these methods are guaranteed to provide the desired 
results, but the reliability of their detection algorithms may increase with time. Currently, 
the step tablet recognition algorithm, which relies on identifying the darkest and lightest 
spots on the image and predicting where the corners of the tablet are based on these 
values, appears to perform more reliably than the gel detection algorithm. Gel detection 
implements a modified Sobel filter to detect band edges. The algorithm then attempts to 
calculate the median directionality of detected bands, and rotate the gel accordingly. 
Manual orientation has so far proven the most reliable method for rotating for gel 
analysis. The user can input a desired angle of rotation and tell the program if the image 
should be flipped in the vertical or the horizontal directions. The user may use ImageJ’s 
line selection tool to draw a line over a desired image feature and ask the plug-in to make 
the line selection horizontal. The program will automatically calculate the desired angle 
of rotation with respect to the original image’s orientation and report that angle back to 
the user. 
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2. Image Calibration 
 
Image calibration is a necessary step for reliable optical densitometry evaluations. 
Images may be scanned using different scanners or different scanner settings, which 
changes how a black or white pixel value in an image is related to absolute values of 
optical density. This is also important because the relationship between optical density 
and pixel value is rarely a linear function, but more often is a logarithmic function. 
If an image is not scanned with a step tablet or without a step tablet of known 
optical density values, then the user has the option of calibrating the image using 
ImageJ’s built-in calibration function “Uncalibrated OD”. Although this is not the most 
accurate method of calibration, it does at least attempt an exponential relationship 
between optical density and pixel value. 
Alternatively, the user may interact with the step tablet outlining tool that is 
displayed on the image. This tool is a modified and enhanced version of ImageJ’s region 
of interest (Roi) selection boxes. It can therefore be resized and relocated at will. The 
height and the amount of sampling to calculate pixel values can be adjusted in the GUI’s 
calibration panel. The number of steps as well as each step’s width and OD value can be 
adjusted using the displayed table interface. The calculated average pixel value for each 
step is automatically recalculated any time the step tablet is changed. Finally, the type of 
function that will be used to map pixel values to optical densitometry values can be 
selected from amongst 12 built-in options. However, every time the step tablet is adjusted 
and the average pixel values of steps are calculated, the fit function yielding the best fit is 
automatically calculated and displayed in its selector. 
Once the user has outlined the step tablet, selected the appropriate fit function, 
and pressed the calibrate button, the image’s pixel values are calibrated according to the 
inner mechanisms of ImageJ’s calibration and function. Pixel values can be automatically 
transformed into optical density values. 
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3. Marking Lanes 
 
Once the image is calibrated, the gel lanes are ready to be marked. Although the 
gel selection panel does not currently have methods for automatic lane or band detection, 
the java programming interface allows for such methods to be easily incorporated into the 
program if they are developed. 
Currently, gel lanes must be traced manually. A set of templates for common gel 
sizes and numbers of lanes are incorporated into the program for easy selection. Like the 
step tablet selection tool, the gel selection tool is an extended version of ImageJ’s roi 
selectors. Therefore, the user can resize or translate the gel in the image window. 
Alternatively, the lane width, lane length, and directionality of the gel can be determined 
in GelAnalyzer’s GUI. It is an important component of gel analysis that all lanes have the 
same width because the average optical density is calculated of a band is calculated as the 
average OD across the width of the lane. In order for all lanes to share the same amount 
of noise in this calculation, lane widths are kept constant across all lanes. 
Lanes can be individually placed using the GUI’s input table. Lanes can also be 
named, either by manually typing in the lane names or by loading the lane names from a 
comma-delimited file. In order to correct for possible lane shifting, lanes can be 
manipulated individually on the gel image once the “Individual Lanes” adjustment mode 
is selected. The lane selection tool is a spline tool, where the center of the lane is 
determined by a spline through a set of node points. This allows for curvature in the lane 
and let’s the user define specific locations that the center of the lane must pass through. 
Nodes can be added or removed by holding down the “alt” key while clicking on the 
image window. The lane selection tool is also a type of roi selector, and thus it can be 
translated at will. 
It is important to note that although the spline allows for curvature in a lane, the 
profile plot of the lane is calculated as the average OD over a given width of pixels at a 
specific pixel height in the image. The profile plot does not adjust its calculation to take 
into account the angle of curvature in the lane. 
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4. Background Subtraction 
 
Once lanes have been selected, the GelAnalyzer plug-in automatically calculates 
the plot profile of the lane as the average optical density at each integral pixel position 
along the height of the lane. The user is then offered the option to correct individual lanes 
by a specified background lane. This is a useful tool if the user desires to remove the 
background staining of the gel itself, based on a lane not loaded with any sample, or if the 
user wishes to subtract the background bands of a control sample. 
Each lane or all lanes can be selected as background, as being corrected by the 
background lane, or for not being corrected at all. In the current version of the program, if 
multiple lanes are chosen as background, then the average profile plot of these lanes is 
calculated as the background to use for subtractions. The background selection tool 
allows for the input of a horizontal offset of the current lane in comparison to the 
background profile plot. This enables the user to correct for smiles in the gel that causes 
the same bands in different lanes to run at slightly different positions from each other. 
Although this kind of correction would ideally allow for horizontal scaling to align peaks 
with each other, the program does not currently implement that ability. Offsets can be 
calculated by an algorithm that attempts to match up peaks, though this automated 
algorithm is not guaranteed to work often offsets lanes about one to two pixels off from 
the ideal horizontal offset. 
Since some lanes may stain differently than other lanes, scalars can be applied to 
each lane in order to have the baselines of the background match the baselines of the 
sample lane. An algorithm is provided that calculates the ideal scalar for matching the 
median OD values of the two lanes. This algorithm was used so as to attempt to match 
the baselines of the lanes, which ideally are the most prevalent OD value in each lane. 
When determining the background, scalars, and offsets of each lane, profile plots 
are shown depicting the relative values of the raw profile plot, the background profile 
plot, and the final adjusted profile plot if the lane is selected for background correction. 
These plots are updated any time a change is made to the lane’s offset or scalar in order 
to visually aid the user. 
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5. Peak Analysis 
 
Having defined lanes and defined whether sample lanes are to be corrected by 
background lanes, the user can analyze the individual peaks in each lane. When this panel 
of the GelAnalyzer GUI is first opened or anytime the lane and background definitions 
are changed, an automated peak detection algorithm run in an attempt to detect all of the 
peaks. This algorithm scans the profile plot for any local maxima in the plot and defines 
those positions as peaks. This is not ideal, in that smoothing of the profile plot may 
produce fewer spurious peaks 
For each lane, the user can specify a variable number of peaks and can name each 
peak individually. Each peak can be selected graphically or a horizontal apex position can 
be typed into the peaks table. Once a new apex value is given to the program, it will 
automatically recalculate where the nearest apex is for the selected peak and will try to 
detect the upper and lower limits of the peak. The user can also manually adjust the 
bounds of the peak. Peaks bounds are displayed in the gel image so that the user can 
compare peak locations across lanes and can visually see where in the gel the peak is 
located. The number of peaks in a lane, the peaks’ names, the peaks’ values, and the 
peaks’ bounds can be individually selected for each lane or can be applied to all lanes. 
A baseline value can also be adjusted for calculating the integrated optical density 
of the peak. The baseline can be assigned a specific numerical value to set as a flat 
baseline for the entire profile peak. Most often, this baseline would be set to 0.0. 
Alternatively, the user can set the baseline mode to be sloped, which will calculate a 
linear sloped baseline from the minimum bound of the peak to the maximum bound of 
the peak. This baseline can be adjusted individually for each lane, or can be set for all 
lanes in the gel. 
Once the peaks are defined, the positive integrated optical density between the 
profile plot and the baseline is automatically calculated. This represents the optical 
density for that protein band, while the apex value represents the distance migrated. 
These values can be saved in a comma-delimited file that can be read by most data 
analysis or spreadsheet software. 
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APPENDIX B. HIS-TAGGED TAILSPIKE CONSTRUCTS 
 
When β-helix mutants were initially investigated for their ability to fold in vitro in 
the context of the full length tailspike protein, his-tagged constructs of these mutants 
were prepared. Dr. Peter Weigele and Phil Campbell cloned the wild-type gene 9 
sequence into a pET21b vector using the BamHI and NdeI restriction digest cloning sites. 
The use of these cloning sites added a total of 22 amino acids to the end of the protein. 
DNA sequencing confirmed the addition of the amino acid sequence 
“ADPNSSSVDKLAAALEHHHHHH” to the C-terminus of the protein. This plasmid, 
termed pET(TSPK:H6), was subsequently used as a template for site directed 
mutagenesis, as performed in Chapter 2. Resulting plasmids were confirmed by 
sequencing and were transformed into BL21(DE3) cells in preparation for over-
expression. 
Over-expressed proteins were purified under denaturing conditions using a Ni-
NTA metal affinity column to purify the his-tagged tailspike proteins. Proteins were 
purified to >90% purity. As a control for the purification of proteins under denaturing 
conditions, wild-type his-tagged tailspike proteins were purified under native conditions 
from the supernatant fraction of the same over-expression culture used to produce the 
wild-type proteins for denaturing purification. Natively purified wild-type his-tagged 
chains were named WN, while wild-type his-tagged chains purified under denaturing 
conditions were called WD. 
After an one hour incubation in 8 M urea at pH 3, proteins were examined for 
their ability to refold as performed in Chapter 5. While WN was able to refold, none of 
the other tailspike sequences were able to refold under the tested conditions. In this 
experiment, WD was also unable to fold to a native trimeric form and instead aggregated 
as determined by native gel electrophoresis. 
Various experimental conditions were adjusted in an attempt to get the WD 
sample to refold like the WN sample. As a control for this experiment, wild-type tailspike 
protein that lacked the his-tag was also simultaneously refolded. Various purification and 
unfolding buffers were examined for their effects on the tailspike chains. In the initial 
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purification, 7 M urea of varying pH from 8 to 4.6 were used to bind, wash, and elute the 
tailspike protein from the nickel column. The denaturing purification buffers were 
adjusted to elute the proteins with varying concentrations of immidazole at pH 8. The 
denaturing buffers were further adjusted to replace urea with 6 M guanidine 
hydrochloride. Independent of the buffer conditions used to purify the wild-type his-
tagged tailspike protein under denaturing conditions the WD sample would not refold. 
The unfolding buffer used before dilution with refolding buffer was also adjusted. 
Initial investigations used an 8 M urea solution at pH 3.0, as the natively folded tailspike 
protein will not unfold at neutral pH even in high concentrations of urea. Further 
investigations used the neutral pH buffer used in Chapter 5. Independent of the unfolding 
buffer used, the WD sample did not refold. This is in contrast to the data presented in 
Chapter 5, which demonstrated that the wild-type full length tailspike protein was able to 
refold out of aggregated inclusion bodies. 
Further experimentation demonstrated that the inability to refold was not rescued 
by the presence of DTT or BME. The introduction of 1,10-phenanthroline, an iron 
chelator, or the additon of iron sulfate did not influence the folding of the WD or WN 
samples. Experimentation did not reveal any conditions under which the WD protein 
samples were able to refold to a trimeric tailspike protein. 
In contrast, it was discovered that incubation in 6 M urea at pH 3.0 at 10ºC for an 
extended period of time, approximately 5 days, caused the WN sample to no longer be 
able to refold. A control reaction of natively purified, wild-type tailspike lacking the 
histidyl tag was simultaneously examined. After 5 days of incubation in an acidic urea 
solution, the wild-type tailspike lacking a his-tag was still able to refold as it had after 
one hour of incubation. The results indicate that the C-terminal 22 amino acid tag that 
includes six histidines was sensitive to the presence of denaturants in a time-dependent 
manner. 
We hypothesized that the observed sensitivity was likely due to chemical 
modifications of the protein, most likely in the C-terminal tag. The MIT biopolymers 
group analyzed WN and WD samples by mass spectroscopy to determine if any 
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molecular weight differences existed between proteins in the two stock samples. Initial 
Maldi analysis revealed that a molecular weight difference of 154 daltons. Trypsin digest 
followed by ion spray or Maldi demonstrated that two extra bands resulted from digestion 
of the WN sample that were not present in the WD samples. The molecular weights of 
these bands, however, did not map to expected masses from in silico digests. 
Upon attempting to purify these tailspike proteins by HPLC in preparation for 
repeating the mass spectrometry experiments, samples behaved unexpectedly. Samples 
either stuck to the column or samples eluted in broad and mixed peaks. 
When the above mass spectrometry experiments were repeated with stock sample 
that had been refrigerating for nearly two months, no mass difference could be detected. 
To date, it is unclear what modifications or interactions may have been occurring 
to cause the observed inability to refold. The only clear result is that the 22 amino acid C-
terminal tag was likely responsible in a manner dependent upon long time exposure to 
denaturant. 
